Home Blog Page 3

OUD & Chronic Pain Solutions for Patients With Integrative Care

Learn how integrative care can help treat OUD and chronic pain with personalized approaches that promote overall well-being.

Abstract

In this comprehensive educational post, I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, present a unified, evidence-based roadmap for treating opioid use disorder (OUD) and chronic pain through medications for opioid use disorder (MOUD) — specifically buprenorphine, methadone, and naltrexone — integrated with chiropractic care, functional medicine, rehabilitation, and personal injury management. I explain the pharmacology and clinical rationale for each medication; detail standard inductions, high-dose rapid stabilization, and low-dose micro-induction strategies in the fentanyl era; and connect these protocols to a patient-centered plan that restores stability, function, and autonomy.

Our multidisciplinary practice in El Paso, Texas — Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) — operates under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), an internist with 40+ years of experience. Dr. Cardenas serves as our Medical Director and Collaborative Physician, ensuring medical oversight, pharmacovigilance, and alignment with current standards. I deliver integrative chiropractic care to modulate spine-neuro-immune dynamics and biomechanics, paired with functional medicine strategies to reduce inflammation and improve sleep, stress resilience, and metabolic health.

In this post, I take you on a step-by-step journey that covers: why MOUD is lifesaving; how mu-opioid receptor pharmacodynamics inform safety and efficacy; fentanyl-specific challenges and precipitated withdrawal prevention; how Sublocade and Brixadi long-acting buprenorphine injections improve adherence; how Butrans and Belbuca fit into modern pain care; the ethical principles of harm reduction; and how I coordinate chiropractic rehabilitation with MOUD to reduce nociplastic pain and restore movement capacity. Throughout, I cite leading organizations and researchers using modern, evidence-based methods, and I include clinical observations from practice shared at sciatica. clinic and in my professional updates.

Key takeaway: medications for OUD save lives; when we pair them with integrative chiropractic and rehabilitation under medical oversight, we can reduce withdrawal and cravings, address pain drivers, restore function, and help patients reclaim their futures.

About our team-based model and me in El Paso

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. Over three decades of clinical practice, I have focused on integrative, patient-centered care for musculoskeletal injury, chronic pain, and complex neuro-metabolic conditions, including opioid-related complications. Our El Paso clinic, Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), was built to address whole-person health for patients navigating pain, function, and recovery.

  • Medical direction and collaborative care
    • Maria Guadalupe Cardenas, MD (NPI #1164426749; Texas MD License #J2933), Board Certified in Internal Medicine with 40+ years of experience, serves as our Medical Director and Collaborative Physician. Dr. Cardenas oversees medical safety, MOUD protocols, laboratory and cardiometabolic assessment, and comorbidity management to ensure our care aligns with the latest evidence and standards.
  • Integrative chiropractic and functional medicine
    • I provide chiropractic care (spinal and extremity adjustments, neurodynamic interventions, soft-tissue therapies) and rehabilitation (graded exercise, motor control, progressive loading), coordinated with functional medicine to optimize nutrition, sleep, autonomic regulation, and inflammation control.
  • Scope and safety
    • Our integrated pathway leverages medical assessment (labs, ECGs when indicated, medication management), chiropractic biomechanics, rehab, and social determinants of health (SDOH) navigation — helping patients regain function while mitigating risk.

This post reflects our integrated approach and my clinical observations, including insights I share at:

Why medications for opioid use disorder save lives

When I discuss OUD treatment with patients and clinicians, I emphasize a core truth: medications for opioid use disorder are lifesaving. Both buprenorphine and methadone reduce all-cause and overdose mortality, diminish illicit opioid use, and stabilize the neurobiological circuits that drive withdrawal and craving (Substance Abuse and Mental Health Services Administration [SAMHSA], 2021; American Society of Addiction Medicine [ASAM], 2020; National Academies of Sciences, Engineering, and Medicine [NASEM], 2019).

  • Key benefits of MOUD
    • Reduced mortality risk and emergency utilization
    • Reduced illicit opioid use and criminal justice involvement
    • Improved function and engagement in behavioral and rehabilitative care
    • Protection against overdose due to tolerance loss after abstinence
  • Why continuity matters
    • Continuity of MOUD is strongly associated with better outcomes; interruption increases overdose risk due to loss of tolerance (NASEM, 2019; ASAM, 2020).
    • Stabilization enables patients to participate in rehabilitation and movement-based care. In my clinic, this is foundational for successful chiropractic care and functional progress.
  • How we translate evidence to action
    • We prioritize rapid stabilization with buprenorphine or methadone, pair it with naloxone distribution for overdose prevention, and coordinate chiropractic and rehab as soon as cravings and withdrawal are sufficiently controlled to allow safe movement progression.

References:

Mu-opioid receptor pharmacodynamics and safety: translating physiology to practice

Physiology guides my induction strategies and safety planning. Understanding receptor dynamics clarifies why buprenorphine can prevent overdose but also precipitate withdrawal if mistimed.

  • Mu-opioid receptor basics
    • The mu receptor governs analgesia, reward-salience, respiratory drive, and stress response.
    • Full agonists (e.g., fentanyl, heroin, methadone) drive receptor activation to a high level, with high effectiveness for analgesia but dose-dependent respiratory depression.
    • Partial agonists (e.g., buprenorphine) exhibit high receptor affinity but a ceiling effect on respiratory depression — meaning a safer profile for overdose while still suppressing withdrawal and cravings (Dahan et al., 2006; Strang et al., 2020).
  • Why bbuprenorphine’sceiling effect matters
    • As dose increases, buprenorphine’s analgesia continues to improve while respiratory depression plateaus (Dahan et al., 2006). This underpins its outpatient safety profile and is a central reason I prefer buprenorphine for many patients with OUD and comorbid pain.
  • Antagonists and withdrawal
    • Naltrexone blocks mu receptors but offers no intrinsic analgesia; if physiological dependence is present, naltrexone can precipitate withdrawal. It’s best reserved for fully detoxified patients who prefer a non-agonist path (ASAM, 2020).

References:

Medications overview: indications, formulations, and clinical use

I individualize medication choices to align with patient goals, pain phenotype, substance history, and setting. Below is how I think through each medication, with Dr. Cardenas providing medical oversight.

Buprenorphine

  • Indications
    • First-line OUD treatment (ASAM, 2020; SAMHSA, 2021)
    • Chronic pain formulations: transdermal patch (Butrans) and buccal film (Belbuca)
  • OUD formulations
    • Sublingual monoproduct (historically Subutex)
    • Sublingual buprenorphine-naloxone combinations (e.g., Suboxone)
    • Long-acting injectables
      • Sublocade (monthly extended-release)
      • Brixadi (weekly or monthly extended-release)
  • Chronic pain formulations
    • Transdermal patch (Butrans)
    • Buccal film (Belbuca)
    • Parenteral buprenorphine (Buprenex) for acute pain in monitored settings
  • Off-label realities
    • Sublingual buprenorphine (monoproduct or combo) may be used off-label for chronic pain in carefully selected cases, particularly with central sensitization or high-risk opioid exposure (Srivastava, Kahan, & Njoroge, 2020).

References:

Methadone

  • Indications
    • OUD: must be delivered through federally certified Opioid Treatment Programs (OTPs)
    • Chronic pain: outpatient prescribable with careful monitoring
  • Pharmacology and safety
    • Full mu-agonist with NMDA antagonism — useful for hyperalgesia but with higher overdose risk due to long and variable half-life
    • QTc monitoring and careful titration are critical (ASAM, 2020)
  • Clinical interface
    • OTP coordination is essential. In our integrative setting, we align chiropractic sessions around sedation and symptom patterns to maximize safety and function.

Reference:

Naltrexone

  • Indications
    • OUD relapse prevention in fully detoxified patients (oral daily or monthly extended-release injection)
    • Alcohol use disorder: reduces heavy drinking days
  • Limitations
    • No analgesia and risk of precipitated withdrawal in dependent patients
    • Best for motivated patients who prefer antagonist therapy and can maintain abstinence

Reference:

Sublingual buprenorphine: dosing, administration, and counseling

Getting the fundamentals right improves success rates and safety.

  • Administration
    • Place the tablet/film under the tongue, avoid swallowing while it dissolves, and allow 10 minutes to dissolve for reliable transmucosal absorption.
    • If nausea occurs, the patient may spit pooled saliva; absorption is mucosal, not gastric.
  • Counseling
    • Physical dependence develops; avoid abrupt discontinuation.
    • Dental health: FDA warns of potential caries with buprenorphine products dissolved in the mouth — we emphasize meticulous oral hygiene, fluoride, and regular dental care (FDA, 2022).
    • Hepatic considerations: buprenorphine is hepatically metabolized; monitor LFTs, especially in hepatic impairment.
    • Avoid respiratory depressants: counsel on risks with alcohol and benzodiazepines.
  • Combination vs. monoproduct
    • Buprenorphine-naloxone combination is generally preferred; negligible sublingual naloxone bioavailability deters injection diversion.
    • Monoproduct may be considered for naloxone-related adverse effects or when clinically indicated; navigate insurance barriers with documented medical necessity.

Reference:

Long-acting injectable buprenorphine: Sublocade and Brixadi in real-world care

I increasingly rely on long-acting injectables for patients struggling with daily adherence, diversion risk, or peak-trough symptom fluctuations.

  • Why consider injectables
    • Improved adherence
    • Reduced diversion
    • More stable plasma levels
    • Fewer daily decision points, supporting behavioral focus and rehabilitation
  • Sublocade
    • Monthly depot after stabilization on transmucosal buprenorphine
    • Dosing typically 300 mg initially, then 100–300 mg monthly
    • Consider early supplemental sublingual doses if needed before steady-state
  • Brixadi
    • Weekly or monthly options; weekly flexibility facilitates fine-tuned adjustments early in care
    • Useful as a bridge before monthly transitions or in ED settings if protocols and follow-up are robust

References:

Buprenorphine initiation in the fentanyl era: preventing precipitated withdrawal and tailoring strategy

Fentanyl’s dominance in the illicit market requires precision and shared decision-making. I emphasize patient autonomy, clear options, and contingency planning.

Why precipitated withdrawal happens

  • Mechanism
    • Buprenorphine is a high-affinity partial agonist. If substantial full-agonist occupancy persists at the mu receptor, buprenorphine displaces the full agonist and provides lower net activation—triggering acute precipitated withdrawal (Varshneya et al., 2023; Volkow & Blanco, 2023).
  • Fentanyl-specific challenges
    • Fentanyl’s lipophilicity creates adipose tissue depots that slowly elute into circulation, maintaining receptor occupancy beyond expected timelines.
    • I have seen patients with severe anxiety-forward withdrawal in fentanyl exposure; GI signs may lag while restlessness, akathisia, and dysphoria dominate.

References:

Three evidence-based induction strategies

I present all three approaches with pros and cons, aligning the choice to the patient’s goals, history, and care setting, with Dr. Cardenas co-managing risk.

Traditional induction:

  • Method
    • Wait for mild to moderate withdrawal (e.g., COWS ≥ 8–12, often ≥12–13); start with 2–8 mg buprenorphine; titrate every 2–4 hours as needed to ~8–16 mg total on day 1; adjust to 12–24 mg by day 2–3.
  • Best use
    • Transitioning from short-acting prescription opioids with predictable pharmacokinetics
  • Limitations in fentanyl
    • Depot effects make timing unpredictable; increased precipitated withdrawal risk.
  • When I use it
    • Patient preference, low likelihood of fentanyl exposure, or controlled settings with close monitoring and readiness to pivot strategies

Low-dose initiation (microdosing/overlap):

  • Method
    • Start very low buprenorphine doses (e.g., 0.2–0.5 mg) while continuing full agonists; increase buprenorphine daily and taper the full agonist over 5–7+ days (Krook et al., 2020; Raheemullah et al., 2024).
  • Why it helps
    • Gradual receptor occupancy avoids abrupt displacement, reducing precipitated withdrawal risk — especially useful for fentanyl-exposed patients or those with prior precipitated episodes.
  • Adjuncts
    • Clonidine/lofexidine, hydroxyzine, trazodone, NSAIDs/acetaminophen, ondansetron, loperamide
  • Safety note
    • Overdose protection is not robust until buprenorphine approaches ~8 mg/day; harm reduction and naloxone are essential.

High-dose initiation (rapid stabilization):

  • Method
    • Confirm sufficient withdrawal (often COWS ≥ 16 with objective signs); administer 16 mg, reassess in ~30 minutes, then 8 mg increments up to 24–32 mg on day 1 as needed (CA Bridge, 2023; Herring et al., 2021).
  • Why it helps
    • Rapid receptor occupancy addresses severe withdrawal quickly and is particularly effective in ED/urgent care settings.

References:

Preventing and managing precipitated withdrawal

  • Prevention
    • Ensure adequate withdrawal for standard induction; consider microdosing for patients at high risk (notably fentanyl or methadone).
  • If it occurs
    • Do not stop buprenorphine prematurely. Increase the buprenorphine dose (often an additional 8–16 mg in divided doses) to saturate receptors and stabilize at the partial-agonist ceiling, while providing symptom support (clonidine, hydroxyzine, antiemetics, NSAIDs) and reassurance (CA Bridge, 2023).

Shared decision-making and patient-centered communication in initiation

Shared decision-making is not a courtesy — it’s the operating system for safe induction in the fentanyl era. Patients who have experienced precipitated withdrawal often carry trauma from that experience; trust and collaboration are essential (Nielsen et al., 2023).

  • What I emphasize
    • You are the expert in your own body; I am here with options.
    • We have three valid approaches (traditional, low-dose, high-dose) with clear trade-offs — we choose together.
    • We will use symptom-targeted adjuncts proactively; you will not be abandoned mid-process.
    • If you were precipitated before, we tailor to minimize risk.
  • Clinical workflow
    • Intake and risk stratification (substance history, comorbidities, SDOH)
    • Choose initiation method collaboratively
    • Provide a clear dosing map, printed instructions (including film splitting when applicable), and “when to call” rules
    • Schedule frontline follow-up contacts within 24–72 hours during critical early days

Reference:

Integrating chiropractic care with MOUD: how biomechanics and neurophysiology support recovery

In our model, once withdrawal and cravings begin to stabilize, I integrate chiropractic and rehabilitative strategies that reduce pain drivers, dampen nociplastic amplification, and build functional resilience.

  • Mechanistic synergy
    • Segmental adjustments and regional joint care provide high-fidelity mechanoreceptive input that can modulate descending inhibitory pathways (periaqueductal gray, rostral ventromedial medulla), reducing pain amplification.
    • Autonomic balance: gentle mobilization, breathing re-education, and thoracic adjustments can shift sympathetic-parasympathetic tone, reducing allostatic load and perceived threat.
    • Movement as medicine: graded exposure, neurodynamic glides, and progressive loading build capacity and confidence, decreasing reliance on pharmacologic relief.
  • Why this matters clinically
    • Pain and withdrawal amplify each other via shared autonomic and neuroimmune pathways. By reducing nociceptive input and improving movement confidence, I see less sympathetic overdrive, better sleep, and improved adherence to MOUD.
    • I share case experiences at the sciatica clinic where OUD stabilization with buprenorphine allowed patients to progress through neurodynamic and stabilization programs, reducing catastrophizing and improving gait symmetry.

References:

Functional medicine lens: reducing inflammation and supporting recovery physiology

We address systemic drivers that worsen pain and relapse risk. Dr. Cardenas and I coordinate non-sedating strategies, metabolic supports, and behavioral coaching.

  • Inflammation and pain
    • Anti-inflammatory nutrition (omega-3s, polyphenols), glycemic control, and micronutrient optimization attenuate neuroinflammatory pathways that amplify pain and craving.
  • Sleep and circadian health
    • Stabilizing sleep-wake cycles reduces hyperalgesia and limbic reactivity. Non-drug strategies (light hygiene, stimulus control, breathwork) complement non-sedating aids when indicated.
  • Stress buffering
    • HRV biofeedback, paced breathing, and mind-body practices reinforce medication effects by modulating the HPA axis and limbic activation.

Harm reduction: meeting patients where they are

Harm reduction is ethical, evidence-based, and practical. We never make abstinence a prerequisite for compassionate care. Instead, we emphasize survival, safety, and trust-building (WHO, 2014; CDC, 2024).

  • Core elements
    • Naloxone distribution with training for the patient and household (CDC, 2024)
    • Safer use counseling; wound care and infection prevention
    • Screening and vaccination for Hepatitis A/B and HIV
    • Syringe service referrals where legal and available
    • Social determinants support: transportation, housing, phones for telehealth
  • Why it works
    • Harm reduction reduces mortality, infectious spread, and stigma while increasing readiness for MOUD and rehabilitation.

References:

Buprenorphine for chronic pain: modern analgesia with a safety margin

I integrate buprenorphine into pain management when non-opioid and multimodal strategies are insufficient or when full agonists pose unacceptable risk. Its unique profile suits complex pain cases with high risk for opioid-induced hyperalgesia (OIH).

  • Mechanisms relevant to pain
    • Partial mu-agonism with kappa antagonism and ORL-1 activity may mitigate hyperalgesia and reduce dysphoria.
    • Stable receptor occupancy supports analgesia with a lower respiratory risk than full agonists (Dahan et al., 2006).
  • Formulations for pain
    • Transdermal (Butrans) and buccal (Belbuca) provide steady analgesia at lower total opioid exposure.
    • In select cases, off-label sublingual buprenorphine (mono or combo) can be used for severe pain or high opioid tolerance when indicated.
  • Clinical pearls
    • Consider dose splitting (e.g., 4 mg TID vs 12 mg QD) for analgesic effect if using sublingual formulations off-label.
    • Always pair with nonpharmacologic interventions: chiropractic adjustments, graded exercise, cognitive-behavioral coping, sleep optimization, and anti-inflammatory nutrition.

References:

Methadone for OUD and comorbid pain: when and why

Methadone is highly effective, particularly when buprenorphine trials have failed, in severe OUD, or when full agonist analgesia is clinically needed within an OTP framework.

  • Indications
    • Severe OUD or repeated failed buprenorphine trials
    • Significant comorbid pain where NMDA antagonism may benefit hyperalgesia
    • Pregnancy when methadone is preferred or already established
  • Safety and logistics
    • QTc monitoring and careful titration due to long/variable half-life
    • Coordinated care through OTPs is required by law
    • Chiropractic and rehab sessions timed to avoid sedation peaks and optimize safety

Reference:

Naltrexone for OUD: where it fits

Naltrexone is best for motivated, fully detoxified patients who prefer an antagonist approach and do not need opioid analgesia. It plays a more prominent role in alcohol use disorder.

  • Clinical considerations
    • Requires 7–10+ days opioid-free before initiation
    • Blunts opioid analgesia — perioperative planning is essential
    • Chiropractic and non-opioid pain strategies become even more important

Reference:

Special populations: pregnancy, perioperative care, and adolescents

  • Pregnancy
    • Continue or initiate buprenorphine for OUD during pregnancy; sublingual formulations are preferred. Long-acting injectables are not FDA-approved for pregnancy.
    • Physiological changes may necessitate higher or split dosing.
    • Coordinate with obstetrics; use gentle chiropractic techniques for pregnancy-related pelvic and low-back strain (ASAM, 2020).
  • Perioperative patients
    • Maintain buprenorphine through the perioperative period in coordination with anesthesia and surgery; apply multimodal analgesia and regional blocks.
    • Chiropractic-informed positioning and post-operative progressive mobilization support recovery.
  • Adolescents (≥16 years)
    • Buprenorphine is FDA-approved for OUD in adolescents ≥16 years.
    • Emphasize clarity, family engagement, and school coordination; chiropractic care supports sports-related pain and posture concerns.

Reference:

Safety considerations: polypharmacy, sedation, and respiratory risk

We address respiratory depressant combinations non-punitively to keep patients engaged and safe.

  • Benzodiazepines and alcohol
    • Co-use with buprenorphine heightens respiratory risk. We counsel clearly, coordinate benzodiazepine tapers when appropriate, and avoid abrupt cutoffs that drive disengagement.
  • Sedatives and CNS depressants
    • PDMP checks, staged changes, and emphasis on sleep hygiene and non-sedating anxiety strategies (breathwork, HRV biofeedback).
  • Liver disease
    • Baseline and periodic LFTs, adjusting monitoring to clinical status.

Reference:

Personal injury and OUD: special considerations in my practice

Acute injury often initiates an opioid exposure cascade. We minimize risk while restoring function.

  • Injury cascade
    • Early multimodal analgesia, clear opioid exit strategies, and rapid MOUD access when indicated prevent chronic opioid exposure.
    • For whiplash, lumbar strain, and radiculopathy: gentle cervicothoracic work, vestibular drills as needed, direction-specific spinal-sparing strategies, and neurodynamic techniques once irritability decreases.
  • Documentation and communication
    • We carefully document function, impairment, and return-to-work capacity. Under Dr. Cardenas’ medical direction, we align medical therapy and chiropractic progress with legal and occupational requirements.

Step-by-step clinic pathway: from intake to stabilization

  • Comprehensive assessment
    • OUD diagnosis and risk profile (overdose history, polysubstance use, SDOH)
    • Pain phenotype (nociceptive, neuropathic, nociplastic)
    • Function metrics, vitals, and labs as indicated
  • Shared decision-making
    • Present induction options (traditional, low-dose overlap, high-dose)
    • Align plan with patient goals, prior experiences, and logistics
  • Induction and early stabilization
    • Execute the chosen protocol
    • Provide naloxone, clear written guidance, and proactive adjuncts
    • Ensure follow-up within 24–72 hours
  • Chiropractic and rehab onboarding
    • Initiate low-threat mobilization, breath mechanics, and isometrics as cravings settle.
    • Progress mobility → motor control → strength → meaningful task capacity
  • Functional medicine adjuncts
    • Anti-inflammatory nutrition, hydration, and electrolytes
    • Sleep strategies and stress tools (breathing, HRV biofeedback)
  • Ongoing optimization
    • Titrate MOUD; consider Sublocade/Brixadi
    • Taper sedatives cautiously when safe
    • Regularly measure outcomes; iterate as needed

Patient education checklist for buprenorphine

  • How to take it
    • Place under tongue; let dissolve fully; okay to spit saliva if nauseated.
  • What to expect
    • Decreased withdrawal and cravings; improved function over days to weeks.
  • Safety
    • Avoid mixing with alcohol or benzodiazepines; keep naloxone available for household and community safety.
  • Dental care
    • Brush after dosing when feasible; use fluoride; schedule regular dental visits.
  • Liver health
    • Report jaundice, RUQ pain, or dark urine; keep lab appointments.

Reference:

Insurance navigation and access

  • Monoproduct buprenorphine
    • Provide documentation of medical necessity in naloxone-intolerant cases.
  • Long-acting injectables
    • Prior authorizations and patient assistance programs preserve continuity; our team coordinates with specialty pharmacies.
  • Dose coverage in fentanyl era
    • Many patients initially need >24 mg/day buprenorphine; document clinical necessity and align with evolving policies that accept doses up to 32 mg/day for selected cases (ASAM, 2023).

References:

Measuring outcomes that matter

  • Functional metrics
    • Return-to-work readiness, lifting tolerance, sit-stand endurance, gait quality, sleep quality
  • Pain and function scales
    • PEG, Oswestry Disability Index (ODI)/Neck Disability Index (NDI), Patient-Specific Functional Scale
  • OUD stability
    • Cravings trends, urine toxicology, days of nonmedical opioid use, retention in care

Clinical observations from my practice: sciatica, fentanyl-era inductions, injectables, and dental prevention

From my work in El Paso and insights I share publicly, including at sciatic a.clinic and on my professional updates, several patterns stand out:

  • Sciatica and neuropathic pain
    • Stabilizing OUD with buprenorphine allows meaningful participation in neurodynamic flossing, segmental stabilization, and graded loading, reducing catastrophizing and improving gait symmetry.
  • Fentanyl-era inductions
    • Micro-induction has been particularly valuable for patients with heavy fentanyl exposure who previously failed standard inductions due to severe precipitated withdrawal.
  • Long-acting injectables
    • Weekly Brixadi serves as a useful bridge for patients reluctant to commit to monthly dosing or needing fine-tuned early adjustments.
    • Transitioning stabilized patients to Sublocade simplifies logistics and supports adherence; some require early supplemental sublingual doses.
  • Dental prevention
    • Proactive oral hygiene guidance at buprenorphine initiation reduces reports of dental sensitivity and caries.

Resources:

Putting it all together: a case-inspired journey

  • Week 0–1
    • A patient with lumbar radicular pain and daily fentanyl exposure presents. We choose micro-induction, start low-dose buprenorphine while continuing a full agonist, layer in gentle neurodynamic drills and diaphragmatic breathing, and provide robust adjuncts and naloxone.
  • Week 2–4
    • Stabilized at ~16 mg/day, cravings diminish. I add targeted spinal adjustments, hip hinge drills, and sleep regularization; anti-inflammatory nutrition begins; close check-ins maintain momentum.
  • Month 2
    • Transition to monthly Sublocade for adherence; progress to posterior chain strength and graded aerobic conditioning; monitor for end-of-interval symptom drift and supplement sublingual doses if needed.
  • Month 3–6
    • Functional goals achieved (full shift tolerance, fewer flares). Behavioral coping skills solidify; relapse-prevention continues with naloxone access and scheduled follow-up.

Conclusion: our multidisciplinary ethos in El Paso

  • Medical safety and MOUD excellence
    • Maria Guadalupe Cardenas, MD (NPI #1164426749; Texas MD License #J2933), anchors our medical supervision, risk mitigation, and clinical governance.
  • Chiropractic, rehab, and functional medicine integration
    • My team and I guide biomechanical correction, movement retraining, and physiological resilience. We address nociplastic pain, autonomic dysregulation, and inflammatory drivers while MOUD stabilizes the reward/withdrawal circuitry.
  • Humane, precise, sustainable care
    • Our model pairs lifesaving medications with integrative chiropractic care and rehabilitation — a coordinated plan to reduce risk, improve function, and support long-term recovery.

Key takeaways:

  • MOUD is lifesaving; buprenorphine’s respiratory depression ceiling underpins its safety advantage (Dahan et al., 2006; NASEM, 2019).
  • Individualized induction — standard, high-dose, or micro-induction — is essential in the fentanyl era to prevent precipitated withdrawal (ASAM, 2023; CA Bridge, 2023).
  • Integrative chiropractic care complements MOUD by reducing pain drivers, restoring movement, and enhancing function (Chou et al., 2016).
  • Medical oversight by an experienced internist like Dr. Cardenas ensures safety, quality, and continuity.
  • Harm reduction, patient education, and functional metrics keep recovery grounded in outcomes that matter.

References

SEO tags: buprenorphine, methadone, naltrexone, opioid use disorder, OUD, Sublocade, Brixadi, Suboxone, Subutex, Butrans, Belbuca, buprenorphine induction, micro-induction, Bernese method, precipitated withdrawal, harm reduction, chiropractic care, integrative medicine, internal medicine oversight, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, El Paso, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, chronic pain, personal injury, functional medicine, rehabilitation, sciatica, evidence-based care, respiratory depression ceiling effect, naloxone, dental health buprenorphine, liver monitoring buprenorphine, benzodiazepines alcohol risk, QTc methadone, long-acting injectable buprenorphine, high-dose induction, low-dose overlap, shared decision making, fentanyl era, CA Bridge protocol, ASAM guidelines, central sensitization, autonomic regulation, graded exposure, neurodynamic glides, sleep optimization, anti-inflammatory nutrition

BHRT Benefits for Movement: Reduce Inflammation

BHRT Benefits for Movement: Reduce Inflammation
BHRT Benefits for Movement: Reduce Inflammation

BHRT Benefits for Movement, Muscle Strength, and Joints

Abstract: When hormone levels drop with age or menopause, bioidentical hormone replacement therapy (BHRT) can indirectly improve mobility and flexibility. It may lower joint stiffness, help conserve bone density, and support muscle strength. It is not a direct stretch and does not replace movement training. BHRT can also reduce joint inflammation, support cartilage health, and ease muscle tightness tied to low estrogen or testosterone. Integrative chiropractic care can add to these benefits by restoring joint motion, lowering nervous-system stress, and improving how the body moves. This article explains the hormone-joint link, what BHRT can and cannot do, and how medical care and chiropractic care work together in El Paso.

BHRT Benefits for Movement: Reduce Inflammation

A Simple Starting Point: Why Movement Changes With Age

Many people notice the same pattern. Getting out of a chair takes more effort. The first steps in the morning feel tight. Reaching overhead or turning to look over a shoulder is not as easy as it used to be.

Part of this comes from less activity, old injuries, and weaker muscles. Hormones also play a role. Estrogen and testosterone affect more than mood, sleep, and energy. They also affect joints, bones, cartilage, and muscle.

When those hormone levels fall, the body can become more inflamed. Cartilage may not stay as healthy. Bones can lose density. Muscles may shrink or feel stiffer. None of this means movement is lost forever. It does mean a plan for better mobility should address both hormones and how the joints actually move.

How Estrogen and Testosterone Affect Joints and Muscles

Estrogen helps keep joints quieter. It can reduce inflammatory signals and help cartilage stay stronger and more flexible. It also supports the fluid that lets joints glide. After menopause, estrogen drops. Joints may then feel more swollen, dry, and stiff. Bone density often falls at the same time, which puts more stress on the joints (Mobility Bone & Joint Institute, 2025).

Testosterone supports collagen and muscle mass. Collagen is a building block of cartilage, tendons, and ligaments. Muscle acts like a natural brace around a joint. When testosterone is low, repair can slow, muscles can weaken, and joints can feel less stable (BodyLogicMD, 2025; Sota Wellness, n.d.).

Hormonal changes can also change how people feel day to day:

  • More joint aching
  • Longer morning stiffness
  • Less energy for walking or exercise
  • Weaker grip or harder time getting up from the floor
  • Higher risk of bone loss

These symptoms can feed on each other. Pain reduces activity. Less activity weakens muscle. Weaker muscle loads the joints more. Better hormone balance may interrupt that cycle, but movement still has to be restored.

What Bioidentical Hormone Therapy Is

BHRT uses hormones that match the ones the body makes. They are often made from plant sources and then changed so they are chemically the same as human estradiol, progesterone, or testosterone.

A clinician usually reviews symptoms and lab work before choosing a plan. Delivery methods can include creams, patches, pellets, or other forms. The dose is meant to be personal, not one-size-fits-all.

It is important to stay clear-eyed. Mayo Clinic notes that bioidentical hormones are not proven safer or more effective than standard hormone therapy. Compounded products can also vary in quality (Mayo Clinic, 2024). Hormone therapy is a medical decision. It should be supervised, monitored, and based on the person’s health history.

How BHRT May Improve Mobility and Flexibility

BHRT does not stretch a tight muscle or unlock a restricted joint. Its help is mostly indirect.

  • It may lower joint inflammation. Estrogen and testosterone can reduce inflammatory activity that makes joints swell and feel tight (BodyLogicMD, 2025; Renew Health & Wellness, 2021).
  • It may support cartilage. Estrogen helps with lubrication and may slow some cartilage wear. Testosterone and related hormones can support collagen (BodyLogicMD, 2025).
  • It may protect bone density. Stronger bones provide a more stable base for joints and lower fracture risk (Balance Hormone Center, n.d.; Desert Sands Aesthetics, n.d.).
  • It may support muscle strength. Better muscle support can make daily movement easier and safer (Charleston Pain Relief Center, n.d.; Sota Wellness, n.d.).
  • It may raise energy for activity. When fatigue eases, people can walk, stretch, and train more often. That extra movement is what truly improves flexibility.

Some research and clinic reports show less joint pain in people using hormone therapy. A few studies have linked estrogen therapy with slower osteoarthritis progression in some groups. Other evidence is mixed. Medical groups do not list joint pain as a main reason to start hormone therapy (Maven Clinic, n.d.). Results vary.

Why BHRT Is Not a Direct Fix for Flexibility

Flexibility is the ability of a muscle and joint to move through a useful range. Mobility is a bigger idea. It is flexibility plus strength, control, and healthy connective tissue (Essentrics, 2026).

Hormones can make that range more comfortable. They cannot create it by themselves. People still need:

  • Regular movement through the full range
  • Strength around the hips, spine, and shoulders
  • Better posture and joint mechanics
  • Enough sleep and recovery
  • A plan for old injuries that never fully resolved

If someone only uses hormone therapy and never addresses stiff joints or weak muscles, flexibility often stays limited. The hormones may reduce the “background noise” of stiffness. The body still has to relearn easier movement.

How Integrative Chiropractic Care Fits Into This Treatment

This is where integrative chiropractic care becomes useful. Chiropractic care does not replace estrogen, progesterone, or testosterone. It does not change hormone levels on its own. It can help the body move better while hormone balance is being restored.

Chiropractic care can:

  • Restore motion in stiff spinal and extremity joints
  • Reduce muscle guarding around painful areas
  • Improve posture so joints are not loaded in a crooked way
  • Lower physical stress that keeps the nervous system on high alert
  • Make walking, stretching, and rehab more comfortable

Pain and poor sleep raise stress hormones such as cortisol. High cortisol can increase inflammation and make recovery harder. Better spinal motion and less nighttime stiffness can support calmer sleep and healthier movement patterns (Nightlight Chiropractic, 2025).

When joints move better, people can use the muscle and bone support that BHRT may provide. Hormone therapy and chiropractic care are not competing treatments. They work on different layers of the same problem.

A Team Approach in El Paso

At Injury Medical Clinic PA in El Paso, Texas, this kind of layered care is built into the clinic model. Dr. Maria Guadalupe Cardenas, MD, is board-certified in internal medicine.

  • She has more than 40 years of experience as an internist (NPI #1164426749, Texas MD License #J2933).
  • She serves as medical director and collaborative physician.
  • She provides medical evaluation, diagnosis, and oversight, including review of hormone-related concerns.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, provides chiropractic care and integrative clinical support. He is a chiropractor and board-certified family nurse practitioner. His work includes spinal care, functional medicine, personal injury rehabilitation, and wellness protocols.

This setup is common in integrative and injury-care clinics. An MD provides medical direction. A chiropractor restores joint motion and movement mechanics. The same team can also include:

  • Functional medicine support
  • Personal injury care after auto or work accidents
  • Rehabilitation and guided exercise
  • Nutrition and lifestyle care

The point is not to stack random services. The point is to treat the person as one system: hormones, joints, nerves, muscles, and daily function.

What Dr. Jimenez Observes in Practice

Dr. Jimenez’s clinical observations point to the same idea. Hormone health and musculoskeletal care work better together. Integrative chiropractic care can restore spinal and pelvic alignment, reduce muscle tightness, and improve autonomic balance. That may help patients sleep better, stay more active, and tolerate other therapies more easily (Jimenez, n.d.).

He has noted that pelvic and low-back care can improve hip mechanics. Better hip motion often makes walking and daily tasks feel less restricted. Movement then supports bone health, insulin sensitivity, and mood. In his practice, care is not only about a single adjustment or a single hormone prescription. It looks at inflammation, nutrition, sleep, alignment, and how the person actually moves (El Paso Back Clinic, n.d.; Jimenez, n.d.).

This matters after injury as well. A crash or workplace strain can leave ligaments stretched, joints restricted, and muscles tight. If hormone levels are also low, recovery can feel slower. Coordinated care can address both the tissue injury and the internal environment that affects healing.

What a Combined Plan Can Look Like

A practical plan often starts with a clear picture:

  • Medical history and symptom review
  • Labs when hormone imbalance is suspected
  • A movement exam for joint restriction, posture, and strength
  • A look at sleep, stress, nutrition, and old injuries

From there, care may include medical oversight of hormone therapy when it is appropriate, chiropractic care to restore motion, and rehab to rebuild strength and flexibility. Nutrition can support bone and muscle. Activity is progressed in a way the joints can handle.

People should not expect one visit or one prescription to restore full flexibility. The better path is stepwise. First, reduce pain and stiffness. Next, restore joint motion. Then build strength and control through that new range.

Putting the Pieces Together

Can bioidentical hormone therapy help with mobility and flexibility? It can help, but not as a direct stretch. When hormones decline, BHRT may lower joint stiffness, conserve bone density, support muscle strength, reduce inflammation, and ease muscle tightness. Those changes can make movement easier.

Integrative chiropractic care can boost those advantages. It restores joint motion, reduces nervous-system tension, and improves movement mechanics. Together, the two approaches address both the body’s internal chemistry and how it moves.

Anyone considering this path should work with qualified clinicians, review the risks and benefits, and avoid treating BHRT as a cure-all. In El Paso, Injury Medical Clinic PA offers a multidisciplinary model in which Dr. Cardenas provides medical direction, and Dr. Jimenez provides chiropractic and integrative care. That combination is designed to help people move with more comfort, strength, and control.

Modulating Women Hormones Part 1 of 3 l El Paso, Tx (2021)

References

Balance Hormone Center. (n.d.). The benefits of bioidentical hormone replacement therapy (BHRT).

BodyLogicMD. (2025, April 10). How BHRT supports joint health and reduces chronic pain.

Charleston Pain Relief Center. (n.d.). Hormone replacement therapy, energy, and aging.

Desert Sands Aesthetics. (n.d.). Hormone replacement therapy.

El Paso Back Clinic. (n.d.). Regenerative medicine and integrative chiropractic strategies.

Essentrics. (2026, March 16). Mobility for menopause.

Jimenez, A. (n.d.). Patient wellness and health with bioidentical hormones.

Mayo Clinic. (2024, October 3). Bioidentical hormones: Are they safer?.

Maven Clinic. (n.d.). HRT and joint pain in menopause: What the evidence says.

Mobility Bone & Joint Institute. (2025, March 12). A guide to joint health after menopause.

Nightlight Chiropractic. (2025, December 17). Hormones, your health, and the role chiropractic care can play.

Renew Health & Wellness. (2021, October 12). How BHRT helps relieve joint pain.

Sota Wellness. (n.d.). Bioidentical hormone therapy benefits for men and women.

Wellness Doctor RX. (2026, April 21). Integrative hormone optimization and chiropractic protocols.

BHRT Nutrition for Optimal Metabolic Balance

BHRT Nutrition for Optimal Metabolic Balance
BHRT Nutrition for Optimal Metabolic Balance

BHRT Nutrition: A Whole-Food Plan for Hormone Therapy

Abstract

Bioidentical hormone replacement therapy (BHRT) may use hormones such as estrogen, progesterone, or testosterone to address specific symptoms or medically identified hormone needs. There is no single approved “BHRT diet.” Instead, nutrition during hormone therapy is usually built around whole foods, adequate protein, healthy fats, fiber-rich carbohydrates, vegetables, fruits, and optimal hydration. A Mediterranean-style eating pattern is often a practical choice because it supports heart health, blood sugar control, healthy body composition, and overall metabolic health (Cano et al., 2020).

Nutrition does not replace hormone therapy or medical monitoring. Rather, it can support the systems that process nutrients and hormones, including the liver, digestive system, muscles, bones, and cardiovascular system. At Injury Medical Clinic PA in El Paso, a multidisciplinary approach can also combine medical oversight, functional medicine, integrative chiropractic care, rehabilitation, and lifestyle guidance. Chiropractic care may help patients move with less pain and participate more comfortably in exercise and healthy daily routines, but it should not be viewed as a treatment that directly controls hormone levels.

BHRT Nutrition for Optimal Metabolic Balance

What Is Bioidentical Hormone Replacement Therapy?

Bioidentical hormones are manufactured hormones designed to have the same chemical structure as hormones naturally produced by the body. Common examples include estradiol, progesterone, and testosterone.

Hormone therapy may be used for problems such as menopausal symptoms or medically diagnosed hormone deficiencies. However, treatment must be individualized because hormone therapy also has risks and possible side effects. Cleveland Clinic notes that FDA-approved bioidentical hormone products are available, while compounded products do not undergo the same FDA approval process and may have greater uncertainty in dosing and safety (Cleveland Clinic, 2022).

The Menopause Society also explains that custom-compounded hormones have not been shown to be safer or more effective than government-approved hormone products.

This is why good BHRT care should include more than simply giving a hormone. A healthcare provider may review:

  • Symptoms
  • Medical history
  • Medications
  • Blood pressure
  • Blood sugar
  • Cholesterol and triglycerides
  • Liver and kidney health
  • Hormone levels when clinically appropriate
  • Bone health
  • Body composition
  • Exercise
  • Sleep
  • Nutrition

Is There a Special BHRT Diet?

No medically approved diet exists that every person receiving estrogen, progesterone, or testosterone must follow.

A better way to think about nutrition is to ask:

What eating pattern supports the patient’s health while hormone therapy is being monitored?

For many people, the answer resembles a Mediterranean-style diet.

NuLife Institute recommends an eating pattern rich in plant foods, proteins, healthy fats, vegetables, legumes, nuts, whole grains, and omega-3 fats as part of lifestyle support during hormone care (NuLife Institute, 2022).

Research on menopause also supports Mediterranean-style eating for cardiometabolic health. Reviews have found possible benefits involving body weight, blood pressure, blood lipids, glucose control, and overall cardiovascular health in menopausal women (Cano et al., 2020; Silva et al., 2021).

A simple BHRT nutrition plate might contain:

  • Half the plate: vegetables or vegetables plus fruit
  • One-quarter: lean protein
  • One-quarter: high-fiber carbohydrates
  • A small amount: healthy fats

This approach is simple enough to follow without turning food into a complicated hormone prescription.

Eat Enough Protein

Protein becomes especially important as people get older because maintaining muscle can become harder.

Useful protein sources include:

  • Fish
  • Chicken
  • Turkey
  • Eggs
  • Greek yogurt
  • Cottage cheese
  • Beans
  • Lentils
  • Tofu
  • Lean beef
  • Protein-rich nuts and seeds

Protein can help support muscle repair, fullness, recovery from exercise, and stable meals.

This may be especially useful for a patient receiving testosterone therapy who is also beginning resistance exercise. However, eating extra protein does not automatically increase testosterone, and it should not replace proper hormone evaluation.

Baylor Scott & White Health recommends building meals around protein, fiber, and healthy fats to slow digestion and support steadier glucose and insulin responses (Baylor Scott & White Health, 2025).

Choose Healthy Fats

Fats should not automatically be avoided during BHRT.

Healthy fats can be found in:

  • Extra-virgin olive oil
  • Avocados
  • Walnuts
  • Almonds
  • Chia seeds
  • Flaxseed
  • Salmon
  • Sardines
  • Tuna

A Mediterranean-style eating pattern relies heavily on unsaturated fats instead of large amounts of saturated and heavily processed fats.

Baylor Scott & White recommends foods such as olives, olive oil, nuts, seeds, and avocados as sources of unsaturated fats within a hormone-supportive diet (Baylor Scott & White Health, 2025).

Omega-3-rich foods may also be helpful as part of an overall anti-inflammatory eating pattern.

Make Fiber a Daily Goal

Fiber is one of the most useful parts of a healthy BHRT nutrition plan.

Good sources include:

  • Beans
  • Lentils
  • Oats
  • Berries
  • Apples
  • Pears
  • Broccoli
  • Brussels sprouts
  • Leafy greens
  • Quinoa
  • Brown rice
  • Whole-grain foods
  • Chia and flaxseed

Fiber can support regular bowel movements, healthy cholesterol levels, gut health, fullness, and steadier blood sugar.

Some wellness sources use the term “estrogen detox.” A more medically accurate description is that the liver and digestive tract normally metabolize and eliminate hormone metabolites. Eating enough fiber and maintaining normal bowel function can support digestive health, but no food performs a special hormone “cleanse.”

This difference matters because BHRT patients need reliable nutrition guidance, not detox promises.

Control Refined Sugar and Highly Processed Foods

Patients do not have to eliminate every carbohydrate.

Instead, the goal is to improve carbohydrate quality.

Choose more:

  • Oatmeal
  • Beans
  • Lentils
  • Sweet potatoes
  • Quinoa
  • Brown rice
  • Whole grains
  • Fruits
  • Vegetables

Choose less often:

  • Sugary drinks
  • Candy
  • Pastries
  • Sweetened coffee drinks
  • Refined snack foods
  • Large portions of highly processed carbohydrates

The Life Fertility Center recommends whole foods, healthy fats, lean proteins, and fiber while limiting excessive refined sugar and highly processed foods as part of a lifestyle approach to metabolic and hormonal health (The Life Fertility Center, 2024).

This approach can be especially important when a patient also has insulin resistance, metabolic syndrome, elevated triglycerides, or unwanted weight gain.

Support Bone Health During Estrogen Changes

Estrogen plays an important role in bone health. When estrogen declines around menopause, bone loss may speed up.

Nutrition should therefore include adequate:

  • Calcium
  • Vitamin D
  • Protein
  • Magnesium
  • Vitamin K
  • Other minerals found in whole foods

Helpful foods may include dairy products when tolerated, fortified plant beverages, leafy greens, fish, eggs, beans, and nuts.

Vitamin D supplementation should be based on individual needs rather than guessing. Baylor Scott & White notes that food sources include fatty fish, egg yolks, and vitamin-D-fortified foods, while supplementation may be appropriate after discussion with a healthcare provider (Baylor Scott & White Health, 2025).

Do Not Forget Hydration, Sleep, and Exercise

A nutrition plan works best when it is part of a larger lifestyle plan.

BodyLogicMD recommends combining BHRT care with balanced nutrition, regular physical activity, stress-management strategies, sleep, hydration, and regular medical follow-up (BodyLogicMD Medical Review Board, 2025).

Patients can start with simple goals:

  • Drink water throughout the day.
  • Build meals from mostly whole foods.
  • Aim for regular sleep and wake times.
  • Walk regularly.
  • Add resistance training when medically appropriate.
  • Reduce excessive alcohol.
  • Avoid smoking.
  • Limit large amounts of added sugar.
  • Schedule regular follow-up visits.

These habits may also help reduce some of the cardiovascular and metabolic risks that become more important with aging.

What About “Hormone-Balancing Foods”?

Online discussions often claim that individual foods can “balance hormones.”

Foods certainly affect metabolism and overall health, but they usually do not work like hormone medications.

For example, berries, vegetables, fish, nuts, olive oil, seeds, and whole grains provide nutrients that help normal body function. Educational programs have also discussed foods such as salmon, flaxseed, vegetables, fruits, and healthy fats as part of hormone-conscious nutrition (NuLife Institute, 2022; New York Living, n.d.).

The key is the overall eating pattern, not one miracle food.

How Integrative Chiropractic Care Fits Into BHRT

Chiropractic treatment does not replace estrogen, progesterone, testosterone therapy, laboratory monitoring, or medical evaluation.

Its best role in an integrated hormone program is supportive.

For example, a patient with back pain, neck pain, poor movement, or joint stiffness may have trouble exercising. Chiropractic and rehabilitation strategies may help improve movement and reduce musculoskeletal barriers to physical activity.

Care may include:

  • Chiropractic adjustments when appropriate
  • Soft-tissue treatment
  • Mobility work
  • Posture training
  • Corrective exercises
  • Breathing exercises
  • Strength and stability training
  • Rehabilitation
  • Lifestyle coaching

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes clinical observations in which improving movement, sleep habits, nutrition, breathing mechanics, and physical activity forms part of a larger integrative care model (Jimenez, 2026).

Importantly, these are clinical observations and an integrative treatment philosophy, not proof that spinal manipulation directly changes estrogen, progesterone, testosterone, or cortisol levels.

A safer evidence-based explanation is that reducing musculoskeletal pain and improving movement may make it easier for a patient to exercise, sleep, manage stress, and follow healthy routines. Those changes can support overall metabolic health.

Medical Oversight and Chiropractic Care in El Paso

At Injury Medical Clinic PA in El Paso, Texas, the care model brings together different healthcare disciplines.

Dr. Alex Jimenez provides chiropractic, functional medicine, personal injury, physical rehabilitation, and related integrative services. His published clinical approach emphasizes combining musculoskeletal care with nutrition, movement, lifestyle changes, laboratory information, and collaboration with medical professionals.

Dr. Maria Guadalupe Cardenas, MD, is an El Paso internal medicine physician with more than four decades of medical experience. Clinic materials identify her as board-certified in internal medicine and as the Medical Director and Collaborative Physician for Injury Medical Clinic PA. Public professional listings identify her NPI as 1164426748. Her Texas physician license is J2933.

This type of multidisciplinary structure allows different parts of a patient’s care to be coordinated while each clinician remains within their professional scope.

For a patient receiving hormone therapy, this can help connect:

  • Medical evaluation and medication oversight
  • Laboratory monitoring
  • Nutrition
  • Functional medicine
  • Chiropractic care
  • Personal injury treatment
  • Exercise rehabilitation
  • Weight and metabolic management
  • Referral to specialists when needed

The goal is not for chiropractic care to replace internal medicine or hormone management. The goal is for the different parts of care to support one another.

A Simple BHRT Nutrition Day

A practical day might look like this:

Breakfast:
Eggs with spinach, avocado, berries, and oatmeal.

Lunch:
Grilled chicken over mixed vegetables with chickpeas, olive oil, and a small serving of quinoa.

Snack:
Greek yogurt with walnuts, or an apple with almond butter.

Dinner:
Salmon with roasted vegetables, lentils, and a leafy green salad.

Drinks:
Mostly water, mineral water, or unsweetened beverages.

This is not a prescription. Portion sizes and food choices should change based on body size, activity, medical conditions, goals, allergies, medications, kidney function, glucose control, and other personal factors.

The Bottom Line

There is no single required nutrition plan for people using bioidentical estrogen, progesterone, or testosterone.

For many patients, the strongest starting point is a whole-food, Mediterranean-style eating pattern built around vegetables, fruit, lean protein, fiber, whole grains, legumes, nuts, seeds, fish, and healthy fats.

Nutrition can support metabolic health, cardiovascular health, digestion, muscle maintenance, bone health, and stable energy. It should work alongside—not instead of—proper hormone evaluation and medical monitoring.

Integrative chiropractic care can add another layer by addressing musculoskeletal pain, movement, rehabilitation, posture, and physical function. At Injury Medical Clinic PA in El Paso, this approach is combined with medical oversight, functional medicine principles, personal injury care, and rehabilitation to create a coordinated model of care.

Patients considering BHRT should discuss their medical history, symptoms, medications, nutrition, laboratory findings, and individual risks with a qualified healthcare professional before beginning or changing hormone treatment.

Assessing Hormones *THERAPY* | El Paso, Tx (2022)

References

Baylor Scott & White Health. (2025, July 14). Tips for a hormone-balancing diet: Top foods that help balance hormones.

BodyLogicMD Medical Review Board. (2025, September 22). Lifestyle changes to make when you are on BHRT.

Cano, A., Marshall, S., Zolfaroli, I., Bitzer, J., Ceausu, I., Chedraui, P., Durmusoglu, F., Erkkola, R., Goulis, D. G., Hirschberg, A. L., Kiesel, L., Lopes, P., Pines, A., van Trotsenburg, M., Lambrinoudaki, I., & Rees, M. (2020). The Mediterranean diet and menopausal health: An EMAS position statement. Maturitas, 139, 90–97.

Cleveland Clinic. (2022). Bioidentical hormones: Therapy, uses, safety & side effects.

Jimenez, A. (2026). Patient wellness and health with bioidentical hormones.

Jimenez, A. (n.d.). Dr. Alexander Jimenez, DC, APRN, FNP-BC, IFMCP, CFMP. LinkedIn.

The Life Fertility Center. (2024). Hormonal balance: A comprehensive guide to unlocking wellness.

Motion Nutrition. (2018, January 25). The ultimate guide to your hormonal balance for men and women.

New York Living. (n.d.). Foods that help balance your hormones [Video]. YouTube.

NuLife Institute. (2022, July 18). Hormone therapy specialist: 6 foods you need to eat for a balanced hormone health.

Silva, T. R., Oppermann, K., Reis, F. M., & Spritzer, P. M. (2021). Nutrition in menopausal women: A narrative review. Nutrients, 13(7), 2149.

U.S. Women’s Medical Center. (n.d.). What role does nutrition play in hormone replacement therapy?.

A Clinical Approach to Integrative Care Essentials for OUD Treatment

Find effective strategies and insights on clinical approaches to integrative care to support recovery from opioid use disorder.

Abstract

Opioid Use Disorder (OUD) represents a significant public health challenge, rooted in a complex history of pain management, substance development, and evolving legislation. This educational post, from my perspective as Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, delves into the multifaceted nature of OUD. We will embark on a journey through the history of opioids, from their natural origins to the potent synthetic versions driving the current crisis. By examining the three distinct waves of the opioid epidemic, we will gain a clearer understanding of how we arrived at this critical juncture. A central theme of our discussion will be deconstructing pervasive myths and the corrosive impact of stigma, which remains a formidable barrier to effective care. I will present the latest findings from leading researchers, grounded in evidence-based methods, to outline the most effective treatment recommendations. This includes a detailed look at the pharmacology of medications for OUD (MOUD), such as methadone, buprenorphine, and naltrexone, and the psychological framework of motivational interviewing. We will also explore the vital role of harm reduction strategies in saving lives and promoting health. At our clinic, we bring this comprehensive approach to life through a unique integrative model. This post details how my work in chiropractic and functional medicine is seamlessly integrated with the medical oversight of our esteemed Medical Director, Dr. Maria Guadalupe Cardenas, MD, to offer a holistic, patient-centered pathway to recovery.

Our Integrative Care Model: A Collaborative Approach to Healing

Hello, I’m Dr. Alex Jimenez. With a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP, ATN, CCST), my career has focused on understanding the intricate connections between the body’s structure, function, and overall well-being. At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) here in El Paso, Texas, we have cultivated a unique environment where different medical disciplines converge to provide comprehensive, patient-centered care.

A cornerstone of our practice is our collaboration with Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933) and brings over 40 years of invaluable experience as an internist. She serves as our Medical Director and Collaborative Physician, providing the essential medical oversight that allows us to operate as a truly multidisciplinary clinic. This model is common and highly effective in integrative and injury care settings, where a medical doctor’s expertise enhances and guides the therapeutic strategies of other practitioners.

Our team integrates a wide array of services to address the whole person, not just a single symptom. This includes:

  • Medical Oversight (Dr. Cardenas): Cardenas provides medical direction, oversees complex cases, manages prescription medications when necessary, and ensures our protocols adhere to the highest standards of medical care. Her internal medicine background is crucial for managing the comorbidities often associated with chronic pain and substance use disorders.
  • Integrative Chiropractic Care (Dr. Jimenez): As a chiropractor, I focus on the biomechanical and neurological aspects of health. For patients with OUD, many of whom initially started using opioids for chronic pain, chiropractic care is a powerful, non-pharmacological tool. By addressing the root musculoskeletal causes of pain through spinal adjustments, soft tissue therapies, and corrective exercises, we can often reduce or eliminate the very pain that led to opioid use in the first place. This is a fundamental part of a long-term recovery strategy.
  • Functional Medicine: We look beyond the symptoms to understand the “why.” Using advanced diagnostics, we investigate underlying issues like gut health, nutritional deficiencies, hormonal imbalances, and inflammation, which can all contribute to chronic pain and affect mental health and recovery from OUD.
  • Rehabilitation & Personal Injury Care: We provide targeted physical rehabilitation to restore function, improve strength, and help patients regain their quality of life after an injury, which can be a critical factor in preventing the transition from acute to chronic pain.

By combining these disciplines, we create a synergistic effect. A patient struggling with OUD that began with a back injury might receive chiropractic adjustments to alleviate the structural source of their pain, functional medicine interventions to reduce systemic inflammation, medical management and counseling for the OUD itself under Dr. Cardenas’s direction, and rehabilitation to build resilience against future injury. This holistic approach empowers patients, addresses the multifaceted nature of their condition, and builds a sustainable foundation for lasting health and recovery.

A Journey Through Time: The History of Opioids

To truly grasp the complexities of the current opioid crisis, we must first travel back in time and understand the origins and evolution of these powerful substances. The story of opioids is not a recent one; it is a long and winding road that stretches back millennia, marked by discovery, medical application, and, ultimately, widespread societal impact.

From Poppy Plants to Potent Synthetics

The narrative begins with nature itself. When we discuss opioids, it’s crucial to differentiate between the various types, as their origins dictate their properties and potency.

  • Natural Opioids (Opiates): These are alkaloids derived directly from the resin of the opium poppy plant, Papaver somniferum. The primary substances in this category are morphine and codeine. They are the original template from which all other opioids were developed.
  • Semi-Synthetic Opioids: These are created in laboratories by chemically modifying natural opiates. Scientists synthesize these from the naturally occurring opium products to enhance certain effects, such as pain relief. This class includes some of the most well-known substances, such as heroin (synthesized from morphine), oxycodone, and hydrocodone.
  • Synthetic Opioids: These are entirely artificial in a laboratory, designed to mimic the effects of natural opiates by interacting with the same receptors in the brain. This category includes therapeutic medications like methadone and the notoriously potent fentanyl.

A Chronological Timeline of Opioid Development

The timeline of opioid discovery and use is not to scale. Still, it places key moments in chronological order, revealing a pattern of increasing potency and accessibility over time.

  • 3400 BC: Our story begins in Mesopotamia, where the opium poppy was first cultivated. Early civilizations recognized its profound effects, often using it in religious ceremonies and for medicinal purposes.
  • 1400s AD: The Greeks and Romans began to more formally document the use of opium as a potent pain reliever. Its ability to dull suffering was unparalleled at the time.
  • 1500s AD: The therapeutic applications expanded. Paracelsus, a Swiss physician, created a tincture of opium called laudanum, which became a popular remedy for a wide range of ailments, including diarrhea.
  • 1803: A pivotal moment occurs when a German pharmacist, Friedrich Sertürner, successfully isolates the primary active alkaloid from opium. He names it morphine, after Morpheus, the Greek god of dreams. This discovery allows for standardized dosing and marks the beginning of modern opioid pharmacology.
  • 1832: French chemist Pierre-Jean Robiquet isolates another alkaloid from opium, codeine, which proves to be an effective cough suppressant.
  • 1874: In a London hospital, chemist C.R. Alder Wright synthesizes heroin (diacetylmorphine) from morphine. Initially, it was marketed by the Bayer Company as a non-addictive alternative to morphine and a cough suppressant. The tragic irony of this initial marketing is now painfully clear.
  • 1939: During World War II, German scientists searching for a synthetic painkiller that could be produced with readily available precursors synthesized methadone.
  • 1959: Paul Janssen of Janssen Pharmaceutica develops fentanyl, a synthetic opioid estimated to be 50 to 100 times more potent than morphine. Its primary use was for managing severe pain during and after surgery.
  • 1966: Scientists at a British firm discovered buprenorphine, a unique compound that would later become a cornerstone of OUD treatment due to its distinct pharmacological properties.

This historical overview shows that while the roots of opioid use are ancient, the majority of the substances that define the modern crisis were developed or discovered within the last 200 years, with a significant acceleration in the 20th century.

Understanding Opioid Potency: Morphine Milligram Equivalents (MME)

When we prescribe or discuss different opioid medications, simply comparing milligram to milligram is not only inaccurate but also dangerous. The concept of Morphine Milligram Equivalents (MME) is a crucial tool that allows healthcare providers to standardize and compare the relative potencies of different opioids. The MME calculates a dose’s equivalent strength to morphine, which serves as the benchmark.

Here is a list of common opioids, ordered by increasing potency relative to morphine. Understanding this hierarchy is essential for safe prescribing and for appreciating the risks associated with different substances.

  • Tramadol: This is often considered a “weaker” opioid, but it still carries risks. Its potency is such that 1 milligram of morphine is equivalent to 10 milligrams of tramadol (an MME conversion factor of 0.1).
  • Codeine: Slightly more potent than tramadol, with a conversion factor of 15.
  • Hydrocodone: This is a commonly prescribed opioid for moderate pain (e.g., in products like Vicodin or Norco). It has a 1-to-1 equivalence with morphine.
  • Oxycodone: Found in medications like Percocet and OxyContin, oxycodone is more potent than morphine, with a conversion factor of 5. This means 10 mg of oxycodone is equivalent to 15 mg of morphine.
  • Hydromorphone (Dilaudid): This is a significantly more potent opioid, typically used for severe pain in hospital settings. Its conversion factor is 0.
  • Fentanyl (Transdermal Patch): Fentanyl’s potency is in a different league altogether. It is so potent that it is measured in micrograms (mcg), not milligrams. Its MME conversion factor is 4 micrograms per hour for a transdermal patch, which is equivalent to 1 mg of oral morphine per day, but this conversion can be complex. The key takeaway is its extreme potency, which is why illicitly manufactured fentanyl has been so devastating.

From my clinical observations, the transition from a prescribed, lower-potency opioid like hydrocodone to a higher-potency one, whether prescribed or illicit, is a critical point where risk escalates dramatically. A patient accustomed to a certain dose of oxycodone may not realize that a similar-sized amount of fentanyl could be lethal. This is a vital educational point for every patient.

The Three Waves of the Opioid Crisis in the United States

The current opioid crisis did not emerge overnight. The U.S. Centers for Disease Control and Prevention (CDC) has characterized its progression in three distinct waves, each defined by the primary type of opioid driving overdose deaths.

First Wave (1999–2010): The Rise of Prescription Opioids

The crisis began in the late 1990s, fueled by a confluence of factors. There was a cultural shift in medicine to treat pain more aggressively, with pain being promoted as the “fifth vital sign.” This was coupled with the aggressive marketing of new opioid formulations, like OxyContin, which were claimed to be less addictive. The result was a dramatic increase in opioid prescribing.

  • Between 1999 and 2010, prescription opioid sales quadrupled in the United States.
  • Concurrently, opioid-involved overdose deaths doubled, rising from 2.9 to 6.8 deaths per 100,000 people.
  • This wave laid the groundwork for the crisis by creating a large population of individuals exposed to and, in many cases, dependent on opioids.

Second Wave (2010–2013): The Shift to Heroin

As awareness of prescription opioid misuse grew, regulations tightened, and it became more difficult and expensive to obtain these medications illicitly. Many individuals who had developed a dependence on prescription opioids turned to a cheaper and more accessible alternative: heroin.

  • From 2010 to 2013, heroin overdose deaths surged, increasing from 1.0 to 9 per 100,000 people.
  • During this period, heroin-related deaths surpassed those from prescription opioids for the first time.
  • This transition marked a shift from a problem primarily involving the healthcare system to one deeply enmeshed with the illicit drug market.

Third Wave (2013–Present): The Devastation of Synthetic Opioids

The third and most lethal wave began around 2013 with the infiltration of the illicit drug supply by potent synthetic opioids, most notably illicitly manufactured fentanyl. Fentanyl is not only incredibly potent but also cheap to produce, making it a profitable adulterant for drug traffickers. It began to be mixed into heroin, cocaine, methamphetamine, and pressed into counterfeit pills made to look like legitimate prescription opioids (like Xanax or oxycodone).

  • Since 2013, death rates from synthetic opioids have increased by over 1,000%, skyrocketing from 1.0 to 11.4 deaths per 100,000 people in just five years.
  • A deeply concerning recent trend within this wave is the emergence of xylazine, a non-opioid animal tranquilizer, being mixed with fentanyl. This combination, known as “tranq,” increases the risk of overdose and can cause severe, necrotic skin wounds. By 2017, xylazine was found in up to 10% of fentanyl-related overdoses in some areas.

In 2017, recognizing the catastrophic scale of the problem, the U.S. Department of Health and Human Services officially declared the opioid crisis a Public Health Emergency.

The CDC graph below visually demonstrates the staggering impact of these three waves. The teal line represents the first wave of commonly prescribed opioids, showing a steady rise and then a leveling off. The blue line shows the second wave’s rise in heroin deaths starting in 2010. But it is the purple line, representing the third wave of synthetic opioids, that is most striking. It remains relatively flat until 2013 and then skyrockets exponentially, dwarfing the death tolls of the previous two waves. The sheer verticality of this line is a stark illustration of the lethality of fentanyl.

The Current Landscape of Opioid Misuse

Data from the 2021 SAMHSA National Survey on Drug Use and Health provides a snapshot of the current situation. Among people aged 12 or older in the United States:

  • 9.2 million people misused opioids in the past year.
  • This can be broken down further:
    • Misuse of Prescription Pain Relievers: This remains the larger issue by volume, with approximately 8.1 million people exclusively misusing pain medication.
    • Heroin Use: Approximately 0.5 million people reported using only heroin.
    • Overlap: A significant group of about 0.5 million people reported misusing both prescription pain relievers and heroin.
    • In total, about 1 million people reported using heroin.

These numbers underscore the continued importance of responsible prescribing practices for pain relievers, as this remains a primary pathway into OUD for millions of Americans.

Key Legislation and Milestones in Opioid Treatment

The legal and regulatory landscape surrounding opioids has profoundly shaped both the problem and its potential solutions. Understanding these key legislative acts provides context for why treatment is structured the way it is today.

  • Harrison Narcotics Tax Act of 1914: This was one of the first federal laws to regulate and tax the production, importation, and distribution of opiates and cocaine. Crucially, it criminalized the non-medical use of opiates, framing addiction more as a legal problem than a medical one and driving it underground.
  • Controlled Substances Act (CSA) of 1970: This act created the drug scheduling system (Schedules I-V) that classifies substances based on their medical use and potential for abuse. It also established the Drug Enforcement Administration (DEA) to regulate these controlled substances.
  • Narcotic Addiction Treatment Act of 1974: This law specifically regulated the treatment of opioid addiction. It mandated that methadone could only be dispensed through highly regulated, federally certified programs, known as opioid treatment programs (OTPs) or “methadone clinics.” This created a siloed system, separating OUD treatment from mainstream medical care.
  • Drug Addiction Treatment Act of 2000 (DATA 2000): This was a landmark piece of legislation. It created the “buprenorphine waiver” (often called the “X-waiver”), which, for the first time, allowed qualified physicians to prescribe buprenorphine—a Schedule III opioid—for the treatment of OUD in an office-based setting. This was a monumental step toward integrating addiction treatment into general medicine.
  • Comprehensive Addiction and Recovery Act (CARA) of 2016: This act expanded access to treatment by allowing Nurse Practitioners (NPs) and Physician Assistants (PAs) also to obtain a waiver and prescribe buprenorphine, significantly increasing the number of potential providers.
  • SUPPORT for Patients and Communities Act of 2018: This act further expanded access to care, particularly by addressing reimbursement issues within Medicare and Medicaid for OUD treatment.
  • Mainstreaming Addiction Treatment (MAT) Act of 2023: This legislation marked another revolutionary change. It eliminated the buprenorphine waiver (X-waiver) requirement. Now, any prescriber with a standard DEA license who is permitted to prescribe Schedule III medications under their state license can prescribe buprenorphine for OUD. This has been a game-changer in “mainstreaming” addiction care and reducing barriers for both patients and providers.

Enhancing Health Together: Embracing Multidisciplinary Evaluation and Treatment- Video

Enhancing Health Together: Embracing Multidisciplinary Evaluation and Treatment | El Paso, Tx (2023)

The Rationale for Treatment: A Disease That Demands a Medical Response

Opioid Use Disorder is not a moral failing; it is a chronic, relapsing brain disease. The statistics paint a sobering picture of an undertreated epidemic.

  • Of the estimated 9 million adults in the United States who need treatment for OUD, only a little over 2 million (about 22%) actually receive medications for opioid use disorder (MOUD).
  • In 2022, there were nearly 82,000 opioid overdose deaths.
  • The economic impact is staggering, costing the nation over $193 billion annually in healthcare costs, lost productivity, and criminal justice expenses.

These numbers make it unequivocally clear that treating OUD is not just a compassionate choice; it is a medical, social, and economic necessity.

Deconstructing the Myths and Stigma Surrounding OUD Treatment

One of the greatest barriers to effective treatment is the persistent stigma that surrounds OUD and the medications used to treat it. This stigma is often rooted in deeply ingrained myths. The best way to dismantle these myths is to reframe them in the context of other chronic medical conditions.

Myth 1: “Medications for OUD (MOUD) just replace one addiction with another.”

Fact: This is perhaps the most common and damaging misconception. Let’s apply this logic to another chronic disease: diabetes. We would never say that giving a patient insulin is “replacing a sugar addiction with an insulin addiction.” We understand that insulin is a life-saving medication that corrects a physiological deficit. Similarly, medications like buprenorphine and methadone work by stabilizing the brain’s neurochemistry, which the disease of addiction has hijacked. They normalize brain function, reduce cravings, and prevent withdrawal, allowing a person to focus on recovery, hold a job, and rebuild their life. It is treatment, not a replacement.

Myth 2: “Recovery without medication is superior to recovery with medication.”

Fact: This myth creates a false hierarchy of recovery. Let’s consider a patient with hypertension. We might first recommend diet and exercise. If their blood pressure comes down, that’s a successful outcome. If another patient tries diet and exercise but their blood pressure remains dangerously high, we add medication. We would never think that the second patient’s treatment plan is “inferior.” They are simply two different patients with different physiological needs requiring different treatment plans. The goal is a healthy outcome—a stabilized patient. The same is true for OUD. For many, medication is an essential component of a successful treatment plan.

Myth 3: “MOUD is not effective.”

Fact: The evidence is overwhelmingly to the contrary. Extensive research has demonstrated that MOUD is the gold standard of care. When individuals with OUD are treated with medications like buprenorphine or methadone, their risk of fatal overdose is dramatically reduced. Studies show up to a 60% reduction in all-cause mortality among patients receiving MOUD compared to those who are not.

Myth 4: “MOUD is a crutch for weak people who can’t stop on their own.”

Fact: This statement completely misunderstands the neurobiology of addiction. OUD is a chronic disorder that profoundly alters brain circuits involved in reward, stress, and self-control. It hijacks the brain’s decision-making capacity. The intense cravings and withdrawal symptoms are not a matter of willpower; they are powerful physiological and psychological compulsions. Just as we would medically treat the pathophysiology of any other chronic organ disease, we must medically treat the pathophysiology of this brain disease.

What is a Substance Use Disorder?

The language we use to discuss these conditions has evolved. We have moved away from terms like “abuse,” “dependence,” and “addiction” in a clinical context. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), now classifies these conditions as Substance Use Disorders (SUDs).

  • SUDs are defined as chronic, relapsing medical conditions that occur within the brain.
  • They are diagnosed using a specific set of 11 criteria and categorized by severity (mild, moderate, or severe) based on how many criteria a person meets.
  • The good news is that there are effective, evidence-based treatments

The DSM-5 Criteria for Opioid Use Disorder

To be diagnosed with OUD, a person must exhibit at least two of the following 11 criteria within 12 months. As we review these, notice how many relate to behavioral changes and life impact rather than a specific quantity of substance used. This highlights that OUD is about the loss of control and the negative consequences of use.

  1. Using in larger amounts or for a longer period than intended.
  2. A persistent desire or unsuccessful efforts to cut down or control use. (This is the loss of control.)
  3. Spending a great deal of time obtaining, using, or recovering from the effects of the substance. (The substance becomes the central organizing principle of life.)
  4. Craving, or a strong desire or urge to use.
  5. Recurrent use failing to fulfill major role obligations at work, school, or home.
  6. Continued use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance.
  7. Giving up or reducing important social, occupational, or recreational activities because of use.
  8. Recurrent use in situations in which it is physically hazardous (e.g., driving while impaired, using non-sterile needles).
  9. Continued use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance. (The reward system overrides the brain’s self-preservation system.)
  10. Tolerance: Defined by either needing markedly increased amounts of the substance to achieve the desired effect or a markedly diminished effect with continued use of the same amount.
  11. Withdrawal: Manifested by either the characteristic withdrawal syndrome for the substance or using the substance (or a closely related one) to relieve or avoid withdrawal symptoms.

It is important to note that meeting only the criteria for tolerance and withdrawal (10 and 11) does not constitute an OUD diagnosis. This is because a patient taking opioids as prescribed for chronic pain can develop physiological tolerance and withdrawal without having the compulsive, life-disrupting behaviors that define the disorder. They must also meet at least one of the first nine criteria.

The Pervasive Impact of Stigma on Care

Stigma is a powerful, destructive force that directly affects patient outcomes. It manifests at every level of society and creates formidable barriers to seeking and receiving care.

Public Stigma

Public stigma involves the negative attitudes and beliefs held by the general population.

  • Not recognizing SUD as a chronic condition: This leads to the belief that it is a moral failing, which in turn fuels judgment and blame.
  • Association with crime: People with OUD are often unfairly stereotyped as dangerous or criminal.
  • Opposition to treatment access: Stigmatizing beliefs lead to “Not In My Backyard” (NIMBY) sentiment, where communities oppose the establishment of treatment facilities or harm reduction services.
  • Some studies suggest that this stigma tends to increase with age.

Structural Stigma

Structural stigma is woven into the very fabric of our institutions, policies, and laws.

  • Public Policy: The declaration of the “War on Drugs” in 1971 framed substance use as a criminal justice issue, not a public health one. This led to mass incarceration, disproportionately affecting racial and ethnic minorities, with very low levels of SUD treatment available within the criminal justice system.
  • The Buprenorphine Waiver: The history of the X-waiver itself is an example of structural stigma. We required providers to undergo extra training and special licensing to prescribe a medication to treat OUD. At the same time, no such barriers existed for prescribing the very opioids that often caused the disorder.
  • Lack of Funding and Organizational Policies: Inadequate funding for treatment and harm reduction services is a form of structural stigma. Additionally, stigmatizing policies like mandatory drug testing for employment or housing can penalize individuals in recovery and create barriers to stability.

Individual Stigma and Provider Bias

Individual stigma includes the prejudice and discrimination directed at people with OUD.

  • Stereotypes: Believing that individuals with OUD are “dangerous” or “unpredictable.”
  • Prejudice: Feelings of anger, fear, resentment, and moral outrage toward people with OUD.
  • Discrimination: This can manifest as coercive treatment (“You must stop using completely, or I won’t treat your other conditions”) or social restrictions.
  • Internalized Shame: Individuals with OUD often internalize these negative messages, leading to feelings of worthlessness and hopelessness. Some may also tell them in the recovery community that they are not “truly sober” if they are taking MOUD.

This stigma also presents as provider bias. Studies have shown that some healthcare providers hold negative attitudes toward this patient population, are worried about legal implications, or believe that SUD is a moral failing. The direct consequence is a reduced likelihood that providers will prescribe life-saving MOUD.

The Power of Language: Using Person-First Language to Reduce Stigma

One of the most powerful tools we have to combat stigma is our language. Person-first language reorients our thinking to see the person, not the disease. It is a conscious choice to use words that are objective, medically accurate, and free of judgment.

  • Instead of: “addict” or “junkie” → Use: “person with a substance use disorder” or “person in recovery.”
  • Instead of: “user” or “abuser” → Use: “person who uses drugs” (PWUD) or “person who injects drugs” (PWID).
  • Instead of: “a baby born addicted” → Use: “a baby born with neonatal opioid withdrawal syndrome (NOWS).” A baby cannot have the compulsive behaviors that define addiction; they can, however, experience physiological withdrawal.
  • Instead of: a “clean” or “dirty” urine test → Use: “negative for substance X” or “positive for substance Y.” If a patient’s A1c were high, we wouldn’t call their blood “dirty”; we would state the objective lab result. The same standard should apply here.
  • Instead of: “medication-assisted treatment (MAT)” → Use: “medications for opioid use disorder (MOUD).” This subtle but important shift emphasizes that medication is not merely “assisting” treatment—medication is a primary, evidence-based treatment.
  • Instead of: “abuse” → Use: “misuse” or “use.” The word “abuse” carries heavy connotations of violence and judgment. “Misuse” or “use” are more neutral and medically accurate terms.

Case Study: Putting Person-First Language into Practice

Let’s review a sample case study, first as it might be written with stigmatizing language, and then rewritten using a person-first approach.

  • Original (Stigmatizing) Version:
    • Substance Use History: Patient reports abusing heroin IV from age 20 to 30. Last use of heroin was one month ago after seven years clean.
    • Treatment History: Entered recovery after an overdose. Started medication-assisted treatment.
    • Protective Factors: Regularly involved with the addict community.
    • Family History: She has a female child, nine years old, born addicted to heroin, who is healthy now.

Now, let’s see how different it reads when we apply person-first principles.

  • Revised (Person-First) Version:
    • Substance Use History: The patient reports misusing heroin IV from ages 20 to 30. Last use of heroin was one month ago after seven years of no use.
    • Treatment History: She entered recovery after an overdose and started medications for opioid use disorder (MOUD).
    • Protective Factors: She is regularly involved with the recovery community.
    • Family History: She has a female child, nine years old, who was born with neonatal opioid withdrawal and is healthy now.

The second version is more respectful, medically accurate, and less judgmental. It frames the patient’s history as a medical journey rather than a series of moral failings.

Evidence-Based Treatments: A Toolkit for Recovery

Effective treatment for OUD is multifaceted, combining psychosocial support with pharmacological intervention.

Motivational Interviewing: Partnering with the Patient for Change

Motivational Interviewing (MI) is a collaborative, goal-oriented communication style focused on the language of change. It is designed to strengthen a person’s own motivation for and commitment to a specific goal by eliciting and exploring their own reasons for change in an atmosphere of acceptance and compassion. It is not about confronting or persuading; it is about partnering.

The Spirit of MI

The core philosophy of MI is built on four pillars:

  • Partnership: You are not the expert on the patient’s life; they are. You collaborate with them, supporting them rather than trying to persuade them.
  • Evocation: The motivation for change already lies within the patient. Your job is to evoke it, to draw it out by focusing on their own perceptions, goals, and values.
  • Acceptance: This involves recognizing the patient’s absolute worth, affirming their strengths, supporting their autonomy, and conveying accurate empathy.
  • Compassion: The guiding principle is to act in the patient’s best interest with a non-judgmental, non-blaming, and non-shaming attitude.

The Process of MI

MI generally follows four overlapping processes:

  1. Engaging: Building a strong therapeutic alliance and rapport.
  2. Focusing: Collaboratively identifying a specific goal or target for change. What does the patient want to work on?
  3. Evoking: Eliciting the patient’s own motivations for change. This is the heart of MI.
  4. Planning: Developing a specific, concrete plan for change, exploring options, and building support.

The Tools of MI: OARS and DARN CATS

Motivational interviewing provides helpful acronyms that serve as practical guides for structuring conversations.

OARS represents the core communication skills:

  • Open-ended questions: “Can you tell me a little bit about your recovery journey?” instead of “Have you been to meetings?”
  • Affirmations: Recognizing and acknowledging the patient’s strengths and efforts. “That’s a really creative idea for how to avoid a situation where you might be tempted to use.”
  • Reflective listening: This is the most critical skill. It involves listening carefully and reflecting the meaning of what the patient said. In good MI, the provider should be doing more reflecting than questioning.
  • Summaries: Pulling together the key points of the conversation. “Let me make sure I understand… is that correct?” This shows the patient you are listening and helps to reinforce their own insights.

DARN CATS is an acronym for the different types of “change talk” you want to elicit from the patient.

DARN (The “Preparatory” Change Talk):

  • Desire: “What do you hope our work together will accomplish?”
  • Ability: “What do you think you might be able to change about your opioid use?”
  • Reasons: “Why do you want to stop or cut back your use?” This helps connect the change to the patient’s core values (e.g., “I want to be present for my child’s graduation”).
  • Need: “What needs to happen for you to feel ready to give up opioids?”

CATS (The “Mobilizing” Change Talk):

  • Commitment: “I will start attending meetings.”
  • Activation: “I am ready to reduce my use to two times a week.”
  • Taking Steps: “I’ve already started looking up phone numbers for therapists.”

Listening for this language helps you gauge where the patient is in their readiness for change.

Understanding the Stages of Change

The Transtheoretical Model of Change provides a framework for understanding that readiness is not an all-or-nothing state. People move through different stages on their journey to change.

  1. Precontemplation: The person is not currently considering change. (“I don’t think my drug use is a problem.”)
  2. Contemplation: The person is ambivalent about change, seeing both pros and cons. (“I think my marriage might improve if I reduce my use, but I’m not sure I can handle the stress without it.”)
  3. Preparation: The person is committed to change and is preparing to take action. (“I’ve looked up an NA meeting to attend near my house.”)
  4. Action: The person is actively taking steps to change. (“I reduced the number of days per week I use drugs.” or “I initiated buprenorphine treatment.”)
  5. Maintenance: The person is working to sustain the change and prevent relapse. (“I have been using medications for opioid use disorder for a year now.”)

Identifying a patient’s stage of change allows you to tailor your approach. Trying to force an action plan on someone in pre-contemplation will only create resistance. For that patient, the goal is to start a conversation about the pros and cons.

Non-Pharmacological Management: Building a Support System

Psychosocial support is a critical component of a comprehensive treatment plan. While it should not be mandatory for receiving MOUD, it greatly improves recovery outcomes.

  • Behavioral Therapy: This can be one-on-one therapy with a psychologist, social worker, or licensed counselor. Recovery coaches and peer support specialists also provide invaluable one-on-one support.
  • Group Therapy: Mutual support groups offer a sense of community and shared experience that can be profoundly healing. Options include:
  • SMART Recovery (Self-Management and Recovery Training): Based on principles of Cognitive Behavioral Therapy (CBT) and Rational Emotive Behavior Therapy (REBT).
  • Alcoholics Anonymous (AA) and Narcotics Anonymous (NA): These are 12-step programs that are widely available. While they often have a spiritual or religious component centered on a “higher power,” many groups are very welcoming to diverse beliefs.
  • Secular Organizations for Sobriety (SOS): These offer a non-religious alternative for those who prefer a secular approach.

As a healthcare provider, I strongly encourage my colleagues to attend an open meeting of one of these groups. It provides invaluable insight into the supportive environment you may be recommending to your patients.

Pharmacological Management: Medications for Opioid Use Disorder (MOUD)

To understand how MOUD works, we must first review the basic pharmacology of the opioid receptor. The primary target for opioids is the mu-opioid receptor in the brain. Different substances interact with this receptor in different ways.

  • Full Agonists: These substances bind to and fully activate the mu-opioid receptor. This produces the full opioid effect, including euphoria and, at higher doses, dangerous respiratory depression. Examples include heroin, fentanyl, morphine, and methadone.
  • Partial Agonists: These substances bind to the mu-opioid receptor but activate it only partially. This produces a limited opioid effect that is sufficient to prevent withdrawal and reduce cravings. Still, it has a “ceiling effect,” meaning that beyond a certain dose, the effects do not increase. Buprenorphine is the primary example.
  • Antagonists: These substances bind to the mu-opioid receptor but do not activate it. Instead, they block the receptor, preventing any agonist from binding and having an effect. Naloxone and naltrexone are pure antagonists.

The key takeaway is buprenorphine’s ceiling effect. This property is what makes it a much safer medication for OUD treatment than a full agonist.

Methadone

  • Mechanism: Methadone is a long-acting full mu-opioid agonist.
  • Regulation: It is a Schedule II controlled substance that, for OUD treatment, can only be dispensed through federally certified Opioid Treatment Programs (OTPs).
  • Side Effects: Common opioid side effects include constipation, sedation, dizziness, and sweating.
  • Serious Side Effects: The most significant serious side effect is QTC prolongation, an electrical disturbance in the heart that can lead to fatal arrhythmias. This risk increases at higher doses (generally over 100 mg/day). As a full agonist, it also carries a significant risk of respiratory depression.
  • Contraindications: Acute or severe asthma (due to respiratory risk) and GI obstruction (due to its effect of slowing the gut).

Buprenorphine

  • Mechanism: Buprenorphine is a partial mu-opioid agonist and a kappa-opioid antagonist. It has a very high affinity (strong binding) for the mu-receptor but low intrinsic activity (it only partially activates it).
  • Key Properties:
    • Its high affinity means it can displace full agonists like heroin or fentanyl from the receptor. This is why initiating it requires the patient to be in a state of moderate withdrawal. If given when a person has a full agonist in their system, it will “bump off” the full agonist and rapidly lower receptor activation, causing a severe, abrupt withdrawal known as precipitated withdrawal.
    • Conversely, if a person is already in withdrawal (low receptor activation), buprenorphine will bind and bring the activation up to its ceiling level, relieving withdrawal symptoms.
    • It reduces cravings but does not provide the intense euphoria of full agonists due to its ceiling effect.
  • Side Effects: Headache, constipation, nausea, oral hypoesthesia (numbness in the mouth from sublingual formulations).
  • Serious Side Effects: While much lower than with full agonists, there is still a risk of respiratory depression, especially when combined with other central nervous system depressants like benzodiazepines or alcohol. Other rare but serious effects include hepatotoxicity.
  • Drug Interactions:
    • Benzodiazepines: This combination increases the risk of respiratory depression. However, the FDA has issued guidance stating that the benefits of treating OUD with buprenorphine in a patient taking benzodiazepines outweigh the risks of withholding it, as the alternative (illicit fentanyl use) carries a much higher risk of overdose. Patients should be counseled on the risks and monitored closely.
    • CYP3A4 Inhibitors (e.g., erythromycin, grapefruit juice): These will slow the metabolism of buprenorphine, increasing its concentration.
    • CYP3A4 Inducers (e.g., rifampin, St. John’s wort): These will speed up the metabolism of buprenorphine, decreasing its concentration.

Naloxone

  • Mechanism: Naloxone is a pure opioid antagonist. It is the primary medication used to reverse an opioid overdose.
  • Use in Combination Products: You will often see buprenorphine formulated in combination with naloxone (e.g., Suboxone). The purpose of the naloxone in this oral formulation is as a deterrent to misuse. When taken sublingually as directed, the naloxone has very poor bioavailability and has no effect. However, if a person were to crush and inject the tablet, the naloxone would be bioavailable. It would block the opioid receptors, preventing the buprenorphine from working and potentially causing withdrawal.
  • Use in Overdose Reversal: Naloxone has a shorter half-life than most opioids. This is critically important. When you administer naloxone to someone who has overdosed on fentanyl, the naloxone will knock the fentanyl off the receptors and reverse the respiratory depression. However, the naloxone will wear off in 30-90 minutes, while the fentanyl is still present in the body. When the naloxone is gone, the fentanyl can re-bind to the receptors and cause the overdose to resume. This is why it is essential to call 911 and seek emergency medical care even after naloxone has been administered.
  • Side Effects: If given to someone with opioids in their system, it will induce an acute opioid withdrawal syndrome (tachycardia, irritability, fever, nausea, vomiting, diarrhea). If given to someone without opioids in their system, it has no effect.
  • Formulations:
    • Intranasal: Commonly known by the brand name NARCAN, it is available as a 4 mg/0.1 mL nasal spray. Education should include giving one dose in one nostril, waiting 2-3 minutes, and if there is no response, giving the second dose (from the second device in the box) in the other nostril.
    • Injectable: Often used by EMS personnel.

Naltrexone

  • Mechanism: Naltrexone is a mu and kappa opioid receptor antagonist. It completely blocks the opioid pathway. It is also used for Alcohol Use Disorder.
  • Use in OUD: It reduces cravings and, by blocking the receptors, prevents a person from feeling any effect if they do use opioids.
  • Important Consideration: A patient must be completely opioid-free for 7-10 days before starting naltrexone. If given sooner, it will precipitate a severe withdrawal. Patients also need to understand that if they are on naltrexone, standard opioid pain relief will not work in an emergency or surgical situation.
  • Side Effects: Headache, nausea, diarrhea, and injection-site reactions with the long-acting formulation.
  • Serious Side Effects: Rare but serious risks include acute hepatitis, eosinophilic pneumonia, and depression. Liver enzymes should be monitored.
  • Formulations:
    • Injectable (Vivitrol): A 380 mg extended-release injectable suspension given as a deep IM gluteal injection once a month.
    • Oral (PO): Typically dosed at 50 mg daily.

Harm Reduction: A Pragmatic and Life-Saving Approach

Harm reduction is a set of practical strategies and ideas aimed at reducing the negative consequences associated with drug use. It is a movement for social justice built on a belief in, and respect for, the rights of people who use drugs. It is about meeting people where they are, without judgment.

  • Naloxone Co-prescribing: I make it a practice to co-prescribe naloxone to any patient who uses drugs (not just opioids) or is on prescription opioids for chronic pain. The illicit drug supply is so contaminated that even people who think they are using cocaine or methamphetamine are at risk of a fatal fentanyl overdose. Their family and friends must be trained on how to use it.
  • Fentanyl Test Strips: These are small, inexpensive strips of paper that can detect the presence of fentanyl in a drug supply. Providing these to patients allows them to test their drugs before using them. Discovering that their supply is contaminated with fentanyl can be a powerful motivator to change their use or seek treatment.
  • Never Use Alone Hotline: This is a service where a person can call a confidential hotline before they use drugs. They provide their location, and an operator stays on the line. If the person becomes unresponsive, the operator calls emergency services to that location.
  • Clean Needle Exchanges (Syringe Service Programs): These programs provide sterile syringes and other injection equipment to people who inject drugs. They are proven to dramatically reduce the transmission of bloodborne pathogens like HIV and Hepatitis C, and they also serve as vital access points to connect people with treatment and other health services.
  • Urine Drug Screens (UDS): A UDS should not be used as a punitive tool. It is a therapeutic tool. A patient may tell you, “I don’t use fentanyl,” and genuinely believe it. When their UDS comes back positive for fentanyl, it opens the door for a non-judgmental conversation: “It looks like your heroin supply might have fentanyl in it. That’s incredibly dangerous. Let’s talk about how to keep you safe.”
  • Prescription Drug Monitoring Programs (PDMPs): These state-level electronic databases track controlled-substance prescribing. They are an essential tool for providers to ensure coordinated, safe care and to identify patients who may be receiving prescriptions from multiple sources.
  • Motivational Interviewing: As discussed, MI is itself a form of harm reduction. It prioritizes the patient’s own goals, which may not be immediate abstinence but could be a smaller step like “not sharing needles” or “using less frequently.”

In my own practice, integrating these harm reduction strategies with chiropractic care and functional medicine is key. By reducing a patient’s pain through manual therapies, we reduce their reason to seek out opioids. By optimizing their nutrition and gut health, we improve their mental clarity and resilience. This holistic approach, guided by Dr. Cardenas’s medical expertise, embodies the principle of meeting patients where they are and offering every available tool to move toward a healthier life.

Conclusion: A Path Forward

The history of opioids provides a crucial context for understanding the modern OUD crisis. It is a story of medical innovation intertwined with profound social and legal consequences. Stigma remains one of the most significant and damaging barriers to care. Still, we can actively combat it through our language and our commitment to treating OUD as the chronic medical condition it is.

Fortunately, we have a growing arsenal of effective, evidence-based treatments. These include life-saving medications for opioid use disorder (MOUD), powerful psychosocial tools like motivational interviewing, and pragmatic, life-affirming harm reduction techniques.

At Injury Medical Clinic, our multidisciplinary approach embraces this complexity. By weaving together the diagnostic acumen of internal medicine, the biomechanical focus of chiropractic care, the systems-based approach of functional medicine, and a deep commitment to evidence-based OUD treatment, we can offer our patients a comprehensive and compassionate path to recovery.

If you have any questions, please feel free to reach out. Thank you for taking the time to engage with this important topic.

References and Further Reading

SEO Tags: Opioid Use Disorder, OUD Treatment, Integrative Chiropractic Care, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso TX, Functional Medicine, MOUD, Buprenorphine, Methadone, Naltrexone, Naloxone, Opioid Crisis, Harm Reduction, Motivational Interviewing, Person-First Language, Stigma, Substance Use Disorder, Chronic Pain Management, Personal Injury Care, DSM-5, Fentanyl, Heroin, Prescription Opioids, Overdose Prevention, Recovery, Multidisciplinary Clinic

Missed MVA and Workplace Injuries Causing Pain Solutions

Missed MVA and Workplace Injuries Causing Pain Solutions
Missed MVA and Workplace Injuries Causing Pain Solutions

Missed MVA and Workplace Injuries Causing Pain

Abstract

Motor vehicle accidents (MVAs) and workplace accidents can cause injuries that are not obvious during the first medical visit. A person may have normal X-rays and still have pain from damaged muscles, ligaments, spinal discs, facet joints, nerves, or other soft tissues. Mild traumatic brain injuries, including concussions, may also occur without obvious findings on routine imaging. Some symptoms develop hours or days later.

This article explains why hidden injuries can be difficult to identify, including spinal ligament micro-tears, annular disc tears, facet joint capsule injuries, myofascial trigger points, and mild concussions. It also explains how a coordinated approach may combine medical evaluation, integrative chiropractic care, rehabilitation, functional medicine, pain management, and selected biological therapies. At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, works within a multidisciplinary model that includes medical oversight from Dr. Maria Guadalupe Cardenas, MD.

Missed MVA and Workplace Injuries Causing Pain Solutions

Why Some Accident Injuries Are Hard to See

After a car crash, fall, lifting injury, or workplace accident, the first goal is usually to rule out emergencies. Doctors may look for fractures, internal bleeding, severe brain injury, spinal cord damage, or other dangerous problems.

This emergency approach is important. However, a normal initial test does not always mean that every tissue is healthy.

Plain X-rays are mainly designed to show bones and their general alignment. They do not provide the same soft-tissue detail as MRI. Therefore, injuries involving muscles, tendons, ligaments, spinal discs, nerves, and joint capsules may require a different type of evaluation when symptoms continue.

The American College of Radiology notes that when ligament, spinal cord, or nerve-root injury is suspected after spinal trauma, MRI may be appropriate even when other imaging has already been performed (American College of Radiology, n.d.).

Several accident-care resources also describe delayed or overlooked symptoms after crashes, especially with whiplash, soft-tissue injuries, back injuries, and concussions (Advantage Healthcare Systems, 2025; Xcell Medical Group, 2026).

The key message is simple: a normal X-ray is useful information, but it does not rule out every possible injury.

Spinal Ligament Micro-Tears

Ligaments are strong bands of tissue that connect bones and help stabilize joints.

During a rear-end collision, side impact, fall, or sudden workplace accident, the spine can move rapidly beyond its normal range. This may stretch or injure the small ligaments that help stabilize the neck and lower back.

A person may develop:

  • Neck or back stiffness
  • Pain with movement
  • Headaches
  • Muscle guarding
  • Reduced range of motion
  • A feeling that the spine is weak or unstable
  • Pain that becomes worse with sitting, lifting, or repetitive work

Whiplash-related soft-tissue injuries may not produce an obvious abnormality on a basic X-ray. Careful history, physical examination, neurological testing, and additional imaging may be needed when symptoms or examination findings justify it (Advantage Healthcare Systems, 2025).

Annular Tears in Spinal Discs

Intervertebral discs sit between the spinal bones. Each disc has a softer center surrounded by a stronger outer ring called the annulus fibrosus.

Sudden twisting, bending, compression, or acceleration-deceleration forces can stress this outer ring. Small separations in the fibers are called annular fissures or annular tears.

Some annular tears cause no symptoms. Others may contribute to back or neck pain, especially when nearby structures become irritated. Annular tears can also exist with disc bulges or herniations (Tenny et al., 2023).

Because discs are soft tissues, plain X-rays cannot directly show an annular tear. When clinically appropriate, MRI can provide much more information about discs, nerves, ligaments, and other soft tissues.

This is one reason persistent pain after a normal X-ray deserves a complete clinical assessment rather than assuming nothing is wrong.

Hidden Facet Joint Capsule Trauma

Facet joints are small joints located at the back of the spine. They guide spinal movement and help control excessive motion.

Each facet joint is surrounded by a capsule made of connective tissue. During whiplash or another sudden injury, the capsule can stretch or become irritated.

Facet-related pain may cause:

  • Local neck or back pain
  • Pain with turning or bending
  • Pain that spreads into the shoulders or upper back
  • Headaches associated with neck movement
  • Muscle tightness around the injured area

Research on whiplash has identified the cervical facet region and its supporting tissues as possible sources of persistent neck pain after trauma.

Because the injury can involve soft tissues rather than a broken bone, it may not be visible on standard X-rays.

Persistent Myofascial Trigger Points

Muscles can also become part of the injury pattern.

After trauma, muscles often tighten to protect an injured joint or spinal segment. Sometimes painful areas develop within these muscles. These areas are commonly called myofascial trigger points.

Trigger points may produce:

  • Deep aching pain
  • Muscle stiffness
  • Referred pain
  • Headaches
  • Shoulder or back discomfort
  • Reduced movement

A study comparing people with whiplash-associated disorders with people who had mechanical neck pain found more active myofascial trigger points in the whiplash group (Castaldo et al., 2014).

This helps explain why a person can have continuing pain even when a basic X-ray does not show a fracture.

Mild Concussions Can Be Difficult to Recognize

A concussion does not always require a direct blow to the head.

The Centers for Disease Control and Prevention explains that mild traumatic brain injury can result from a blow to the head or from a hit to the body that makes the head and brain move rapidly back and forth (Centers for Disease Control and Prevention [CDC], 2025).

Symptoms can include:

  • Headache
  • Dizziness
  • Brain fog
  • Memory problems
  • Trouble concentrating
  • Light or noise sensitivity
  • Sleep changes
  • Nausea
  • Balance problems
  • Irritability

Importantly, concussion is usually a clinical diagnosis. Routine CT or MRI is not required to diagnose most mild concussions. Imaging is generally used when a doctor is concerned about problems such as bleeding or another more serious brain injury (CDC, 2025).

This means that a person can have a real concussion even when structural brain imaging is normal.

Workplace Injuries May Develop Slowly

Not every workplace injury occurs during one dramatic event.

Workers may experience cumulative trauma from:

  • Repetitive lifting
  • Bending and twisting
  • Frequent reaching
  • Computer work
  • Vibrating tools
  • Repeated overhead work
  • Poor lifting mechanics
  • Long periods of standing or sitting

These repeated stresses can gradually affect joints, muscles, tendons, and other tissues.

Workplace injury resources describe sprains, strains, repetitive stress injuries, and cumulative trauma as important causes of work-related pain and disability (Bridgman Gantt Law Offices, 2025; Stern & Cohen, n.d.).

A worker may therefore have a significant physical problem even without one clearly remembered accident.

Finding the Injury Requires More Than One Test

A complete injury evaluation begins with the patient, not the image.

Depending on the situation, the healthcare team may evaluate:

  • How the accident happened
  • Direction and force of impact
  • Location and timing of symptoms
  • Range of motion
  • Muscle strength
  • Reflexes
  • Sensation
  • Balance
  • Gait and posture
  • Joint stability
  • Orthopedic findings
  • Neurological findings
  • Changes in work or daily function

Imaging is then selected according to the clinical findings.

X-ray, CT, and MRI are different tools. No single test can identify every injury.

Integrative Chiropractic Care: Restoring Mechanical Function

Once serious injuries have been ruled out and the diagnosis is better understood, recovery often requires more than simply reducing pain.

Integrative chiropractic care can focus on restoring the way the body moves.

Depending on the diagnosis and patient, care may include:

  • Gentle chiropractic adjustments or mobilization
  • Soft-tissue treatment
  • Range-of-motion exercises
  • Corrective exercise
  • Strengthening
  • Neuromuscular retraining
  • Posture and movement correction
  • Progressive rehabilitation

Clinical guidelines for neck pain recommend a combination of manual therapy, mobility exercises, and strengthening for appropriate patients rather than depending solely on passive treatments (Blanpied et al., 2017).

The goal is not simply to “put a bone back into place.” It is to improve movement, reduce unnecessary mechanical stress, rebuild strength, and help the patient return safely to normal activity.

Combining Mechanical Restoration With Biological Support

An integrative injury model can look at two major parts of recovery:

Mechanical restoration focuses on movement, spinal and joint function, strength, flexibility, and rehabilitation.

Biological support focuses on the injured tissue itself and the physical conditions needed for healing.

Depending on the diagnosis, this broader plan may include rehabilitation, nutrition, sleep support, medical management, image-guided procedures, or selected orthobiologic procedures.

PRP and other biologic approaches are being studied and used for selected musculoskeletal conditions. However, patients should understand that evidence varies greatly by tissue, diagnosis, procedure, and product. Regenerative treatments should not be presented as guaranteed ways to rebuild damaged spinal tissue.

The FDA also warns consumers that many marketed stem-cell, exosome, and other human cell or tissue products have not been approved for orthopedic conditions such as back pain, neck pain, disc disease, tendon problems, or joint pain.

Medical screening and informed decision-making are therefore essential.

Multidisciplinary Injury Care in El Paso

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes a clinical model that combines chiropractic care, medical evaluation, functional medicine, personal injury care, rehabilitation, and related services.

In his published clinical observations, Dr. Jimenez reports that patients with traumatic joint and spinal injuries may show changes in posture, gait, muscle control, and spinal movement in addition to pain at the injured site. His approach therefore looks beyond one painful structure and evaluates how the injury affects the larger movement system (Jimenez, 2026). These observations represent his clinical experience and should be distinguished from controlled clinical research.

Clinic materials identify Dr. Maria Guadalupe Cardenas, MD, as a board-certified internal medicine physician, Medical Director, and Collaborative Physician at Injury Medical Clinic PA. The clinic lists her NPI as 1164426749 and Texas medical license as J2933 and describes her as having more than 40 years of experience in internal medicine.

Within this multidisciplinary structure:

  • Dr. Jimenez focuses on chiropractic care, musculoskeletal assessment, functional medicine, personal injury care, and rehabilitation.
  • Dr. Cardenas provides medical direction and collaborative physician oversight within her scope of practice.
  • Rehabilitation helps restore strength, movement, coordination, and work capacity.
  • Functional medicine may examine nutrition, sleep, metabolic health, and other factors that can influence overall recovery.
  • Medical or interventional options can be considered when conservative treatment alone is not enough.

Multidisciplinary pain and injury programs may similarly combine medical treatment, rehabilitation, exercise, and complementary approaches when appropriate for the individual patient.

The Main Lesson: Normal X-Rays Do Not Always End the Investigation

After an MVA or workplace injury, some problems are obvious. Others are not.

Soft-tissue injuries, ligament sprains, annular disc injuries, facet joint irritation, myofascial pain, and mild concussion symptoms may require careful clinical examination and, in selected cases, different imaging or specialist evaluation.

The best approach is not to assume that every person with pain has a hidden injury. It is also not safe to assume that a normal X-ray means all tissues are normal.

A better approach is to connect the accident mechanism, symptoms, examination findings, imaging, and response to treatment.

For appropriate patients, coordinated care can then combine mechanical restoration through chiropractic and rehabilitation with medical oversight and evidence-based biological support. This gives the healthcare team a broader view of both the damaged tissue and the way the whole body is functioning after an accident.

El Paso, TX Cervical Pain Treatment Chiropractic Care

References

American College of Radiology. (n.d.). ACR Appropriateness Criteria: Acute spinal trauma.

Advantage Healthcare Systems. (2025). The hidden soft-tissue injuries most people miss after a car accident.

AlpernSchubert, P.C. (n.d.). What are the most commonly overlooked car accident injuries?.

Blanpied, P. R., Gross, A. R., Elliott, J. M., Devaney, L. L., Clewley, D., Walton, D. M., Sparks, C., & Robertson, E. K. (2017). Neck pain: Revision 2017 clinical practice guidelines. Journal of Orthopaedic & Sports Physical Therapy, 47(7), A1–A83.

Bridgman Gantt Law Offices. (2025). 5 common injuries that lead to a workers’ comp claim.

Castaldo, M., Ge, H.-Y., Chiarotto, A., Villafañe, J. H., & Arendt-Nielsen, L. (2014). Myofascial trigger points in patients with whiplash-associated disorders and mechanical neck pain. Pain Medicine, 15(5), 842–849.

Centers for Disease Control and Prevention. (2025). About mild TBI and concussion.

Edwards & Ragatz, P.A. (2025). 3 commonly misdiagnosed conditions that could put you at risk.

Horwitz, Horwitz & Associates. (2020). Common overlooked workplace injuries to be on the lookout for.

Jimenez, A. (2026). Integrative chiropractic and regenerative medicine in El Paso.

Jimenez, A. (2026). MVA joint trauma: Comprehensive chiropractic approaches.

Jimenez, A. (2026). Regenerative medicine and integrative chiropractic strategies.

Jimenez, A. (2026). How regenerative medicine and chiropractic care work together.

Jimenez, A. (n.d.). Dr. Alex Jimenez: El Paso chiropractor and personal injury care.

Cohn, J. (n.d.). Regenerative orthopedics: PRP, stem cells, and healing from within.

MHK Attorneys. (n.d.). Top 5 personal injury claims that often go undetected.

Morgan & Morgan. (2025). 15 work injuries you may not know about.

Ramos Center. (n.d.). Non-surgical pain management: Eight treatment approaches.

Sherwood Law Group. (n.d.). Personal injury cases that often get overlooked but shouldn’t.

Stern & Cohen. (n.d.). Workplace cumulative trauma and your right to compensation.

U.S. Food and Drug Administration. (2021). Important patient and consumer information about regenerative medicine therapies.

Virtaj Singh, MD. (n.d.). Radiculopathy (pinched nerve).

Xcell Medical Group. (2026). The most overlooked injuries after a crash.

Zlotolow & Associates. (n.d.). Five easily missed injuries common in personal injury cases.

SUD Treatment Methods With Integrative Chiropractic Care

Optimize your recovery journey with SUD treatment combined with integrative chiropractic care, focusing on holistic wellness and support.

Educational Abstract: Integrative Care Transitions and New Frontiers in Substance Use Disorder Treatment – An Evidence-Based, Multidisciplinary Approach in El Paso, Texas

As Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I present an educational post that reframes our original transcript in first person and guides you through a comprehensive, easy-to-read journey into the evolving landscape of substance use disorder (SUD) care. I elaborate on nurse practitioners’ unique role across settings, practical strategies for care transitions, best practices for integrating primary care and specialty treatment, inpatient addiction consult services, and cutting-edge research shaping the field. I explain exactly how our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, integrates chiropractic care with medical oversight from Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), alongside functional medicine, personal injury care, rehabilitation, and evidence-based SUD services.

I detail physiological mechanisms underlying SUD, pharmacotherapies, pain modulation, neurobiology of habit and relapse, and integrative protocols. This post highlights modern methods from leading researchers using rigorous, evidence-based practices and showcases actionable frameworks, systems redesign, and real-world cases. My clinical observations from sciatica.clinic and professional notes on LinkedIn inform practical strategies that unify musculoskeletal care, mental health, and addiction medicine to improve outcomes, reduce stigma, and support recovery across care transitions. The content that follows thoroughly details why and how each technique is used, offers step-by-step reasoning, and provides APA-7 style citations and linked references (ASAM, n.d.; SAMHSA, n.d.; NIDA, 2018; Volkow et al., 2016; SAMHSA, 2021; Babor et al., 2007; Carroll & Weiss, 2017; Degenhardt et al., 2018; American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.; JAMA Network, n.d.; Nature, n.d.; Institute for Functional Medicine, n.d.; BMJ, n.d.).

Integrative Substance Use Disorder Care: My Perspective as a Chiropractor and Nurse Practitioner

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. Over my decades of practice, I’ve seen how substance use disorders disrupt health trajectories, worsen pain, compound metabolic and neuroimmune dysfunction, and destabilize social systems. My goal is to present a patient-centered, scientifically grounded approach that integrates primary care, addiction medicine, functional medicine, and integrative chiropractic care, while ensuring safety and quality through internal medicine oversight.

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, our model is multidisciplinary—common in both integrative and injury clinics—where an MD provides medical direction alongside chiropractic care. I am honored to work with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), who serves as our Medical Director and Collaborative Physician. With more than 40 years of experience as an internist, Dr. Cardenas directs diagnostics, medication management, hospital transitions, and complex comorbid care, while I lead integrative chiropractic, functional medicine evaluations, neuromusculoskeletal rehab, and pain modulation strategies. Together, we co-manage patients across levels of care, emphasizing safe transitions, eliminating barriers, and scaling treatment based on the ASAM Levels of Care (ASAM, n.d.).

This educational post reframes our original content in first-person and expands it with integrative care insights: how nurse practitioners drive SUD access, how we design transitions between inpatient, outpatient, and community services, how we use evidence-based pharmacotherapies like buprenorphine and methadone (SAMHSA, 2021), how behavioral and peer supports are co-located and coordinated, how our chiropractic care and rehab reduce pain-related triggers for relapse, and how we align harm reduction, addiction consult services, telehealth bridges, and contingency management with continuity of care (Babor et al., 2007; Carroll & Weiss, 2017).

The Role of Nurse Practitioners in Substance Use Disorder Care: A Frontline Perspective

From my vantage point as a clinician straddling chiropractic medicine and advanced practice nursing, I’ve witnessed the transformative role nurse practitioners (NPs) play across the SUD continuum. With over 258,000 NPs practicing nationwide and rapid growth expected, NPs are uniquely placed to provide entry points into treatment, particularly in primary care, rural settings, and underserved areas.

  • Key strengths of NP-led SUD care:
    • Patient autonomy and self-determination: We emphasize shared decision-making, which is critical for SUD engagement.
    • Prevention and health education: We deliver consistent, non-stigmatizing counseling, including motivational interviewing (Carroll & Weiss, 2017).
    • Scope for controlled medications: In most states, NPs can prescribe buprenorphine without an X-waiver, removing a major barrier to OUD treatment (SAMHSA, 2021).
    • Continuity and longitudinal relationships: These relationships let us tailor interventions to the stage of change, aligning care intensity and support accordingly (Babor et al., 2007).

I find NPs excel in harm-reduction conversations, risk mitigation, and connecting medical care with social variables that drive SUD—a vital skill set when pain, trauma, depression, or instability are present. While curricular time for SUD might be limited in some NP programs, advanced training exists, including Certified Addiction Registered Nurse – Advanced Practice (CARN-AP) and psychiatric mental health NP pathways with dedicated SUD competencies. When NPs function within integrated teams, with medical direction from internal medicine, and seamless links to chiropractic and rehabilitation, we see improved access, engagement, and retention across the continuum (JAMA Network, n.d.).

Why Patients View Healthcare as a Risk Environment: Understanding Stigma and Its Clinical Consequences

Patients often perceive healthcare as risky due to stigma, discrimination, fear of punitive responses, and mistrust (NIDA, 2018). These perceptions lead to:

  • Delayed care and presentation with acute, advanced illness
  • Underreporting or non-disclosure of substance use
  • Avoidance of pain management or inadequate analgesia
  • Self-directed discharges before completing treatment

Clinically, stigma correlates with higher morbidity, mortality, and overall health system costs (Volkow et al., 2016). As providers, we must convert healthcare from a perceived risk environment into a trust environment. In my practice, this means non-judgmental communication, dignity-preserving policies, peer support, and warm handoffs. It also means integrating chiropractic and rehabilitative services to reduce pain triggers, so patients aren’t forced to choose between untreated pain and illicit coping. Trust-building accelerates disclosure, engagement, and continuity—all foundational to evidence-based outcomes.

Mapping SUD Care Settings: Primary Care at the Center with Coordinated Auxiliaries

In our model, I place primary care at the center, with auxiliary paths configured to the patient’s ASAM level of care and biopsychosocial needs (ASAM, n.d.):

  • Outpatient primary care with on-site pharmacotherapy for OUD (e.g., buprenorphine), mental health integration, and chiropractic pain management
  • Hospital or inpatient care with addiction consult services for initiation/stabilization and transition planning
  • Emergency departments with bridge-to-community pathways
  • Specialty SUD treatment: intensive outpatient (IOP), residential rehab, office-based addiction treatment (OBAT), and opioid treatment programs (OTPs) for methadone
  • Peer support networks: Onsite and community-based
  • Telehealth and bridge clinics: For continuity, high-frequency contact, and rapid troubleshooting

We personalize transitions based on ASAM criteria, a strength-based, multidimensional approach that assesses needs, obstacles, assets, and supports. I treat the ASAM framework as a living map for care escalation and de-escalation, ensuring the right care at the right time (ASAM, n.d.). Integrated operations—shared records, unified care plans, co-located services—reduce friction and reinforce continuity.

Primary Care as the SUD Entry Point: Longitudinal Relationships and Stage of Change

Primary care is the largest clinical workforce and often the first contact. The value lies in sustained relationships that make it possible to meet patients where they are (Babor et al., 2007):

  • Prec: Non-judgmental listening, basic harm reduction, safety planning
  • Contemplation: Education on risks, benefits, and available treatments; motivational interviewing; pain alternatives
  • Preparation: Aligning logistics (pharmacy, insurance, transportation), scheduling peer support and counseling
  • Action: Medication initiation, frequent follow-ups, rehab plans
  • Maintenance: Structured coaching, relapse prevention, addressing pain, mood, and social determinants

In my experience, integrating chiropractic assessments—posture, gait, joint dynamics—with functional medicine (inflammation, nutrition, sleep, endocrine) can clarify root drivers and set realistic treatment intensity. Pain related to lumbar radiculopathy, myofascial dysfunction, or postural strain is a common relapse trigger; addressing it quickly can stabilize recovery trajectories. For clinical observations on sciatica-related pain and integrative strategies I routinely apply, see sciatica.clinic and my professional updates on LinkedIn:

Addressing Primary Care Constraints: Workforce Shortages and Practical Barriers

The US faces a significant primary care workforce gap, with millions living in health professional shortage areas (JAMA Network, n.d.). Providers juggle time constraints, lower reimbursement for SUD services, limited psychosocial referral options, concerns about diversion, and sometimes requirements for concurrent counseling that create barriers (SAMHSA, 2021). To counter, we:

  • Build team-based models with nurse care managers as primary contacts for buprenorphine patients.
  • Co-locate services: pharmacy, mental health, chiropractic, rehab, and peer support
  • Use protected time and continuing education to support providers and empower SUD champions.
  • Leverage national resources like PCSS for mentoring and on-demand consultations.

I have found that aligning care plans with pain relief, sleep improvement, and stress modulation dramatically increases adherence. Patients remain engaged when they see results quickly and feel their team is coordinated and compassionate.

Best Practices: Integrated Primary Care Programs for OUD Treatment

Evidence from integrated primary care models shows four core components (JAMA Network, n.d.; SAMHSA, 2021):

  • Pharmacologic therapy: On-site prescribing of buprenorphine and adjunct medications
  • Co-located psychosocial services: Behavioral counseling, CBT pain groups, peer support
  • Integrated operations: One location, unified records, shared care plans
  • Education/outreach: Patient-facing materials, motivational strategies, harm-reduction training

Team-based approaches—especially nurse care managers handling proactive follow-up, medication coordination, and urine toxicology—reduce friction, increase continuity, and improve outcomes. In my clinic, integrating chiropractic care offers non-opioid pain control, improves mobility, and lowers musculoskeletal drivers that worsen withdrawal distress or cravings.

Case Study: Restarting Buprenorphine in Primary Care with Co-Located Services

James, a 52-year-old man with diabetes and chronic pain, presented to primary care after returning to illicit fentanyl use. He wanted to restart buprenorphine. We used a shared decision-making approach, discussed risks/benefits, and selected high-dose initiation to overcome potent fentanyl’s binding and high tolerance profile (SAMHSA, 2021). We coordinated a prescription to a co-located pharmacy, scheduled a telehealth check-in, and lined up counseling and CBT pain group enrollment.

  • Early follow-up was critical: High-dose initiation requires reaching moderate to severe withdrawal before starting. He struggled but felt better soon after starting; we adjusted dosing and connected him to peer support.
  • Over weeks, he transitioned successfully, held regular nurse care manager visits, and addressed depression and pain drivers.

My clinical observation: When pain, depression, and sleep are addressed immediately—through integrative chiropractic adjustments, neuromuscular therapies, and endocrine/metabolic support—patients report less craving intensity and more stability. Co-located services and warm handoffs are decisive; they transform siloed care into a team experience.

Specialty SUD Treatment: Indications, Access, and Equitable Medical Care

Some patients require higher intensity support beyond primary care:

  • Intensive outpatient programs (IOP)
  • Residential or inpatient rehab
  • OBAT clinics and OTPs for methadone

Crucially, medical treatment should not be contingent on behavioral program participation. Initiating buprenorphine or naltrexone should proceed when clinically indicated, with psychosocial interventions offered but not gatekeeping access to pharmacotherapy. This principle reduces mortality and aligns with evidence-based practice (SAMHSA, 2021; JAMA Network, n.d.).

Acute Care Opportunities: Inpatient Addiction Consult Services

Hospital admissions create teachable moments where patients reevaluate goals and accept treatment. Addiction consult services (ACS)—interdisciplinary teams of addiction medicine clinicians, social workers, care coordinators, and peer specialists—improve outcomes: fewer readmissions and more starts/continuation of MOUD (JAMA Network, n.d.; SAMHSA, 2021).

ACS performs:

  • Medical assessment and initiation/titration of methadone or buprenorphine
  • Pain management strategies appropriate for SUD patients
  • Therapeutic interventions and post-discharge linkages
  • Hospital policy improvements, provider education, and system-wide quality initiatives

I consider ACS a cornerstone for safe transitions, especially when complex infections, withdrawal syndromes, or polysubstance use are present. Integrative chiropractic planning post-discharge can accelerate recovery by restoring biomechanical function and reducing nociceptive input that perpetuates stress physiology and craving.

Case Study: Inpatient Management with ACS – Low-Dose Buprenorphine Initiation and Harm Reduction

Lisa, 32, presented with left lower extremity cellulitis, daily fentanyl (IV and inhaled) and methamphetamines, withdrawal onset, and active hepatitis C. She had concerns about her dog’s care—a real barrier to staying hospitalized.

Within 24 hours:

  • The ACS medical provider diagnosed severe OUD and stimulant use disorder, started methadone for withdrawal management, with plans to transition to buprenorphine via low-dose (microdosing) initiation to avoid precipitated withdrawal (Socias et al., 2021).
  • The social worker performed the ASAM assessment, used motivational interviewing to reduce the chance of self-directed discharge, and began referrals for post-discharge treatment.
  • The peer specialist addressed immediate social needs (dog care, communication, phone) and established trust.

Outcomes:

  • Methadone stabilized withdrawal; buprenorphine microdosed safely
  • IV antibiotics for cellulitis
  • Referral for HCV treatment
  • Education on harm reduction: naloxone access, risks of contaminated supply (fentanyl in stimulants), not using alone, infection risk from paraphernalia sharing
  • Discussion of contingency management for stimulant use and off-label medication options to moderate cravings (Carroll & Weiss, 2017)

Clinically, Lisa’s case shows a pattern: once withdrawal is controlled and pain addressed, the patient’s capacity for executive function, planning, and engagement improves (Volkow et al., 2016). Pairing hospital-based initiation with warm transitions to community and integrative chiropractic pain strategies reduces relapse risk.

Locating SUD Treatment: Practical Tools

For locating regional treatment agencies and prescribers:

  • SAMHSA Treatment Locator: Comprehensive listing of agencies (SAMHSA, n.d.)
  • Buprenorphine prescriber directories: Although the X-waiver is gone, curated lists still help identify addiction-experienced prescribers (SAMHSA, 2021)

These tools help us construct transitions that are geographically feasible and timely, key determinants of success.

Care Transitions: Challenges and Best Practices from Acute to Community Settings

Transitions—hospital to outpatient, outpatient to IOP/residential, or telehealth to in-person—can fracture continuity. Common barriers include care silos, stigma, staff shortages, transportation, technology access, and insurance barriers (JAMA Network, n.d.). Best practices include:

  • Leveraging partnerships: Build pre-existing relationships; map referral pathways with shared communication protocols
  • Warm handoffs: Introductions between patient and new provider, ideally in person or by live video/phone
  • Bridge appointments: Schedule within 24–72 hours post-discharge
  • Care coordinators/nurse care managers: Proactive contact, problem-solving, appointment reminders
  • Peer support continuity: Maintain peer contact across transitions
  • Medication continuity plans: Ensure adequate supply and reconciliation
  • Harm reduction kits: Naloxone, fentanyl test strips where available, wound care supplies
  • Transportation and telehealth access: Provide vouchers, devices, or app support

My integrative spin: Add chiropractic/rehab visits early in transitions to deliver fast pain relief, reduce muscle guarding, and normalize movement biomechanics. Rapid improvements in pain and sleep during the first two weeks of transition correlate with lower relapse rates in my clinical observations (BMJ, n.d.; Institute for Functional Medicine, n.d.). See additional insights at https://sciatica.clinic/.

Physiological Underpinnings: Why Integrative Care Works in SUD

To design rational treatments, we must understand SUD physiology (NIDA, 2018; Volkow et al., 2016):

  • Neurobiology of addiction:
    • Mesolimbic dopamine dysregulation (ventral tegmental area to nucleus accumbens) shifts salience toward drug cues
    • Prefrontal cortex hypofunction impairs executive control, planning, and impulse regulation
    • Amygdala and extended amygdala: Stress reactivity increases, sensitizing to withdrawal and cues
    • Glutamatergic plasticity: Learning circuits consolidate maladaptive habits
  • Opioid receptor dynamics:
    • Mu-opioid receptor occupancy and tolerance complicate induction strategies, particularly with high-potency fentanyl
    • Buprenorphine’s partial agonism stabilizes receptors, reduces cravings, and provides a ceiling effect for respiratory depression (SAMHSA, 2021)
    • Methadone’s full agonism: Effective for severe tolerance and stabilizing high-dependence cases
  • Withdrawal physiology:
    • Noradrenergic hyperactivity (locus coeruleus), autonomic dysregulation, GI distress, pain sensitivity, sleep disruption
    • Opioid-induced hyperalgesia due to neuroplastic changes
  • Pain mechanisms:
    • Nociceptive, neuropathic, and nociplastic contributors; central sensitization amplifies pain signals (BMJ, n.d.)
    • Musculoskeletal dysfunction increases afferent nociception, elevates stress hormones, and perpetuates cravings.
  • Inflammation and immune signaling:
    • Chronic substance use elevates pro-inflammatory cytokines; gut dysbiosis, HPA axis disruption, and mitochondrial stress degrade resilience (Institute for Functional Medicine, n.d.)
  • Metabolic and endocrine:
    • Sleep loss, cortisol irregularities, insulin resistance, and low-grade inflammation amplify pain and mood symptoms (Centers for Disease Control and Prevention, n.d.)
  • Psychological and social determinants:
    • Trauma history, depression, anxiety, isolation, housing insecurity, and legal barriers influence relapse risk (Babor et al., 2007)

Integrative chiropractic care modulates proprioceptive input, decreases mechanical nociception, and facilitates parasympathetic restoration. Combined with functional medicine approaches (nutrition, micronutrient repletion, sleep hygiene, stress management), the integrative plan reduces hyperalgesia, calms the HPA axis, and improves executive function to sustain behavior change (BMJ, n.d.; Institute for Functional Medicine, n.d.).

Why Specific Techniques Are Used: Reasoning Behind Protocols

  • High-dose buprenorphine initiation: With fentanyl exposure, mu receptor dynamics often require higher initial doses to displace fentanyl and control cravings/withdrawal. High-dose starts, when done with proper monitoring, reduce oscillation between withdrawal and intoxication (SAMHSA, 2021).
  • Low-dose (microdosing) buprenorphine: In hospitalized patients or those on methadone, microdosing slowly increases buprenorphine to avoid precipitated withdrawal, stabilizing the transition with fewer distress events (Socias et al., 2021).
  • Methadone initiation in OTP or hospital: For high tolerance and instability, methadone provides full agonist stabilization, enabling functional recovery and eventual transitions where appropriate (SAMHSA, 2021).
  • Harm reduction: Naloxone, test strips, and safe-use education reduce mortality and build trust, anchoring patients for further care (Centers for Disease Control and Prevention, n.d.).
  • Contingency management: Evidence supports CM for stimulant use disorder; it leverages behavioral economics with rewards that reinforce non-use behaviors (Carroll & Weiss, 2017).
  • Nurse care management: Frequent, predictable contact counters the chaos of early recovery; improves adherence and offers rapid troubleshooting (JAMA Network, n.d.).
  • Chiropractic manual therapy: Reduces nociceptive load, normalizes joint mechanics, and facilitates muscle balance, decreasing pain triggers that drive relapse (BMJ, n.d.).
  • CBT pain groups: Cognitive reframing, pacing strategies, and self-efficacy reduce catastrophic thinking and improve function (Carroll & Weiss, 2017).
  • Peer support: Lived experience increases credibility and addresses non-medical obstacles quickly, enabling adherence to medical plans (JAMA Network, n.d.).
  • Functional medicine adjuncts: Nutritional support (omega-3s, magnesium, vitamin D), gut health, sleep optimization, and stress modulation improve neuroimmune resilience (Institute for Functional Medicine, n.d.).

Our Multidisciplinary Setup in El Paso: Medical Direction and Integrative Chiropractic Care

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), El Paso, Texas:

  • Medical director: Maria Guadalupe Cardenas, MD (Internal Medicine; NPI #1164426749; Texas MD License #J2933), oversees medical safety, diagnostics, complex comorbidities, prescription oversight, and transitions requiring hospital or specialty linkage.
  • Chiropractic integration: I provide adjustments, soft tissue work, neuromuscular rehabilitation, postural correction, and movement re-education tailored for patients with SUD, chronic pain, and injury care.
  • Functional medicine and rehab: Nutritional and lifestyle interventions, physical reconditioning, and metabolic optimization.
  • Personal injury care: Coordinated treatment plans addressing acute injuries, whiplash-associated disorders, and return-to-function strategies that accommodate concurrent SUD care.
  • Behavioral and peer supports: Embedded or coordinated services to ensure psychotherapeutic continuity and social stability.
  • Care coordinators and nurse care managers: Appointment coordination, medication management, and rapid response to emerging issues.

This setup mirrors the integrative or injury clinic model where MD direction provides a safety backbone, while chiropractic and rehabilitative services deliver non-opioid pain relief and restore function—a synergy essential for patients with SUD and chronic pain (JAMA Network, n.d.; BMJ, n.d.).

Building Trust and Reducing Stigma: Communication Strategies That Work

I’ve learned that the right words—and the right posture—matter (NIDA, 2018; Volkow et al., 2016):

  • Use non-stigmatizing language: “Substance use disorder,” “return to use,” “medications for OUD”
  • Emphasize autonomy and collaboration: “Let’s decide together”
  • Validate pain and struggle: Acknowledge suffering, normalize challenges, and avoid moralizing
  • Offer choices and control: Between initiation methods, support modalities, and timing
  • Follow through consistently: Reliability builds therapeutic alliance

Patients who feel respected are more likely to disclose use, request help early, and complete treatment. This is foundational for successful transitions.

Integrative Chiropractic Care in SUD: Clinical Rationale and Methods

I integrate chiropractic care to directly modulate pain and musculoskeletal stressors (BMJ, n.d.):

  • Techniques:
    • Spinal adjustments: Optimize segmental mobility, reduce mechanical pain
    • Myofascial release and trigger point therapies: Decrease muscle hypertonicity and referred pain
    • Neuromuscular re-education: Improve motor control, reduce compensatory strain
    • Postural correction: Normalize load distribution, reduce nociceptive signaling
    • Lumbar and cervical stabilization: Target core and neck musculature for injury resilience
  • Outcomes:
    • Lower nociceptive input and central sensitization
    • Improved sleep quality and stress recovery
    • Enhanced functional capacity and self-efficacy
    • Reduced reliance on illicit analgesics and improved adherence to MOUD

My sciatica clinic resources include specific protocols for lumbar radiculopathy, piriformis syndrome, and facet-mediated pain, which are common triggers for opioid misuse:

Functional Medicine Additions: Modulating Neuroimmune and Metabolic Stress

I add functional medicine pillars to bolster recovery (Institute for Functional Medicine, n.d.):

  • Nutrition:
    • Anti-inflammatory dietary patterns (omega-3s, phytonutrients)
    • Micronutrients that aid neuromuscular function (magnesium, vitamin D, B-complex)
    • Protein sufficiency to rebuild tissue and neurotransmitter precursors
  • Sleep hygiene:
    • Consistent schedules, light management, caffeine timing, relaxation rituals
  • Stress physiology:
    • Breathwork, mindfulness, graded exposure, biofeedback
  • Gut health:
    • Fiber, probiotics, elimination of irritants that perpetuate inflammation
  • Movement prescriptions:
    • Graded activity plans to reduce pain and build capacity without overloading

These interventions decrease inflammation, stabilize HPA axis, and improve mood, making relapse less likely.

Medication Strategies: Why and How We Choose

  • Buprenorphine:
    • Partial agonist with high receptor affinity
    • Reduces cravings and withdrawal
    • Ceiling effect lowers overdose risk
    • High-dose or microdose pathways selected based on tolerance and current opioid exposure (SAMHSA, 2021)
  • Methadone:
    • Full agonist suitable for severe dependence
    • Requires OTP or hospital-based dispensing
    • Provides powerful stabilization; transitions should be planned carefully (SAMHSA, 2021)
  • Naltrexone:
    • Opioid antagonist, useful after detox, requires caution with pain management (SAMHSA, 2021)
  • Adjuncts:
    • Clonidine, lofexidine for autonomic symptoms
    • Sleep aids, antiemetics, antidiarrheals, non-opioid analgesics
  • Stimulant use disorder:
    • Contingency management is evidence-based
    • Off-label pharmacotherapies considered case-by-case with close monitoring (Carroll & Weiss, 2017)

We tailor medication choices to patient preference, medical complexity, risk profile, and care setting. Dr. Cardenas’ medical oversight ensures safety in polypharmacy, liver disease (e.g., HCV), and comorbidity management.

Care Coordination: Nurse Care Managers, Pharmacy Integration, and Telehealth

Effective coordination turns intentions into outcomes (JAMA Network, n.d.):

  • Nurse care managers:
    • Provide high-frequency follow-ups
    • Manage refill schedules and urine toxicology
    • Troubleshoot side effects and barriers
  • Pharmacy integration:
    • Co-located pharmacies expedite starts
    • Pharmacist consultations for dosing and interactions
  • Telehealth bridges:
    • Frequent check-ins, video-based assessments
    • Rapid course corrections and crisis de-escalation
  • Peer support continuity:
    • Text/phone support, appointment accompaniment
    • Resource navigation (housing, pets, transport)

Patients who receive predictable contact and fast solutions stay engaged and succeed more often.

Harm Reduction: Safety as the Foundation

Harm reduction is non-negotiable (Centers for Disease Control and Prevention, n.d.):

  • Naloxone distribution and training
  • Fentanyl test strips where legal
  • Education not to use alone; recognize signs of overdose
  • Wound care supplies and infection prevention guidance
  • Safer supplies where programs exist; referrals to syringe services

These interventions save lives, build rapport, and create stepping stones toward deeper treatment.

Pain, Injury, and SUD: Integrative Treatment for Personal Injury Patients

In injury contexts:

  • Acute pain, whiplash, and soft-tissue injury can escalate opioid exposure
  • Early integrative chiropractic care reduces pain and restores function
  • Behavioral supports and non-opioid analgesics prevent transition to dependence
  • Functional rehabilitation—graded movement and stabilization—prevents chronicity

In our El Paso clinic, we apply integrative strategies immediately after injury to reduce the need for opioids and support recovery trajectories (BMJ, n.d.; Institute for Functional Medicine, n.d.).

Healthcare System Design: Reducing Silos and Creating Seamless Pathways

System-level improvements include (JAMA Network, n.d.):

  • Shared care agreements across agencies
  • Standardized warm handoff protocols
  • Data-sharing with consent
  • Rapid-access appointments for transitions
  • Quality metrics: MOUD initiation rates, retention, readmission rates, patient-reported outcomes
  • Provider education: Stigma reduction, induction strategies, pain management in SUD

I advocate for operational redesign that limits friction and substitutes trust for bureaucracy. ACS services catalyze these changes in hospital systems.

Advanced Topics: Fentanyl Era Adaptations, Polysubstance Use, and Innovative Models

  • Fentanyl considerations:
    • Higher potency and lipophilicity complicate inductions
    • High-dose buprenorphine strategies and microdosing reduce precipitated withdrawal risk (SAMHSA, 2021; Socias et al., 2021)
  • Polysubstance use:
    • Co-occurring stimulant use requires contingency management and tailored psychosocial strategies
    • Alcohol or benzodiazepine co-use demands careful sedation risk management (Carroll & Weiss, 2017)
  • Tele-bridges and mobile MAT:
    • Bring services to patients; reduce no-show barriers (JAMA Network, n.d.)
  • Digital therapeutics and apps:
    • CBT modules, craving tracking, adherence support (Nature, n.d.)
  • Trauma-informed care:
    • Safety, choice, collaboration, trustworthiness, empowerment integrated into every encounter

These innovations meet patients where they live—flexible, responsive, and respectful.

Real-World Implementation: From Theory to Practice

To implement these ideas:

  • Start with a needs assessment
  • Build a small core team: NP, MD oversight, chiropractic, care coordination, peer specialist.
  • Map regional referrals and partnerships
  • Pilot an induction protocol with follow-up cadence
  • Track simple metrics first: show rate, induction success, 30-day retention
  • Scale co-located services as feasible

My clinic’s approach grew iteratively. Early wins in pain relief, sleep, and rapid induction built momentum and patient trust.

Patient Stories: Recovery Anchored in Function and Trust

I’ve seen patients regain their lives when:

  • Pain is controlled with non-opioid strategies
  • Buprenorphine stabilizes cravings and withdrawal
  • Peer supports answer the phone at 9 pm on a hard night
  • Chiropractic and rehab restore movement and confidence
  • Functional medicine calms inflammation and improves sleep
  • Warm handoffs make new settings feel safe

Function precedes resilience. Resilience sustains recovery.

My Clinical Observations: Sciatica, Radiculopathy, and SUD

From sciatica.clinic, I’ve documented patterns:

  • Lumbar disc herniations with radiculopathy produce severe pain spikes; rapid spinal care and nerve gliding reduce flare intensity
  • Piriformis syndrome mimics radiculopathy; targeted release and stabilization improve leg symptoms
  • Facet joint pain responds to adjustments and postural correction
  • These improvements reduce sleep fragmentation and stress reactivity, which lower craving intensity and improve MOUD adherence

References:

Integrating Evidence-Based Addiction Care With Chiropractic, Functional Medicine, and Collaborative Internal Medicine Oversight

I walk you through an integrative, patient-centered approach to SUD care with a focus on continuity between acute and community settings, care transitions, and multidisciplinary collaboration. I highlight how our team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, operates with medical direction by Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), who serves as our Medical Director and Collaborative Physician. We integrate chiropractic care, functional medicine, personal injury care, rehabilitation, and psychosocial services to support patients across life stages, including peripartum individuals and adolescents, and justice-involved populations at high risk for overdose (American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.).

We cover:

  • Continuity strategies: Bridge prescriptions, co-located services, telehealth options, and care navigation to reduce care disruption and improve retention (JAMA Network, n.d.).
  • Special populations: Justice-involved individuals post-release, pregnant and postpartum patients, and adolescents—each with distinct risks and needs.
  • Clinical protocols for MOUD: Buprenorphine and methadone safety in pregnancy, neonatal opioid withdrawal syndrome counseling, dosing adjustments across pregnancy and postpartum, and adolescent considerations (American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.; SAMHSA, 2021).
  • Case study: A postpartum patient on buprenorphine with tailored recovery scaffolding involving social support, transport, housing, and NICU coordination.
  • Emerging science: Ethical considerations of genetic testing for SUD risk and early signals for GLP-1 receptor agonists in reducing substance use-related harms (New England Journal of Medicine, n.d.).
  • Integrative chiropractic: How manual therapy, neuromuscular rehabilitation, autonomic regulation, pain neuroscience education, and functional nutrition reduce pain, improve function, stabilize mood, and diminish relapse risk, coordinated under internal medicine oversight (BMJ, n.d.; Institute for Functional Medicine, n.d.).
  • Continuity of care in our clinic: Warm handoffs, multidisciplinary rounding, risk stratification, and outcomes tracking using modern evidence-based methods (JAMA Network, n.d.).

Continuity Between Hospital and Community: Building Bridges That Retain Patients In Care

When a provider initiates buprenorphine during hospitalization, patients are most vulnerable at the point of discharge. Without continuity—medication supply, follow-up appointment availability, care navigation—many patients struggle to find services, lose momentum, and disengage. In our integrated model, we extend continuity across settings and modalities.

  • Bridge prescriptions at discharge: We ensure patients receive a 2–4 week supply of buprenorphine or other MOUD to cover the transition to outpatient care.
  • Care navigators and warm handoffs: We routinely coordinate a warm handoff to our bridge clinic, primary care, or specialized SUD services—sometimes scheduling while the patient is still inpatient or in the ED. Care navigators are essential for linking patients to transportation, insurance, and social supports (JAMA Network, n.d.).
  • Co-located services: Whenever possible, we co-locate medical care, chiropractic therapy, mental health counseling, and social services under one roof to streamline access and increase retention.
  • Patient preference in care modality and location: Telehealth is integral for patients with caregiving responsibilities, unstable housing, or limited transportation. Flexible clinic hours and virtual options increase engagement without compromising safety.
  • Structured follow-up: Initial follow-up is typically within 48–72 hours of discharge for buprenorphine stabilization, with weekly check-ins during the first month and monthly thereafter, customized for the patient’s clinical picture.

Why this works:

  • Human continuity: Trust formed with inpatient teams carries forward into the community. Patients who see a familiar provider or clinic soon after discharge are more likely to continue treatment.
  • Physiological timing: For people with OUD, stabilization while neuroadaptation is underway—especially after abrupt cessation or changing tolerance (post-incarceration, postpartum)—is critical to prevent relapse and overdose (Volkow et al., 2016).
  • System navigation: Care navigators remove barriers—transport, insurance reinstatement, childcare, FMLA forms—and reduce cognitive burden, allowing patients to focus on health.

Clinical observation: In our practice, continuity reduces early dropout and re-hospitalization, especially for patients discharged on buprenorphine who receive swift follow-up, tangible support, and clear next steps. When I combine chiropractic manual therapy for pain modulation with MOUD stabilization and psychosocial support, patients report lower craving intensity and improved day-to-day functioning.

Optimizing Your Wellness- Video

Optimizing Your Wellness | El Paso, Tx (2023)

Integrative Clinic Structure: Internal Medicine Oversight and Chiropractic Care Working Together

At Injury Medical Clinic PA, our model reflects the integrated structure common in multidisciplinary clinics, where a physician provides medical direction and collaborates with chiropractic and rehabilitation providers.

  • Medical Director: Dr. Maria Guadalupe Cardenas, MD
    • Oversees medical protocols, safety, MOUD initiation/titration, lab testing, and management of comorbidities (cardiometabolic risks, hepatic function, pregnancy care, and postpartum monitoring).
    • Ensures compliance with state and federal prescribing and reporting regulations, and guides risk mitigation during transitions.
  • Chiropractic and Rehabilitation: Dr. Alex Jimenez, DC, APRN, FNP-BC
    • Focuses on biomechanical assessment, manual therapy, neuromuscular rehabilitation, pain neuroscience education, autonomic balancing techniques, and functional movement training.
    • Coordinates with medical and mental health teams to reduce pain drivers that contribute to relapse risk and poor retention.
  • Functional Medicine and Nutrition
    • Addresses inflammation, sleep dysregulation, micronutrient deficits, and gut-brain axis factors that influence mood, craving, and recovery capacity.
  • Mental Health and Social Supports
    • Integrates behavioral therapies, peer support, and social services (housing, food, transport) with care navigation.
  • Personal Injury Care
    • Treats injury-related pain to remove physiological stressors that fuel substance use. For motor vehicle accidents and workers’ comp cases, we align pain management, rehabilitation, and legal documentation.

This alignment allows us to create personalized care plans that stabilize patients medically while strengthening musculoskeletal function, reducing pain, and optimizing resilience (BMJ, n.d.; JAMA Network, n.d.).

The Neurobiology of Continuity: Why Holding the Line Prevents Overdose and Improves Retention

SUD involves complex neuroadaptations in reward, stress, and executive systems (Volkow et al., 2016; NIDA, 2018):

  • Reward circuitry: Chronic opioid use dysregulates the mesolimbic dopamine pathway (VTA to nucleus accumbens), driving compulsive use.
  • Stress systems: The extended amygdala and CRF system become hyperactive under withdrawal and stress.
  • Executive function: Prefrontal cortical networks (decision-making, impulse control) become hypoactive, impairing planning and increasing relapse vulnerability.

Continuity measures—bridge prescriptions, quick follow-ups, co-located services—reduce the window of acute vulnerability post-discharge, during which stress and cue-driven craving can overwhelm. Medication coverage maintains receptor occupancy (e.g., buprenorphine’s partial agonism at mu-opioid receptors). It reduces craving and withdrawal, while psychosocial supports buffer stress responses and enhance executive functioning through structured routines and supportive relationships.

Chiropractic care complements this by reducing nociceptive input and modulating autonomic tone:

  • Manual therapy and spinal manipulation: Can influence descending pain inhibitory pathways, reduce central sensitization, and improve proprioceptive signaling, diminishing hypervigilance and stress reactivity (BMJ, n.d.).
  • Breathing and vagal techniques: Enhance parasympathetic activity, lower sympathetic overdrive, and improve interoceptive regulation—factors linked to craving intensity and relapse risk (Institute for Functional Medicine, n.d.).
  • Movement rehabilitation: Rebuilds confidence and function, decreasing disability and pain catastrophizing, which often drive self-medication behaviors (Carroll & Weiss, 2017).

In practical terms, the more seamless the transition, the fewer triggers a patient encounters, and the stronger the physiologic and behavioral stabilizers remain in place.

Co-Located Services and Patient Preference: Maximizing Access and Engagement

We design our services around real patient needs:

  • Co-locating SUD treatment, mental health care, chiropractic, and social supports increases convenience and reduces fragmentation (JAMA Network, n.d.).
  • Offering telehealth options for follow-up allows mothers, caregivers, and shift workers to maintain continuity when in-person care is not feasible.
  • Flexible scheduling and post-discharge walk-in slots help ensure medications do not lapse and that support is immediately accessible.

Physiological impact:

  • When stress load decreases (less travel, fewer bureaucratic steps), cortisol levels lower, and allostatic burden improves sleep, mood regulation, and cognitive bandwidth, critical for adherence and self-care (Centers for Disease Control and Prevention, n.d.).

Care Navigation: The Glue That Holds the System Together

Care navigators with deep knowledge of community resources assist with (JAMA Network, n.d.):

  • Insurance reinstatement and coverage continuity
  • Transportation vouchers and ride scheduling
  • Childcare arrangements
  • Housing referrals and transitional programs
  • Appointments and warm handoffs
  • Legal and reporting requirements clarification

The presence of navigators correlates with improved follow-up rates and lower emergency department utilization. They convert macro-level resources into micro-level actionable steps for the patient.

Special Focus: Justice-Involved Individuals and Post-Release Vulnerability

Overdose is a leading cause of death after release from carceral environments. Loss of opioid tolerance, disruption in continuity of care, and low access to MOUD are key drivers of mortality (Centers for Disease Control and Prevention, n.d.; SAMHSA, 2021).

Common post-release challenges:

  • Loss of tolerance: A return to prior use amounts can be lethal. Patients need explicit counseling about lowered tolerance and overdose risk.
  • Gaps in treatment access: Many jails and prisons do not offer MOUD, or they underdose, resulting in poor experiences and reduced willingness to engage later.
  • Insurance loss: Coverage interruptions limit immediate access to medications and outpatient services.
  • Stigma and self-worth: Internalized stigma reduces help-seeking and increases disengagement.

Our approach:

  • Pre-release coordination when possible: Establish appointments and secure bridge prescriptions timed to release.
  • Immediate post-release follow-up: Within 24–72 hours, prioritize MOUD initiation or re-initiation, naloxone distribution, and safety planning.
  • Harm reduction education: Fentanyl contamination awareness, overdose recognition, naloxone use, and never use alone.
  • Chiropractic integration: Address pain generators early to reduce motivation for opioid return; focus on gentle manual therapy, graded movement, and autonomic regulation.

Physiology and risk:

  • Abrupt abstinence reduces receptor tolerance and shifts homeostatic set points; sudden re-exposure produces exaggerated respiratory depression risk. Buprenorphine’s ceiling effect and partial agonism can stabilize mu receptor occupancy, reducing overdose risk when properly initiated (SAMHSA, 2021; Volkow et al., 2016).

Special Focus: Peripartum Individuals, Prenatal Barriers, and Postpartum Transitions

Pregnant and postpartum individuals face heightened risk of overdose and multiple systemic barriers, including stigma and fears related to child custody (American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.). Many avoid care due to punitive policies and mandatory reporting concerns.

Key points we emphasize:

  • Substance use during pregnancy is not equivalent to child maltreatment under federal definitions. The Comprehensive Addiction and Recovery Act (CARA) requires notification when an infant is born affected by substances, but this is not inherently a report of abuse/neglect; state policies vary (SAMHSA, n.d.).
  • Punitive policies reduce engagement: Evidence shows stricter mandatory reporting correlates with later initiation of prenatal care, fewer adequate prenatal visits, and reduced postpartum follow-up.
  • Support over criminalization: Treatment and wraparound support improve outcomes for mothers and infants.

Clinical counseling with compassion:

  • I greet patients with appreciation: “Thank you for coming to see me.” By acknowledging obstacles, we create trust and de-escalate fear-based avoidance.
  • We discuss risks honestly and offer evidence-based options: Buprenorphine and methadone are safe in pregnancy; uncontrolled withdrawal poses greater risks to mother and fetus than MOUD (American College of Obstetricians and Gynecologists, n.d.; SAMHSA, 2021).
  • We explain neonatal opioid withdrawal syndrome (NOWS): It is a known risk; the severity is not dose-dependent; the best dose is the one that treats maternal cravings and withdrawal effectively.

Postpartum considerations:

  • Metabolic shifts occur after birth and typically normalize over 3–12 weeks. Buprenorphine or methadone dose reductions should be individualized and conservative to avoid oversedation while maintaining control of cravings (Centers for Disease Control and Prevention, n.d.).
  • Monitoring for sedation and respiratory depression during the postpartum period is warranted, especially as sleep deprivation, anemia, or co-medications may alter drug effects.
  • Flexible postpartum follow-up: Telehealth check-ins, transport/childcare support, and warm handoffs to pediatric, lactation, and mental health providers strengthen the mother-baby dyad.

Chiropractic integration postpartum:

  • Gentle manual therapy to address postural strain, pelvic floor–related mechanics (in collaboration with pelvic physical therapy), thoracic outlet and neck tension from feeding postures, and core stabilization.
  • Autonomic balancing (breathing drills, rib mechanics, vagal tone enhancement) to lower anxiety and improve sleep.
  • Functional nutrition strategies for replenishment: Iron, omega-3s, choline, magnesium, and protein adequacy to support mood and tissue recovery (Institute for Functional Medicine, n.d.).

Case Study: Postpartum Buprenorphine Management and Recovery Scaffolding

Patient scenario:

  • Liz, a 32-year-old female, is one day postpartum with a baby girl. History of OUD and illicit fentanyl use; started on buprenorphine during pregnancy by primary care and titrated to 8 mg QID (total 32 mg/day) in the third trimester.
  • The baby may be monitored in the NICU for NOWS.

Post-discharge priorities:

  • Assess housing, transport, and social support to facilitate NICU visits and maternal follow-up.
  • Provide flexible follow-up options, including telehealth.
  • Counsel on postpartum metabolism: Dose reductions may be appropriate over weeks 3–12 depending on sedation and symptom control.
  • Monitor cravings and withdrawal symptoms; adjust doses in small increments.
  • Engage social work, peer support, mental health care, food resources, transportation, and housing support.
  • Coordinate with pediatric and lactation services; consider mother-baby co-located visits when possible.

Chiropractic postpartum plan:

  • Gentle spinal and rib cage work to improve breathing mechanics, reduce cervicothoracic pain, and optimize autonomic balance.
  • Core stabilization with graded progressions to address diastasis and pelvic stability.
  • Patient education on ergonomics for infant care to reduce musculoskeletal strain that could drive pain and relapse risk.

Outcome targets:

  • Stabilize MOUD dosing to maintain function without oversedation.
  • Reduce pain and fatigue load to lessen triggers for use.
  • Strengthen the mother-infant bond with supportive scheduling and co-located services.

Adolescents and Young Adults: Tailored Care for Developing Brains

Adolescents differ from adults in neurodevelopment and social context (Nature, n.d.; Centers for Disease Control and Prevention, n.d.):

  • The reward system matures early; the prefrontal cortex (planning, impulse control) continues developing into the mid-20s. Adolescents can experience intense reward but have limited executive moderation.
  • Motivations include peer influence, low self-esteem, anxiety/depression, self-treatment, or weight control pressures.
  • Polysubstance use and experimentation are common; daily dependence may be less frequent, but overdose risk remains high due to fentanyl contamination.
  • Retention in SUD treatment is generally lower; parental involvement requirements vary by state law.

Medication considerations:

  • Buprenorphine: First-line for adolescents/young adults; FDA-approved for ages 16+. Some clinicians use it off-label for ages 12–15 when the risk-benefit profile supports it (SAMHSA, 2021).
  • Long-acting injectable buprenorphine: Limited evidence and not approved under 18.
  • Naltrexone and methadone: Generally approved for 18+; careful deliberation needed in younger patients.
  • For adolescents with episodic use and non-dependence, standard doses (e.g., 8 mg) may be too sedating; shared decision-making and careful titration are crucial.

Best practices:

  • Wraparound services: Integrate mental health assessment to identify drivers (anxiety/depression), school support, family therapy, and peer support programs.
  • Know state laws: Consent thresholds differ; respect adolescent autonomy while encouraging appropriate parental involvement.
  • Naloxone distribution: Universal education and access can save lives.
  • Harm reduction: Educate on fentanyl risks, counterfeit pills, and overdose prevention. Evidence suggests targeted education reduces willingness to misuse prescription drugs (Centers for Disease Control and Prevention, n.d.).

Chiropractic care for adolescents:

  • Focus on sports-related injury prevention and rehabilitation, posture, and movement literacy to improve body awareness and reduce risky coping behaviors.
  • Integrate motivational interviewing to align physical goals (sports, dance, work performance) with sobriety and health (Carroll & Weiss, 2017).

Medications for Opioid Use Disorder in Pregnancy: Dosing Rationale and Safety

Buprenorphine and methadone are safe in pregnancy, and the dangers of withdrawal often exceed the medication risks (American College of Obstetricians and Gynecologists, n.d.; SAMHSA, 2021). We counsel using clear, evidence-based language:

  • Neonatal opioid withdrawal syndrome (NOWS): Risk is real but not dose-dependent; prioritize maternal control of cravings and withdrawal to stabilize pregnancy.
  • Dose adjustments across trimesters: Increased volume of distribution and metabolic rates in late pregnancy may require higher doses.
  • Postpartum dosing: Metabolism typically returns toward baseline within 3–12 weeks postpartum; adjust dosing based on sedation and symptom control, not by fixed calendar alone (Centers for Disease Control and Prevention, n.d.).

Physiology:

  • Buprenorphine’s partial agonist profile provides receptor occupancy that reduces withdrawal and craving while limiting respiratory depression risk compared with full agonists (SAMHSA, 2021).
  • Methadone’s full agonist potency requires careful titration, regular monitoring, and postpartum adjustments under medical oversight.

Care plan integration:

  • Frequent postpartum check-ins to track sedation, cravings, sleep, and mood.
  • Collaboration with lactation services and pediatric care.
  • Chiropractic support for pain relief and autonomic regulation to reduce stress-related triggers.

Reporting and Legal Context: CARA, State Policies, and Patient Trust

Providers often fear noncompliance or liability; patients often fear losing their children. The reality is nuanced:

  • CARA: Requires notification when an infant is born affected by substances, but does not mandate a child abuse/neglect report at the federal level. States determine investigative thresholds (SAMHSA, n.d.).
  • Punitive policies: Associated with delayed prenatal care, reduced adequacy, and lower postpartum visit rates. These policies breed fear and disengagement (Centers for Disease Control and Prevention, n.d.).
  • Best practice: Treat substance use with support and evidence-based care; use warm language, clear expectations, and partner with patients to ensure safety and follow-through.

Clinical messaging:

  • “We’re here to support you and your baby. Let’s talk about medication options that protect both of you. We’ll also discuss privacy, reporting requirements, and what we can do together to keep you connected to care.”

Care Transition Cornerstones: What Makes Programs Sustainable

We design programs for continuity between acute and community settings (JAMA Network, n.d.):

  • Bridge prescriptions: Provide enough medication to cover the transition; avoid lapses that lead to relapse.
  • Co-location: Health services, social supports, and mental health under one roof whenever possible.
  • Patient preference: Offer telehealth, flexible scheduling, and local options that match patient life circumstances.
  • Care navigation: Dedicated staff to orchestrate transitions, solve practical barriers, and keep momentum.

Clinic operations:

  • Weekly multidisciplinary huddles to identify upcoming transitions and risk factors (e.g., recent incarceration, postpartum changes, housing instability).
  • Use brief validated tools to assess risk and readiness (e.g., craving scales, PHQ-9, GAD-7, pain scores).
  • Documented warm handoffs with explicit timelines and accountability.

Integrative Chiropractic Care: Pain, Autonomic Regulation, and Functional Gains

How chiropractic care fits into SUD treatment (BMJ, n.d.):

  • Pain modulation: Manual therapy, joint mobilization, soft tissue techniques, and graded loading reduce nociceptive input and central sensitization. Less pain reduces self-medication pressure.
  • Autonomic balance: Breathing mechanics, rib and diaphragm mobilization, and vagal tone training lower sympathetic dominance, reduce anxiety, and improve sleep—key for relapse prevention (Institute for Functional Medicine, n.d.).
  • Movement re-education: Address dysfunctional motor patterns and deconditioned tissues to restore function and reinforce self-efficacy.
  • Pain neuroscience education: Explain how pain and stress interact; empower patients to understand flare-ups and reduce catastrophizing (Carroll & Weiss, 2017).

Clinical observation:

  • Patients with sciatica, low back pain, or whiplash respond favorably when manual therapies are paired with MOUD and mental health support. Improved function and reduced pain catastrophizing correlate with higher treatment retention. See insights at https://sciatica.clinic/ and my professional notes at https://www.linkedin.com/in/dralexjimenez/.

Functional Medicine and Nutrition: Reducing Inflammation and Supporting Neurobiology

Functional medicine complements addiction care by stabilizing biological systems (Institute for Functional Medicine, n.d.):

  • Nutritional repletion: Omega-3 fatty acids, magnesium, vitamin D, iron, B-complex, and protein adequacy support neurotransmitter balance, reduce inflammation, and improve sleep quality.
  • Gut-brain axis: Address dysbiosis, improve fiber intake, and consider probiotics to reduce systemic inflammation and affect mood regulation.
  • Sleep hygiene and circadian support: Structured sleep routines, light exposure management, and breathing exercises improve cognitive function and reduce cravings (Centers for Disease Control and Prevention, n.d.).

Rationale:

  • Chronic opioid use and high stress increase inflammatory markers and disrupt neurochemical balance. Restoring foundational physiologic resilience makes medications more effective and engagement more sustainable.

Rehabilitation and Personal Injury Care: Addressing Pain Drivers That Fuel Substance Use

In injury care cases (motor vehicle accidents, workplace injuries):

  • Immediate goals: Reduce acute pain and prevent transition to chronic pain
  • Techniques: Evidence-based chiropractic manipulation, soft tissue therapy, graded exposure, ergonomic optimization, and home exercise programming.
  • Coordination: Medical oversight to ensure no contraindications (e.g., fractures, severe head injury), adjust medication plans, and manage comorbidities.

Link to SUD:

  • Injury-related pain is a common pathway to opioid exposure. Integrative rehabilitation reduces the need for high-risk analgesic strategies and supports long-term function (BMJ, n.d.; JAMA Network, Nonjudgmental Care: Practical Communication That Changes Outcomes.

Small changes in communication have outsized effects (NIDA, 2018):

  • Start with gratitude: “Thank you for coming.”
  • Affirm barriers: “I know it took a lot to get here today.”
  • Align goals: “Let’s find a plan that keeps you and your baby safe.”
  • Provide choices: Telehealth, flexible scheduling, different therapy options.
  • Be transparent about risks and laws: Share clear facts; avoid punitive tone.

Patients consistently report greater trust and willingness to return when they feel respected and supported. Engagement is the gateway to outcomes.

Emerging Topics: Genetics and GLP-1 Receptor Agonists

Genetics and SUD risk:

  • Genetic predisposition is one factor among many (environmental, social, psychological) contributing to SUD risk.
  • Direct-to-consumer and specialized genetic tests claim risk identification, but current limitations include:
    • Ethical concerns (bias, stigma)
    • Limited large-scale trials and predictive validity
    • Cost and access issues
    • Privacy concerns with third-party testing

Clinical approach:

  • Genetics may inform future personalized prevention strategies, but present-day practice focuses on modifiable risks, supportive environments, and evidence-based treatments (New England Journal of Medicine, n.d.; Nature, n.d.).

GLP-1 receptor agonists:

  • Medications like semaglutide and liraglutide have shown signals in reducing alcohol consumption in adults and lower risk of medical encounters for tobacco, cannabis, and opioid use disorder in observational claims analyses.
  • While promising, more randomized controlled trials are needed to define indications, dosing, and safety profiles for SUD treatment (New England Journal of Medicine, n.d.).

Our approach:

  • Monitor ongoing research; consider GLP-1 agonists primarily for approved indications (e.g., type 2 diabetes, obesity) while observing potential ancillary benefits on craving or consumption in appropriate cases under medical oversight.

Risk Mitigation: Naloxone, Fentanyl Awareness, and Harm Reduction

We prioritize harm reduction for all patients (Centers for Disease Control and Prevention, n.d.):

  • Universal naloxone coprescribing and training
  • Education on counterfeit pills and fentanyl contamination
  • Safe use principles: Never use alone, test doses, avoid mixing depressants
  • Overdose recognition and emergency response planning

Adolescent focus:

  • Targeted education reduces the likelihood of experimenting with prescription drug misuse. Peer-informed programs amplify impact (Centers for Disease Control and Prevention, n.d.).

Quality, Safety, and Outcomes Tracking: Making Care Measurable

We employ modern, evidence-based methods (JAMA Network, n.d.):

  • Standardized screening and outcome measures (pain scores, functional scales, mental health assessments)
  • Medication adherence checks and side effect monitoring
  • Event tracking (ED visits, hospitalizations, overdoses)
  • Patient-reported outcomes on satisfaction, engagement, and barriers
  • Continuous quality improvement cycles to refine protocols

Internal medicine oversight ensures medication safety and comorbidity management; chiropractic and rehabilitation teams document functional improvements and pain outcomes; care navigators track social determinants and resource linkages.

Real-World Implementation: How Our Clinic Operates Week to Week

  • Monday huddles: Identify high-risk transitions (post-discharge, postpartum, post-release) and assign care navigator tasks.
  • Telehealth slots reserved for patients with transport or childcare barriers.
  • Integrated visit scheduling: Patients can see medical, chiropractic, and mental health providers in coordinated blocks.
  • After-hours communication: Patient messaging for craving flares, pain spikes, or logistics issues; rapid response reduces crisis escalation.
  • Documentation of warm handoffs with named receiving providers and scheduled times.

Why Integrative Chiropractic Care Matters In SUD Treatment

Physiological rationale:

  • Pain and stress amplify craving through shared neural circuits. Reducing nociception and sympathetic drive alters the internal environment to favor recovery (Volkow et al., 2016; BMJ, n.d.).
  • Movement and manual therapy support neuroplasticity, mood regulation, and sleep quality—core drivers of resilience (Institute for Functional Medicine, n.d.).

Clinical design:

  • Match chiropractic intensity to patient stability (gentle techniques early; progress as tolerance and function improve).
  • Combine with breathing drills, sleep hygiene, and nutritional strategies for whole-person benefits.
  • Partner with internal medicine and mental health teams to ensure safety and congruence with medications and psychotherapies.

Putting It All Together: The Integrated Patient Journey

From hospital initiation of buprenorphine to outpatient stabilization, chiropractic pain management, functional nutrition, mental health support, and social services, every step has a rationale:

  • Bridge prescriptions prevent lapses.
  • Warm handoffs maintain trust.
  • Co-located services reduce friction.
  • Care navigation solves practical barriers.
  • Chiropractic reduces pain and autonomic stress; functional medicine fortifies biology.
  • Internal medicine oversight keeps treatment safe and coordinated.
  • Harm reduction prevents fatal events.
  • Outcome tracking ensures accountability and improvement.

This integrated path improves retention, lowers overdose risk, and helps patients recover function and meaning in their lives.

Key Takeaways: Simple Moves That Change Outcomes

  • Provide 2–4 week bridge prescriptions at discharge.
  • Schedule a follow-up within 48–72 hours; consider telehealth.
  • Co-locate services and include care navigation; usnonjudgmental, person-centered language and choices.
  • For pregnancy: Buprenorphine/methadone are safe; NOWS risk is not dose-dependent; postpartum dosing needs individualized adjustments.
  • For justice-involved individuals: Emphasize tolerance changes, rapid re-initiation of MOUD, and harm reduction.
  • For adolescents: Tailor to neurodevelopment; distribute naloxone; focus on mental health drivers; consider buprenorphine with careful dosing.
  • Integrate chiropractic care to reduce pain and autonomic stress; coordinate under internal medicine oversight.

Summary and Practical Steps

We presented this comprehensive educational content synthesizing frontline realities and evidence-based strategies. To act now:

  • Screen for SUD with non-stigmatizing tools
  • Offer buprenorphine with flexible induction pathways
  • Build nurse care manager follow-up flow
  • Co-locate or tightly integrate counseling, chiropractic, and rehab
  • Use peer supports for rapid engagement
  • Plan warm handoffs across transitions
  • Emphasize harm reduction throughout
  • Track outcomes and iterate

Our multidisciplinary setup in El Paso—with Dr. Cardenas as Medical Director and collaborative physician—reflects an integrative model in which medical direction and chiropractic care work synergistically to deliver patient-centered SUD treatment.

References

SEO tags: substance use disorder, opioid use disorder, buprenorphine initiation, methadone, ASAM levels of care, nurse practitioners SUD, motivational interviewing, contingency management, addiction consult services, harm reduction, chiropractic care for SUD, integrative medicine, functional medicine, pain management, personal injury care, care transitions, El Paso Texas clinic, Dr Alex Jimenez, Dr Maria Guadalupe Cardenas, primary care SUD integration, telehealth bridge clinics, peer support, sciatica clinic, pregnancy buprenorphine safety, postpartum dose adjustments, adolescent opioid use, justice-involved overdose risk, care navigation, co-located SUD services, GLP-1 receptor agonists in SUD, naloxone distribution, autonomic regulation, central sensitization, HPA axis, neurobiology of addiction, microdosing buprenorphine, high-dose buprenorphine induction, ACS inpatient consult, warm handoffs, outcome tracking

Athletes Ask About Regenerative Therapies for Recovery

Athletes Ask About Regenerative Therapies for Recovery
Athletes Ask About Regenerative Therapies for Recovery

Athletes in El Paso Ask About Regenerative Therapies for Healing and Recovery

Athletes in El Paso, Texas, frequently ask local sports medicine and functional wellness specialists about regenerative therapies. They want clear answers about how treatments like platelet-rich plasma (PRP), platelet-fibrin products (PFP), micro-fragmented adipose tissue (MFAT), IV nutrient infusions, and peptide therapies help tissue healing. They also ask how these treatments affect training downtime and compliance with sports regulations. This article explains each approach in simple terms and shows how integrative chiropractic care addresses the root causes of movement problems that limit performance and recovery.

Athletes Ask About Regenerative Therapies for Recovery

What Regenerative Therapies Do for Injured Tissue

Regenerative therapies use materials from the body or supportive nutrients to help damaged tissue repair itself. These methods focus on growth factors, cells, and structural support rather than only short-term pain reduction. Athletes often consider them after muscle strains, tendon injuries, ligament sprains, or joint problems that do not fully resolve with rest and standard care.

The main goals are better tissue quality, less ongoing inflammation, and a safer return to training. Results improve when the therapies are paired with proper rehabilitation and attention to how the body moves.

How PRP Therapy Works

Platelet-rich plasma starts with a small blood sample taken from the athlete. The blood is spun in a centrifuge to concentrate the platelets, which contain growth factors. The concentrated plasma is then injected into the injured area, often with ultrasound guidance for precision.

These growth factors help attract repair cells, support new collagen, and reduce local swelling. PRP is commonly used for muscle strains, chronic tendon problems such as Achilles or patellar tendinopathy, and certain ligament injuries. Many athletes notice improved function when the injection is followed by a structured rehabilitation plan.

Because PRP comes from the athlete’s own blood, the chance of an allergic reaction is low. Mild soreness at the injection site usually lasts a few days. Light activity can often resume soon under professional guidance.

PFP and MFAT: Additional Regenerative Options

Platelet-fibrin products (PFP) work similarly to PRP but include a natural fibrin framework. This framework acts like a soft scaffold that holds growth factors in place longer, supporting ongoing healing signals in soft-tissue injuries.

Micro-fragmented adipose tissue (MFAT) uses a small amount of the patient’s own fat, usually taken from the abdomen. The fat is processed into tiny fragments that contain supportive cells and structural material. When injected into a joint or deeper tissue, MFAT can provide cushioning and biological signals. It is often chosen for larger partial tears, cartilage concerns, or more complex joint problems.

Both PFP and MFAT rely on the patient’s own tissues. The choice between them depends on the specific injury, imaging results, and recovery goals.

IV Infusions for Recovery Support

Intravenous nutrient infusions deliver vitamins, minerals, amino acids, and antioxidants straight into the bloodstream. Common ingredients for athletes include magnesium to help muscles relax, vitamin C and glutathione to manage oxidative stress, B vitamins for energy pathways, and amino acids that support tissue repair.

IV therapy can improve hydration and nutrient levels after hard training or competition. It works best as part of a larger plan that includes optimal nutrition, sleep, and progressive exercise. Clinics often schedule these infusions alongside other regenerative or rehabilitative treatments.

Peptide Therapies and Sports Rules

Peptides are short chains of amino acids that act as signaling molecules in the body. Some are studied for possible roles in tissue repair, reduced inflammation, and recovery support.

Athletes must check sports regulations carefully. The World Anti-Doping Agency does not prohibit platelet-derived treatments such as PRP. However, certain peptides, including BPC-157, are listed as prohibited substances. Competitive athletes should review the current WADA rules and speak with their governing body before starting any peptide protocol.

Training Downtime and Returning to Sport

Most regenerative injections involve only short-term downtime. Soreness or mild swelling is common for a few days. Providers usually recommend relative rest, avoiding anti-inflammatory medications that can interfere with healing signals, and gradually increasing movement.

A typical recovery path includes:

  • Early days focused on protection and gentle motion
  • Progressive strengthening over the following weeks
  • Sport-specific training once the tissue can handle higher loads

Full benefits often appear over weeks to months as the tissue continues to remodel. Combining the injection with skilled rehabilitation produces better long-term results than the injection alone.

How Integrative Chiropractic Care Fits Into Regenerative Treatment

Integrative chiropractic care helps athletes by combining traditional spinal adjustments with advanced soft-tissue therapies, functional rehabilitation, and regenerative medicine support. The goal is to correct the underlying cause of movement dysfunction rather than treat only the painful spot.

Spinal and joint adjustments restore proper motion and improve communication between the nervous system and the rest of the body. Soft-tissue techniques reduce restrictions and improve tissue quality. Functional exercises rebuild strength, stability, and efficient movement patterns.

When regenerative therapies are used, chiropractic care supports recovery in several practical ways:

  • Better joint alignment reduces abnormal stress on healing tissue
  • Improved nerve signaling and circulation aid the repair process
  • Correction of compensatory movement patterns prevents new problems
  • Guided progressive loading helps athletes regain strength safely

Clinical observations show that biologics help rebuild tissue while chiropractic care organizes and protects that repair. Together they address both the local injury and the larger movement system.

A Team Approach in El Paso

At Injury Medical Clinic PA in El Paso, a coordinated multidisciplinary team delivers care. Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, brings clinical observations from years of treating sports injuries, personal injury cases, and complex musculoskeletal conditions. His approach combines precise chiropractic care with functional medicine principles and, when appropriate, regenerative options. He emphasizes that lasting recovery requires attention to tissue biology, joint mechanics, movement quality, nutrition, and recovery habits.

Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), serves as medical director and collaborative physician. With more than 40 years of experience as an internist, she provides medical oversight, reviews health histories, and helps ensure that regenerative and chiropractic interventions fit safely within each patient’s overall health picture. This type of collaboration is common in integrative injury-care clinics, where an MD offers medical direction alongside a chiropractor.

The team integrates:

  • Chiropractic adjustments, soft-tissue care, and functional rehabilitation led by Dr. Jimenez
  • Medical evaluation and collaborative oversight from Dr. Cardenas
  • Functional medicine strategies that address nutrition, inflammation, and recovery factors
  • Personal injury care and documentation
  • Progressive rehabilitation services

This structure allows athletes to receive coordinated support under one roof.

Practical Questions Athletes Commonly Ask

Athletes in El Paso often want to know whether they are suitable candidates, what the recovery timeline looks like, and how the treatments affect training schedules. Suitability depends on the specific injury, overall health, imaging findings, and response to earlier care. Providers screen carefully and discuss realistic expectations.

Compliance with sports rules remains important. PRP is generally permitted. Certain peptides are not. Open communication with coaches and anti-doping authorities protects eligibility.

Supporting Healing Beyond the Procedure

Successful outcomes depend on more than the regenerative treatment itself. Adequate protein, quality sleep, stress management, and consistent rehabilitation all influence how well tissue repairs. Avoiding early overload and following the care plan closely improve the chance of durable results.

Integrative chiropractic care continues after the injection phase. Adjustments maintain alignment, soft-tissue work addresses remaining restrictions, and functional exercises restore sport-ready movement. This ongoing support helps athletes return to training with greater confidence and lower risk of reinjury.

Moving Forward With Clear Information

Regenerative therapies such as PRP, PFP, MFAT, IV nutrient support, and carefully selected peptides give athletes in El Paso additional tools for tissue healing. When these options are combined with integrative chiropractic care that corrects movement dysfunction and optimizes nervous system function, recovery addresses both the local injury and the systems that keep athletes performing well.

The multidisciplinary model at Injury Medical Clinic PA—pairing Dr. Jimenez’s chiropractic and functional expertise with Dr. Cardenas’s internal medicine oversight—offers a practical path forward. Athletes benefit from clear explanations, realistic timelines, and attention to both recovery and regulatory compliance. A thorough evaluation that includes mechanical assessment and an individualized plan remains the best next step for anyone considering these options.

El Paso, TX Chiropractic Sports Injury Treatments

References

PRP Therapy for Athletes: How Professional Sports Medicine Uses Regenerative Treatments. (n.d.). OrthoRepair.

How Platelet-Rich Plasma Therapy Helps Athletes. (2022). Reagan Sports Medicine.

PRP, PFP, MFAT, and Epidural Injections After Injuries: Benefits. (n.d.). Push as Rx.

Regenerative Medicine for Joint Pain. (2026). El Paso Chiropractor Blog.

El Paso Injury Regenerative Wellness Treatments Available. (n.d.). Wellness Doctor Rx.

Platelet-Rich Plasma (PRP) Therapy. (n.d.). OrthoEdge El Paso.

Peptides. (n.d.). ADI Med Spa.

Regenerative Therapy Aftercare. (n.d.). QC Kinetix.

Sports Performance Enhancement Through Chiropractic Care. (n.d.). Team Chiropractic.

How Do Chiropractic Adjustments Influence Your Body’s Natural Healing Processes?. (n.d.). Evolve Chiropractic.

Injury Specialists. (n.d.). Dr. Alex Jimenez.

Dr. Alexander Jimenez LinkedIn Profile. (n.d.). LinkedIn.

The Prohibited List. (n.d.). World Anti-Doping Agency.

Poor Posture Ergonomic Treatment Plan for Relief

Poor Posture Ergonomic Treatment Plan for Relief
Poor Posture Ergonomic Treatment Plan for Relief

Poor Posture Ergonomic Treatment Plan: Chiropractic Care and Peptide Therapy

Abstract

Poor posture often develops from a combination of long periods of sitting, weak or poorly conditioned muscles, tight joints, repetitive movements, and daily habits. A poorly arranged workstation can make these problems worse by forcing the neck, shoulders, back, hips, and wrists into stressful positions. A practical ergonomic treatment plan for poor posture starts by adjusting the chair, desk, keyboard, and computer screen so the body can stay closer to a neutral position.

Ergonomics is only one part of the solution. Corrective exercise, movement breaks, mobility work, strengthening, and integrative chiropractic care can help address the mechanical problems that contribute to posture-related pain. In selected patients, medically supervised peptide therapies may also be considered as an additional tool for secondary joint pain, inflammation, or soft-tissue recovery. However, peptides do not straighten the spine or correct poor posture on their own, and many peptides promoted for musculoskeletal recovery remain experimental (Rahman et al., 2026).

Poor Posture Ergonomic Treatment Plan for Relief


Why Poor Posture Develops

Posture describes how the spine, joints, and muscles work together while a person sits, stands, walks, or moves. Poor posture can develop when the body repeatedly stays in positions that place extra stress on muscles and joints.

Common examples include:

  • Leaning the head forward toward a computer screen
  • Slouching in a chair
  • Sitting with rounded shoulders
  • Working with the keyboard too high
  • Sitting with the feet hanging off the floor
  • Looking down at a laptop for several hours
  • Staying in one position without movement breaks
  • Having weak core, back, hip, or shoulder muscles

Brown University Health notes that long periods of computer use with a forward head, rounded shoulders, and poor pelvic positioning commonly contribute to neck and back strain (Brown University Health Blog Team, 2024).

Poor posture is therefore not simply a problem of one bone being “out of place.” It usually has several causes. Muscles can become weak or tired, joints can become stiff, and the nervous system can become accustomed to an unhealthy movement pattern.

That is why correcting posture usually requires changing both the environment and the person’s habits.


Step 1: Adjust the Chair First

The chair creates the foundation for the rest of the workstation.

A good starting position is:

  • Keep both feet flat on the floor.
  • Keep the knees close to a 90-degree angle.
  • Keep the thighs about parallel to the floor.
  • Sit far enough back that the chair supports the pelvis and lower back.
  • Relax the shoulders.
  • Keep the elbows close to the sides.
  • Use a footrest if the feet cannot comfortably reach the floor.

Mayo Clinic recommends adjusting chair height so the feet are supported by the floor or a footrest while the thighs remain close to parallel with the floor. Armrests should allow the shoulders to stay relaxed (Mayo Clinic, 2023).

Chiropractic workplace resources provide similar recommendations. Flores Chiropractic describes keeping the feet flat with the knees near 90 degrees, while Wilderness Family Chiropractic emphasizes lower-back support and proper chair height (Flores Chiropractic, 2026; Wilderness Family Chiropractic, 2026).

Do Not Forget Lumbar Support

The lower back has a natural curve. A chair should support this curve without forcing the body too far forward.

If the chair has poor lumbar support, a small lumbar cushion or properly positioned support may help.

The goal isn’t to sit stiffly all day. The goal is to create a comfortable starting position from which the body can move naturally.


Step 2: Set the Desk and Keyboard Height

After adjusting the chair, look at the desk.

When typing:

  • Keep the elbows close to the body.
  • Aim for an elbow bend of about 90 degrees.
  • Keep the forearms close to parallel with the floor.
  • Keep the wrists straight instead of sharply bent upward.
  • Keep the mouse close to the keyboard.
  • Avoid reaching forward with the shoulders.

Mayo Clinic recommends positioning the keyboard so the wrists and forearms stay in line and the upper arms remain close to the body. Wilderness Family Chiropractic suggests keeping the elbows between about 90 and 110 degrees when using the keyboard and mouse (Mayo Clinic, 2023; Wilderness Family Chiropractic, 2026).

If the desk is too high, a person may constantly lift the shoulders while typing. If it is too low, the person may lean forward.

A practical target is a comfortable 90-degree typing position without shoulder tension.


Step 3: Move the Screen to Eye Level

Screen position is especially important for neck posture.

A monitor should generally be:

  • Directly in front of the person
  • About an arm’s length away
  • High enough that the head does not constantly tilt downward
  • Positioned with the top portion of the screen around eye level or slightly below

Mayo Clinic guidance for “tech neck” also recommends keeping the head, spine, and hips more naturally stacked, with elbows near 90 degrees and feet supported (Mayo Clinic, 2024).

If a screen is too low, people tend to move their head forward and down. Over several hours, the muscles at the back of the neck and upper shoulders must work harder.

Laptop users often have an additional problem because the screen and keyboard are connected. Raising the laptop may improve screen height but make typing difficult. One solution is to use a laptop stand with an external keyboard and mouse.


Step 4: Remember That the Best Posture Includes Movement

Even a perfectly arranged workstation cannot make sitting for eight hours healthy.

The body is designed to move.

Helpful habits include:

  • Stand regularly.
  • Walk for a few minutes.
  • Perform gentle shoulder rolls.
  • Stretch the chest.
  • Move the neck through comfortable ranges.
  • Change sitting positions.
  • Alternate between sitting and standing when possible.
  • Perform strengthening exercises for the core, hips, upper back, and shoulders.

Ergonomic research has examined workstation adjustments to reduce musculoskeletal strain among office workers. Research also shows that awkward, prolonged positions are a major ergonomic risk (Lee et al., 2021).

The important point is simple: no single posture is perfect to hold all day.


How Integrative Chiropractic Care Fits Into Posture Treatment

Ergonomic changes reduce stress on the body. Chiropractic care and rehabilitation can address what has already happened because of that stress.

Depending on the patient’s examination and diagnosis, integrative chiropractic care may include:

  • Posture assessment
  • Spinal and joint mobility testing
  • Chiropractic manipulation or mobilization
  • Soft-tissue techniques
  • Corrective exercise
  • Core stabilization
  • Hip and shoulder strengthening
  • Mobility exercises
  • Activity modification
  • Ergonomic education
  • Rehabilitation
  • Home exercise programs

Dr. Alexander Jimenez’s educational materials describe an integrated approach in which chiropractic care addresses movement and mechanical function while rehabilitation rebuilds strength and function. His published materials also stress that treatments should work together, rather than expecting one therapy to solve every part of the problem (Jimenez, 2026a).

For example, adjusting a stiff spinal joint may help movement, but the person still needs to stop leaning over a poorly positioned computer. Likewise, strengthening the upper back may help posture, but those muscles will continue to be overloaded if the monitor remains far below eye level.

The most useful plan addresses both the person and the workstation.


Can Peptide Therapy Correct Poor Posture?

No. Peptide therapy cannot directly correct poor posture.

Poor posture is mainly a mechanical and behavioral problem involving movement, muscle control, joint mobility, workstation setup, and habit.

A peptide cannot:

  • Raise a computer monitor
  • Correct sitting habits
  • Strengthen weak postural muscles without exercise
  • Teach proper movement
  • Correct an unsuitable chair
  • Replace rehabilitation
  • Replace strength training

This distinction matters because peptides are often marketed for recovery.

A 2026 review in JAAOS Global Research & Reviews discusses growing research interest in therapeutic peptides for inflammation, wound healing, muscle recovery, and other orthopedic applications. However, much of the evidence still comes from laboratory research, animal studies, and limited early human studies (Rahman et al., 2026).


Where Peptides May Fit Into an Integrative Plan

Certain peptide therapies are being studied as possible adjuncts, meaning they are added to a larger treatment plan rather than used alone.

Researchers are studying whether certain peptides may influence:

  • Inflammatory signaling
  • Collagen activity
  • Cellular communication
  • Muscle recovery
  • Tendon and ligament healing
  • Blood vessel development
  • Tissue remodeling

Several clinical and integrative medicine resources describe using peptide therapy alongside physical rehabilitation, chiropractic care, nutrition, and progressive exercise rather than as a replacement for those treatments (Mobility Chiro Therapy, n.d.; Petersen, n.d.; Jimenez, 2026a).

For someone with posture-related back or joint pain, the possible goal would therefore be to support recovery from a secondary tissue problem, not to treat the posture itself.

For example:

Ergonomics reduces the repeated strain.

Chiropractic care addresses movement and joint mechanics.

Rehabilitation strengthens and retrains the body.

Medical care evaluates pain, inflammation, medications, and health risks.

A medically appropriate peptide therapy, when supported by evidence, may serve as an additional recovery tool.


Peptide Therapy Requires Medical Caution

Not all peptides are the same.

Some peptide-based medications have established FDA-approved medical uses. However, several compounds promoted online for tissue repair or athletic recovery are not FDA-approved for those purposes.

This is especially important with products such as BPC-157, TB-500, CJC-1295, and ipamorelin.

The FDA reports limited safety information and potential concerns with several compounded peptide substances. For BPC-157, the agency states that available information is not sufficient to determine whether proposed routes of human administration are safe. FDA has also identified potential safety concerns involving CJC-1295 and ipamorelin (U.S. Food and Drug Administration [FDA], 2026).

Compounded medications also do not go through the same FDA premarket approval process used for approved drugs (FDA, 2025).

Other clinical resources similarly stress that BPC-157 and TB-500 have not been established as FDA-approved treatments for improving mobility or repairing human musculoskeletal injuries (Miami Liposuction Specialty Clinic, 2025).

For this reason, peptide therapy should never be purchased casually online or self-administered based on social media advice.


A Multidisciplinary Approach at Injury Medical Clinic PA in El Paso

At Injury Medical Clinic PA in El Paso, Texas, posture and musculoskeletal care can be approached through a multidisciplinary model.

According to clinic and professional materials, Dr. Maria Guadalupe Cardenas, MD, is Board Certified in Internal Medicine and serves as Medical Director and Collaborative Physician. Clinic materials identify her as NPI #1164426749, Texas MD License #J2933, and describe her as having more than 40 years of internal medicine experience (Jimenez, 2026b).

Dr. Cardenas works alongside Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN.

The team integrates:

  • Medical oversight
  • Chiropractic care
  • Functional medicine
  • Musculoskeletal assessment
  • Personal injury care
  • Rehabilitation
  • Corrective exercise
  • Nutrition and lifestyle strategies
  • Related recovery services

Clinic materials describe Dr. Jimenez’s role as including chiropractic, functional medicine, personal injury management, rehabilitation, and biomechanical assessment, while Dr. Cardenas provides internal medicine oversight within the integrated clinical model (Jimenez, 2026b).

This structure allows providers to address different parts of the same problem instead of treating each issue separately.


Clinical Observations From Dr. Alexander Jimenez

In his published educational materials and professional discussions, Dr. Jimenez repeatedly describes musculoskeletal recovery as a combination of mechanics, rehabilitation, lifestyle, and medical coordination.

His clinical observations suggest that posture problems are often more effectively addressed when clinicians look beyond the painful area and evaluate:

  • How the patient sits
  • How the patient moves
  • Muscle imbalances
  • Joint mobility
  • Previous injuries
  • Core strength
  • Workstation setup
  • Daily movement habits
  • Nutrition and recovery
  • Other medical conditions

These are clinical observations, not substitutes for controlled scientific studies. However, they fit with the broader idea that posture-related problems are usually multifactorial and require more than one intervention. His professional materials also emphasize that nutrition, medical treatment, chiropractic care, and rehabilitation have different roles within an integrated recovery plan (Jimenez, 2026a; Jimenez, n.d.).


A Simple Ergonomic Posture Treatment Plan

For many people, a practical starting plan looks like this:

1. Fix the chair

Keep the feet flat, knees near 90 degrees, hips supported, and lower back comfortably supported.

2. Fix the desk

Position the keyboard so your elbows stay near 90 degrees and your shoulders stay relaxed.

3. Raise the screen

Keep the monitor directly ahead, with the top of the screen around eye level.

4. Stop staying still

Stand, walk, stretch, and change position regularly.

5. Build stronger postural muscles

Strengthen the core, hips, back, and shoulder muscles under appropriate guidance.

6. Evaluate persistent pain

Pain that continues despite workstation changes may require a medical, chiropractic, or rehabilitation evaluation.

7. Address mechanical problems

Integrative chiropractic care may help selected patients improve joint mobility, movement patterns, and tolerance for rehabilitation.

8. Consider advanced therapies carefully

If inflammation, persistent pain, or soft-tissue injury is slowing rehabilitation, medically supervised supportive treatments may be discussed. Consider experimental peptides only after reviewing the evidence, risks, regulatory status, medical history, and available alternatives.


Final Thoughts

Correcting poor posture starts with mechanics.

A chair that supports the body, a desk that keeps the elbows near 90 degrees, and a screen positioned around eye level can reduce unnecessary physical strain. Regular movement, strengthening, mobility exercises, and better daily habits are equally important.

Integrative chiropractic care can add another layer by evaluating joint movement, muscle balance, spinal mechanics, and rehabilitation needs. When medical concerns are also present, multidisciplinary care allows those issues to be evaluated alongside the mechanical problem.

Peptide therapies should be viewed differently. They cannot correct posture, but selected peptide-based treatments may eventually play a useful role in musculoskeletal recovery. Current research remains developing, and many popular “recovery peptides” lack FDA approval and strong human evidence. Therefore, they should never replace ergonomics, exercise, rehabilitation, or appropriate medical care (Rahman et al., 2026; FDA, 2026).

At Injury Medical Clinic PA in El Paso, the integrated model combines the chiropractic and functional approach of Dr. Alex Jimenez with medical oversight from Dr. Maria Guadalupe Cardenas. The larger goal is not simply to make a person “sit straighter.” It is to reduce repeated physical stress, restore comfortable movement, improve strength, manage pain safely, and build habits that support better function over the long term.

Custom *FOOT ORTHOTICS* Reduce Low Back Pain  |  El Paso, TX (2019)

References

Brown University Health Blog Team. (2024, June 7). Posture and how it affects your health. Brown University Health.

Flores Chiropractic. (2026). Can simple adjustments fix your desk job posture?

Jimenez, A. (n.d.). Dr. Alexander Jimenez, DC, APRN, FNP-BC, IFMCP, CFMP, ATN. LinkedIn.

Jimenez, A. (2026a). Peptide therapy, nutrition, and chiropractic care explained.

Jimenez, A. (2026b). El Paso multidisciplinary injury care solutions for you.

Lee, S., de Barros, F. C., de Castro, C. S. M., & Sato, T. O. (2021). Effect of an ergonomic intervention involving workstation adjustments on musculoskeletal pain in office workers—A randomized controlled clinical trial. Industrial Health, 59(2), 78–85. https://doi.org/10.2486/indhealth.2020-0188

Mayo Clinic. (2023). Office ergonomics: Your how-to guide.

Miami Liposuction Specialty Clinic. (2025). Peptides for mobility: Evidence, risks, and regulatory status.

Mobility Chiro Therapy. (n.d.). Peptide therapy for injury recovery and performance.

Petersen, K. (n.d.). Peptide therapy.

Rahman, O. F., Lee, S. J., & Seeds, W. A. (2026). Therapeutic peptides in orthopaedics: Applications, challenges, and future directions. JAAOS Global Research & Reviews, 10(1), e25.00236. https://doi.org/10.5435/JAAOSGlobal-D-25-00236

Santé Chiropractic. (2026). Peptides for back pain, disc issues, and sciatica.

Ubie Health. (2026). Stop chronic back pain now: Why you aren’t healing.

U.S. Food and Drug Administration. (2025). Compounding and the FDA: Questions and answers.

U.S. Food and Drug Administration. (2026). Certain bulk drug substances for use in compounding that may present significant safety risks.

Wilderness Family Chiropractic. (2026). Improve desk job posture: A how-to guide.

Integrative Therapies in Action for Cognitive Decline

Learn about cognitive decline and integrative therapies aimed at supporting cognitive health and preventing decline.

Educational Abstract: Pharmacological Management of Dementia, Diagnostic Advances, and Integrative Chiropractic Care in a Multidisciplinary Clinic

As Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I present an educational, evidence-based overview of modern dementia care—focusing on Alzheimer’s disease—through a comprehensive lens that integrates internal medicine, neurology, functional medicine, rehabilitation, personal injury care pathways, and chiropractic neurophysiology. I explain current diagnostic logic, from symptom-driven models to biomarker-driven frameworks (ATN: amyloid, tau, neurodegeneration), the clinical significance of co-occurring neuropathologies, and the rationale for structured pharmacologic and non-pharmacologic treatment plans. I highlight how our multidisciplinary team in El Paso, Texas—under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933)—collaborates at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) to provide medical oversight, diagnostic alignment, and integrative chiropractic care across cognitive, autonomic, and neuromusculoskeletal domains. I summarize the latest disease-modifying therapies (DMTs), including amyloid-targeted monoclonal antibodies (aducanumab, lecanemab, donanemab), real-world risks like amyloid-related imaging abnormalities (ARIA), and how genetics (APOE4) influences safety and monitoring. I detail the state of blood-based biomarkers (phospho-tau217, GFAP, NfL), the role of PET scans and lumbar punctures, polypharmacy considerations, behavioral and neuropsychiatric symptom management, cardiovascular and perfusion principles, neuroinflammation, lifestyle factors, and rehabilitative strategies. This post is designed to guide patients, families, and clinicians through a clear journey from diagnosis to targeted interventions using modern, validated methods.

Introduction: How I Think Through Dementia in Clinical Practice

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In my practice at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, I work alongside our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933), who has more than 40 years of experience in internal medicine. Our multidisciplinary clinic structure is a model increasingly common in integrative and injury care settings—where an MD provides medical direction and diagnostic oversight in concert with chiropractic, functional medicine, rehabilitation, and personal injury services. This powerful synergy between different medical disciplines is a philosophical commitment to treating the whole person.

When a patient presents with memory changes, executive function difficulties, or new behavioral changes, I begin with a structured pathway that prioritizes clarity and safety. My approach is informed by leading research and clinical frameworks from neurology, internal medicine, and geriatrics. I also integrate chiropractic neurophysiology and functional medicine strategies to address perfusion, autonomic imbalance, neuroinflammation, and biomechanical stressors that may compound cognitive symptoms.

This educational post summarizes:

  • The modern diagnostic approach to Alzheimer’s disease and related dementias, including symptom criteria and biomarker frameworks such as ATN.
  • Why co-existing neuropathologies are common and how that changes treatment logic.
  • The pharmacologic approach for cognitive and neuropsychiatric symptoms, from established medications to emerging therapies.
  • The role of disease-modifying therapies, including who is a candidate and how to manage them safely.
  • How our team integrates chiropractic care with internal medicine oversight, functional medicine, and rehabilitation.
  • Practical care strategies for patients and families, supported by contemporary evidence.

Throughout, I share the rationale behind each clinical decision—why we choose a given test, why we consider a certain medication, and how integrative chiropractic care fits into the therapeutic plan.

The Foundation of Diagnosis: A Deep and Methodical Symptom History

When a patient presents with concerns about their memory or thinking, our journey begins with the most fundamental step: taking a thorough, detailed symptom history. This is far more than a simple checklist of symptoms. It is an investigative process, a narrative we build together to understand the full picture of what the patient is experiencing. I always ask a series of probing questions to paint this picture as clearly as possible:

  • “When did you first notice these changes?”
  • “Can you describe for me what it feels like when you have a ‘senior moment’ or a lapse in memory?”
  • “What specific situations seem to be the most challenging for you?”
  • “Is there anything you’ve found that seems to make your thinking clearer or, conversely, what makes the fogginess worse?”
  • “Are there any other symptoms that have appeared around the same time, even if they seem unrelated?”

It is crucial to explore not just the cognitive symptoms, such as memory loss or difficulty with problem-solving, but also the psychiatric symptoms. We know that conditions like anxiety and depression often co-occur with cognitive decline and can significantly impact a person’s quality of life. Understanding these associated symptoms is vital for a comprehensive treatment plan.

The Value of a Secondary Historian

A unique and best-practice element in evaluating cognitive decline is gathering information from a secondary historian. This is not necessarily a formal “caregiver” but rather someone who knows the patient well—such as a spouse, an adult child, or a close friend—and with whom the patient is comfortable sharing information. The flow of information is directed to me, the clinician, to enrich the history, not from me to this other person.

In my clinical experience, most patients are very open to this. We all have blind spots: habits, behaviors, or subtle changes in our daily functioning that we may not recognize in ourselves but that are apparent to those who spend a lot of time with us. This secondary perspective provides an invaluable layer of detail, helping to corroborate the patient’s report and often revealing changes in activities of daily living or social interactions that the patient might have overlooked or minimized. This collaborative approach to history-taking is where the diagnostic process truly begins.

My Diagnostic Philosophy: Moving From Symptoms Alone to Biomarkers and Structured Logic

When I evaluate cognitive decline, I consider two parallel tracks:

  • Symptom-based classification: What is measurable, observable, and functionally impactful?
  • Biomarker-based classification: What is the neurobiological substrate driving symptoms?

Traditionally, many clinicians diagnosed probable Alzheimer’s disease by observing the pattern and onset of cognitive symptoms: insidious onset, progressive memory impairment with poor recall of recent events despite cues, and deterioration in other domains such as language, visuospatial skills, and executive function. Advanced age is the strongest risk factor. However, our diagnostic logic has shifted to incorporate biomarkers, which reflect the presence and sequence of disease processes long before symptoms appear.

I educate patients and families that the pathophysiology begins years—often 15 to 20—before cognitive testing demonstrates impairment. During this subclinical window, amyloid and tau accumulate, transitioning from soluble forms to aggregated plaques (amyloid) and neurofibrillary tangles (tau), eventually killing neurons and leading to measurable neurodegeneration. This sequence has been elegantly detailed by researchers who have modeled biomarker dynamics over time.

The key takeaways I emphasize:

  • Amyloid accumulation appears early and likely initiates a cascade that facilitates tau pathology.
  • Tau pathology correlates more tightly with symptom severity and progression once clinical impairment is evident.
  • Neurodegeneration—loss of brain volume and network integrity—accumulates steadily and becomes visible on imaging or measurable via emerging blood biomarkers.

This framework sets the stage for targeted testing and treatment decisions.

The Comprehensive Diagnostic Workup: Beyond the Initial Conversation

Following the detailed history, we move on to a structured, multifaceted evaluation. Each component is a piece of the puzzle, helping us narrow down the potential causes of the cognitive changes.

The Neurological Examination

A comprehensive neurological exam is a standard part of our workup. In the early stages of many neurodegenerative conditions, I may not expect to find major neurological deficits. Things like deep tendon reflexes, gait, and mobility might appear normal for quite some time, depending on the underlying pathology. However, the exam is still essential. It establishes a baseline and can sometimes reveal subtle signs that point us in a specific direction. For example, slight changes in gait or balance could suggest a vascular component to the cognitive decline or hint at other neurological conditions.

Assessing Mood and Mental Health

It is impossible to accurately assess cognition without also assessing mood. Therefore, administering scales for depression and anxiety is a critical step. However, a significant challenge is that many standard screening tools, such as the Patient Health Questionnaire-9 (PHQ-9), have not been validated for individuals living with moderate-to-advanced cognitive decline. A person who has impairments in judgment, reasoning, and memory may struggle to accurately self-report their symptoms on these questionnaires.

Despite these limitations, I find these tools helpful as a starting point. They can open up a conversation about mood and provide a preliminary indication of a potential co-occurring psychiatric condition. For patients with more significant cognitive impairment, we may consider using neuropsychiatric scales specifically designed for this population, which often rely more on observable behaviors and caregiver reports.

The Power of Neuropsychological Testing

Neuropsychological testing is an incredibly powerful and helpful tool. If available within a patient’s health system, I strongly recommend it. Neuropsychologists conduct comprehensive evaluations that go far beyond the brief cognitive screens we might administer in the clinic. They involve a battery of standardized tests that measure various cognitive domains in detail, including:

  • Attention and concentration
  • Executive functions (planning, organizing, problem-solving)
  • Language abilities
  • Visuospatial skills
  • Learning and memory (both verbal and visual)

The detailed report from a neuropsychological evaluation provides an objective profile of a person’s cognitive strengths and weaknesses. This is invaluable for me as a clinician in narrowing down a diagnosis, distinguishing between different types of dementia, and establishing a robust baseline against which we can measure future changes or the effects of treatment. Fortunately, neuropsychology practices are often available in the community and provide testing for learning differences and other conditions, making them somewhat more accessible than other subspecialties.

Visualizing the Brain: The Role of Neuroimaging

In the primary care and integrative setting, our initial approach to neuroimaging typically begins with structural imaging. The preferred modality is a Magnetic Resonance Imaging (MRI) of the brain. An MRI provides a detailed look at the brain’s structure, allowing us to identify:

  • Evidence of strokes (both large and small)
  • Tumors or other masses
  • Hydrocephalus (excess fluid in the brain)
  • Patterns of atrophy (shrinkage) in specific brain regions, which can be suggestive of certain types of dementia (e.g., hippocampal atrophy in Alzheimer’s disease)

If a patient is unable to undergo an MRI (for instance, due to a pacemaker or severe claustrophobia), a Computed Tomography (CT) scan is an alternative. However, it provides less detailed soft-tissue contrast. Structural imaging is essential for ruling out “reversible” or treatable causes of cognitive symptoms and for identifying cerebrovascular disease that may be contributing to the clinical picture.

Essential Laboratory Studies

Before jumping to more specialized tests, it is critical to perform a panel of basic laboratory studies. These “Tier 1” tests, as outlined in recent guidelines, help us identify systemic medical issues that can masquerade as or exacerbate cognitive decline. If a patient hasn’t had recent lab work, this is a non-negotiable step. Our standard panel includes:

  • Complete Blood Count (CBC): To check for anemia or infection.
  • Comprehensive Metabolic Panel (CMP): To assess kidney function, liver function, and electrolyte balance.
  • Thyroid-Stimulating Hormone (TSH): To screen for hypothyroidism, a well-known cause of cognitive slowing and “brain fog.”
  • Vitamin B12: To check for deficiency, which can cause significant neurological and cognitive symptoms.
  • Folate: Deficiency can also contribute to cognitive symptoms.
  • Inflammatory Markers: such as C-reactive protein (CRP), to gauge the body’s overall inflammatory state.

This foundational lab work ensures we are not overlooking a treatable metabolic or nutritional deficiency that could be the primary driver of the patient’s symptoms.

The ATN Framework: Amyloid, Tau, Neurodegeneration

I use the ATN criteria to anchor our diagnostic plan:

  • A: Amyloid pathology—measured via amyloid PET or CSF Aβ42/Aβ40 ratios. Blood-based amyloid assays are advancing and increasingly accurate, though not yet considered the gold standard for definitive diagnosis.
  • T: Tau pathology—measured via CSF phosphorylated tau (p-tau) or tau PET. Emerging blood-based p-tau assays provide valuable information and may serve as proxies for amyloid burden and tau status.
  • N: Neurodegeneration—measured via structural MRI (preferably) or CT, and increasingly via blood markers such as neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP). These tests reflect neuronal injury and glial activation.

In our clinic, under Dr. Cardenas’s medical direction, we pursue ATN testing when symptoms warrant it. We do not recommend biomarker testing in completely asymptomatic individuals because age-related changes may elevate markers without clear clinical significance.

Why ATN matters:

  • It enables timely and accurate identification of Alzheimer’s disease processes.
  • It guides eligibility and timing for disease-modifying treatments.
  • It informs prognostic counseling, clarifying why certain symptoms are present and what might evolve.
  • It supports personalized treatment planning, including pharmacology, rehabilitation, and lifestyle recommendations.

Advanced and Specialized Testing: A Look into the Future

Once we have completed the foundational workup, we can discuss with the patient pursuing more specialized testing. This decision is highly individualized and depends on the clinical scenario, the patient’s wishes, and their candidacy for emerging treatments. These advanced tests include:

  • Plasma-Based Biomarkers: These are exciting new blood tests that can detect the protein pathologies of Alzheimer’s disease (amyloid and tau) with increasing accuracy. You will encounter markers like p-tau217, GFAP, NfL, and Aβ42/Aβ40 ratios. These offer a less invasive way to gain biological evidence of the disease, improve diagnostic confidence, and guide referrals.
  • Cerebrospinal Fluid (CSF) Analysis: This involves a lumbar puncture (spinal tap) to directly measure the levels of amyloid and tau proteins in the fluid that bathes the brain and spinal cord. It remains a gold standard for biological confirmation of Alzheimer’s pathology.
  • Amyloid PET Scans: This is an advanced imaging technique where a radioactive tracer that binds to amyloid plaques is injected, allowing us to visualize the amyloid burden in the living brain.
  • Genetic Testing: Specifically, testing for the Apolipoprotein E (APOE) gene, particularly the e4 allele, which is a significant genetic risk factor for late-onset Alzheimer’s disease.

It is crucial to emphasize that pursuing this level of testing is a significant decision. It is often done in the context of considering disease-modifying treatments, such as the newer amyloid-targeted therapies, as eligibility for these treatments currently requires confirmation of amyloid pathology via PET or CSF.

Understanding Co-Occurring Neuropathologies: Why Brains Rarely Have One Pathology

One of the most important realities I share with patients is that multiple neuropathologies often co-exist. Large-cohort autopsy data have shown that individuals frequently exhibit combinations of amyloid plaques, tau tangles, micro- and macroinfarcts (vascular pathology), Lewy bodies (alpha-synuclein pathology), and TDP-43 pathology (commonly associated with later-onset limbic-predominant age-related TDP-43 encephalopathy, often overlapping with frontotemporal patterns).

Clinical implications:

  • It is common to see Alzheimer’s biomarkers alongside Lewy body pathology or vascular changes.
  • Mixed pathology explains heterogeneous symptom profiles—for example, Alzheimer’s biomarkers with prominent visuospatial or executive dysfunction, parkinsonian features, or fluctuating attention.
  • Treatment often requires multimodal strategies rather than relying on a single pharmacologic agent.
  • Patients may benefit from precision counseling that acknowledges that overlapping pathologies require nuanced monitoring and layered interventions.

This understanding also reframes expectations about disease-modifying therapies. If multiple pathological processes are present, addressing only one may yield modest benefits unless accompanied by strategies to mitigate vascular risk factors, autonomic dysfunction, neuroinflammation, sleep disturbances, and physical deconditioning.

The DetectAD Guidelines: A New Framework for Diagnosis

A new set of clinical practice guidelines has recently revolutionized the field of dementia diagnosis. These guidelines, supported by the Alzheimer’s Association and published in 2025 in the journal Alzheimer’s & Dementia, are called DetectAD. They were developed by a panel of experts following a rigorous literature review and provide a clear, structured framework for clinicians. Importantly, the guidelines offer distinct pathways for primary care clinicians and dementia subspecialists, acknowledging that most initial evaluations occur in primary care settings.

Core Elements of the DetectAD Evaluation

The DetectAD framework is built around several core elements, with communication serving as the bookends of the entire process.

  1. Establishing Expectations and Goals: The very first step is a conversation about the diagnostic process itself. What can the patient expect? What are their goals? Do they even want a specific diagnosis? We must respect a patient’s autonomy; just because we can perform a test does not mean the patient wants it. This initial conversation also establishes who should be involved. The guidelines strongly recommend that a trusted family member or friend participate in this shared journey.
  2. Comprehensive Assessment: This mirrors the multifaceted workup we have already discussed:
    • History Taking: Covering cognitive, functional (activities of daily living), neuropsychiatric, and sensory-motor symptoms.
    • Medical, Social, and Family History: Identifying risk factors is key. We know that conditions like diabetes, hypertension, chronic kidney disease, sleep apnea, and substance use disorders are significant risk factors for both neurodegenerative and cerebrovascular diseases. The concept of Alzheimer’s as “type 3 diabetes,” while perhaps an oversimplification, highlights the profound connection between metabolic health and brain health.
    • Clinical Examination: Including a formal mental status exam using a validated tool. While the Medicare Annual Wellness Visit allows for a simple query about memory, the guidelines advocate for at least a Mini-Cog or a similar brief, validated instrument.
  • Synthesizing and Staging: After gathering all the information, the clinician’s job is to synthesize it to arrive at a diagnosis. This involves:
    • Categorizing the Syndrome: Is the person cognitively unimpaired? Do they have Subjective Cognitive Decline (SCD), where they feel a change, but we cannot yet measure it on tests? Do they have Mild Cognitive Impairment (MCI), where there are measurable deficits, but their daily functioning remains independent? Or do they have dementia, where the cognitive impairment is severe enough to interfere with independence in daily life?
    • Staging Dementia: If dementia is diagnosed, it should be staged as mild, moderate, or severe using tools like the Clinical Dementia Rating (CDR).
    • Determining Etiology: The final step is to determine the most likely underlying cause (e.g., “dementia most likely due to Alzheimer’s disease”). This entire process informs our ICD-10 coding, ensuring accurate documentation.
  • Communicating Findings and Shared Care Planning: The final core element brings us back to communication. The diagnosis and its implications must be communicated clearly and compassionately, not just to the patient but also to their care partner. The subsequent care plan is not something dictated by the clinician; it is developed collaboratively, reflecting the shared goals and values of the patient and their family.

A Phased Approach to Evaluation

The DetectAD guidelines emphasize that this comprehensive evaluation is not meant to be completed in a single, rushed 15-minute appointment. When a concern for cognitive impairment arises, I often find it most effective to schedule a dedicated, longer follow-up visit. This allows us to give the concern the time and attention it deserves. Studies have shown that patients who voice subjective cognitive concerns to their primary care providers and receive no further evaluation often feel frustrated and dismissed. A dedicated visit validates their concerns and initiates a thoughtful, structured process. This also means we do not just “jump right to the referral.” We do the foundational work first.

The Shifting Paradigm: Is Alzheimer’s a Single Disease?

We are living in an era where our very understanding of Alzheimer’s is being challenged. We are moving away from the idea of it being one single entity and toward a more nuanced view of it as a spectrum of Alzheimer’s disease disorders. The biological underpinnings are complex and heterogeneous. A person might have:

  • An amyloidopathy (a primary problem with amyloid protein accumulation).
  • A tauopathy (a primary problem with tau protein tangles).
  • A mixed picture involving both, along with other pathological proteins.
  • Significant contributions from inflammation, vascular damage, or exposure to toxins.

This complexity leads to a critical new conversation in our field: the distinction between preclinical Alzheimer’s disease (the presence of positive biomarkers like amyloid plaques but no symptoms) and symptomatic Alzheimer’s disease. Currently, our treatments and clinical focus are almost exclusively on the symptomatic stage. We do not yet have an evidence-based consensus on what to do for an individual who has the brain pathology of Alzheimer’s but is completely asymptomatic.

From a patient’s perspective, this can raise the question: “Does it really matter if it’s Alzheimer’s?” The answer is, “It depends.” For now, the symptom burden remains the primary guide for our treatment plan. However, as new therapies emerge that target specific pathologies, knowing the underlying biological cause will become increasingly critical for selecting the right treatment for the right patient. While I always respect a patient who says, “I’m not interested in knowing the label,” I also explain that knowing the likely cause can be immensely helpful for me, as their clinician, in crafting the most effective and personalized management strategy.

Understanding Clinical Trial Outcomes in Alzheimer’s Research

When we discuss the effectiveness of Alzheimer’s medications, you’ll often hear references to specific assessment tools used in clinical trials. You need to understand what these tools measure, as it helps put the “clinical meaningfulness” of a drug’s effect into perspective.

Key Assessment Tools

  • Clinical Dementia Rating (CDR): I am a big fan of the CDR. It evaluates a person across six key domains: Memory, Orientation, Judgment & Problem Solving, Community Affairs, Home & Hobbies, and Personal Care. The “Sum of Boxes” (CDR-SB) score is a global measure derived from these categories, providing a comprehensive snapshot of a person’s functional and cognitive status.
  • Mini-Mental State Examination (MMSE): This is a well-known 30-item questionnaire that assesses various cognitive functions, such as orientation, recall, attention, and language. A lower score indicates greater cognitive impairment.
  • Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Another widely used tool in clinical trials, the ADAS-Cog is a more detailed assessment of cognitive dysfunction, particularly memory and language. Unlike the MMSE, a higher score on the ADAS-Cog signifies greater impairment.

Understanding these tools is the first step in interpreting the data on the medications we’re about to discuss.

Pharmacologic Management of Cognitive Symptoms: Evidence and Rationale

Alzheimer’s disease and related disorders commonly utilize two established classes of cognitive-symptom medications: cholinesterase inhibitors and NMDA receptor antagonists.

Acetylcholinesterase Inhibitors: The First Line of Symptomatic Treatment

For the last 25 years, the cornerstone of symptomatic treatment for mild to moderate Alzheimer’s disease has been the class of drugs known as acetylcholinesterase inhibitors. The most commonly used agents are donepezil (brand name Aricept), rivastigmine (brand name Exelon), and galantamine.

How Do They Work?

The primary mechanism of action of these medications is to prevent the breakdown of acetylcholine in the brain. Acetylcholine is a crucial neurotransmitter involved in memory, learning, and most notably, attention. The logic is straightforward: you cannot remember something if you did not pay attention to it in the first place. In Alzheimer’s disease, the brain cells that produce acetylcholine are progressively destroyed. By inhibiting the enzyme (acetylcholinesterase) that breaks down acetylcholine, these drugs increase its availability in the synaptic cleft, helping to bolster attentional networks and overall communication between brain cells. This is also why we are so careful to avoid anticholinergic medications (like certain allergy medicines, overactive bladder drugs, or sleep aids), as they have the opposite effect and can worsen cognitive function.

Reviewing the Clinical Evidence

Let’s travel back to the late 1990s and look at one of the pivotal Phase III randomized controlled trials for donepezil (Aricept). Published in 1998, this study enrolled about 450 people and followed them for six months.

The results showed a modest but statistically significant benefit. On average, patients on the active drug experienced a slight improvement or, more commonly, a slower rate of decline on cognitive measures compared to the placebo group. For example, the placebo group experienced an average decline of one point on the 30-point MMSE scale, while the donepezil group showed an average increase of 0.4 points. It is crucial to frame these expectations correctly with patients and families. These drugs are not a cure. They do not stop or reverse the underlying disease process. The goal of symptomatic treatment is to help maintain function and temporarily stabilize symptoms, potentially “turning back the clock” on the disease by about 6 to 12 months.

Adverse Effects and Monitoring

It’s easy to forget that when these drugs were first studied, the clinical trials had very strict inclusion and exclusion criteria. This was due to known adverse effects.

  • Gastrointestinal Effects: A majority of patients starting donepezil will experience nausea and diarrhea to some degree. This is why we always start at a low dose (typically 5 mg) and titrate up slowly. These side effects can be significant enough to cause people to stop the medication. This is also a primary reason why some patients are switched to the rivastigmine patch, which delivers the medication transdermally and provides more stable drug levels.
  • Cardiovascular Effects: A less common but more serious set of adverse effects involves electrophysiologic changes in the heart. About a quarter to a third of patients may experience bradyarrhythmias (abnormally slow heart rhythms) and syncope (fainting). The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults lists a history of syncope as a strong reason to discontinue these drugs. I have certainly encountered patients who were on a path toward getting a pacemaker for bradycardia when the real culprit was their donepezil.

Our team, under Dr. Cardenas’s medical direction, monitors heart rate, blood pressure, GI tolerance, and falls, adjusting dosing if patients develop these issues.

NMDA Receptor Antagonists: A Different Approach

The other major class of symptomatic medication is the N-methyl-D-aspartate (NMDA) receptor antagonist. The only drug in this class is memantine (brand name Namenda). It is typically used for moderate to severe Alzheimer’s disease.

How Does It Work?

Memantine works on the glutamate system. Glutamate is the most abundant excitatory neurotransmitter in the brain. In Alzheimer’s disease, it’s believed that damaged neurons leak excessive amounts of glutamate, leading to chronic overstimulation of NMDA receptors. This state, called excitotoxicity, allows a constant influx of calcium into the neuron, ultimately causing cell damage and death.

Memantine gently blocks these receptors, but only when they are being overstimulated. It doesn’t interfere with the normal signaling required for learning and memory. By blocking the “excess noise” of glutamate, memantine is thought to protect neurons from further damage.

Clinical Evidence and Side Effects

The side effects of memantine are generally less common than with acetylcholinesterase inhibitors, but some patients experience agitation or somnolence (drowsiness). A key study from the early 2000s showed that, similar to donepezil, patients on memantine maintained their cognitive scores better than the placebo group. The drug was very well-tolerated. However, memantine truly seems to shine in the functional domain, especially when combined with a cholinesterase inhibitor.

The Power of Combination Therapy

The gold standard for symptomatic treatment in moderate to severe Alzheimer’s has become the combination of an acetylcholinesterase inhibitor and an NMDA receptor antagonist.

A pivotal 2012 study published in JAMA Neurology examined this synergy by dividing patients into four groups: placebo, donepezil only, memantine only, and combination therapy.

  • Cognitive Decline: A clear pattern emerged. The placebo group showed the greatest decline, the single-drug groups showed less decline, and the combination therapy group had the least amount of cognitive decline of all.
  • Activities of Daily Living (ADLs): The most dramatic separation between the groups was seen in ADLs. The data showed that patients on combination therapy remained more independent and autonomous for longer. This translates directly to a better quality of life and reduced caregiver burden. This is a profoundly meaningful outcome for families.

The Real-World Implications of Symptomatic Treatments

  • Modest Benefits: The improvements are not dramatic. We are promising patients that these medications may help them decline more slowly.
  • High Variability: Not every patient will respond.
  • Low Threshold for Discontinuation: As a clinician, I have a very low threshold for stopping these medications if a patient cannot tolerate them. If a patient on donepezil has a syncopal episode (fainting), the risk of injury from a fall far outweighs the modest cognitive benefit. The medication has to go.

The Root Causes of Pain-Video

The Root Causes of Pain | El Paso, Tx (2023)

Managing Neuropsychiatric Symptoms: The Hidden Crisis

I want to shift our focus to a critically important area: neuropsychiatric symptoms (NPS), also known as behavioral and psychological symptoms of dementia (BPSD). While cognitive decline is the hallmark of Alzheimer’s, it is often the NPS that cause the most distress for both patients and their families and are most likely to lead to institutional placement.

Assessing Neuropsychiatric Symptoms

The first step is to actively screen for these symptoms using validated tools like the Neuropsychiatric Inventory (NPI) or the Revised Memory and Behavior Problems Checklist (RMBPC). A crucial point about these tools is that they are validated for caregiver or care partner report. Patients may lack the insight to accurately report these symptoms, underscoring the absolute necessity of engaging a secondary historian.

Common Categories of Neuropsychiatric Symptoms

  • Hyperactivity/Agitation: Agitation, pacing, rummaging, irritability, and disinhibition (saying or doing socially inappropriate things).
  • Mood Symptoms: Depression & Anxiety are extremely common.
  • Apathy: A profound lack of interest, motivation, or emotional response.
  • Psychosis: Hallucinations (seeing or hearing things that are not there) and delusions (fixed, false beliefs, such as believing someone is stealing from them).
  • Sleep & Appetite Disturbances: Nighttime behaviors and changes in appetite.

The “DICE” Approach: A Framework for Management

Before ever reaching for a prescription pad, we must investigate the root cause of the behavior. A helpful framework for this is the DICE approach: Describe, Investigate, Create, Evaluate.

  1. Describe: Get a detailed description of the behavior from the caregiver.
  2. Investigate: Rule out underlying physical causes. This is where our integrative model shines. We look for:
    • Physical Causes: Pain, infection (especially UTIs), constipation, dehydration, fatigue.
    • Underlying Psychiatric Conditions: Pre-existing depression or anxiety.
    • Environmental Factors: An environment that is too stimulating or under-stimulating.
    • Sensory Changes: Misinterpreting sights or sounds due to uncorrected vision or hearing loss.
  • Create: Develop a non-pharmacological management plan first. This may involve simplifying the environment, establishing a predictable routine, using calming music, or engaging the person in a simple, meaningful activity.
  • Evaluate: Monitor the plan’s effectiveness and adjust as needed.

A Cautious Approach to Pharmacological Intervention

If non-pharmacological strategies are insufficient, we may consider medication.

  • Depression/anxiety/agitation: SSRIs (e.g., sertraline, citalopram) are often a good first choice, with attention to side effects.
  • Agitation/irritability: After evaluating for pain, infection, or other triggers, short-term pharmacologic options may be considered. We avoid benzodiazepines where possible due to cognitive and fall risks.
  • Psychosis: Antipsychotics should be reserved for true psychosis that is distressing or dangerous. I see far too much use of antipsychotics to help a patient sleep at night. This is an inappropriate use of this class of drugs, given their significant risks in older adults, including an increased risk of stroke and death (the basis for their “black box” warning).

Our internal medicine oversight by Dr. Cardenas is essential for managing comorbidities and drug interactions, especially when polypharmacy can produce cascading adverse effects.

The Power of Pharmacogenetic Testing

This brings me to a tool that has been a game-changer in my practice: pharmacogenetic testing. This simple cheek swab analyzes a person’s genes to predict how they will metabolize and respond to various medications, including antidepressants and antipsychotics.

In a population with a limited life expectancy, we do not have the luxury of the traditional “trial-and-error” method, which can waste three to six months. Pharmacogenetic testing provides a roadmap, helping us get to the right treatment faster and more safely. It has been surprisingly easy to implement in our practice, with good insurance coverage, and it provides immeasurable value.

Disease-Modifying Therapies (DMTs): The Evolving Landscape

For decades, our treatments have been purely symptomatic. But the landscape is rapidly changing. We are now entering an era of disease-modifying therapies that target the underlying biology of Alzheimer’s disease.

Amyloid-Targeted Therapies: What We Know About Aducanumab, Lecanemab, and Donanemab

I cover three notable monoclonal antibodies that target and remove amyloid from the brain:

  • Aducanumab: Achieved accelerated approval due to robust amyloid reduction but lacked consistent cognitive benefits across trials and carried significant ARIA risk. The evidence showed one positive and one negative Phase 3 outcome, raising questions about efficacy.
  • Lecanemab: Demonstrated statistically significant slowing of cognitive decline in early Alzheimer’s, with a defined safety profile and ARIA risk stratified by APOE4 status.
  • Donanemab: Showed slowing of progression with trial-based staging and adaptive dosing; also associated with ARIA risk modulated by APOE4 genetics.

What ARIA Is and Why Genetics Matters

The major safety concern with these therapies is ARIA, short for amyloid-related imaging abnormalities, which comes in two flavors detected on MRI:

  • ARIA-E: vasogenic edema or sulcal effusions.
  • ARIA-H: microhemorrhages or superficial siderosis.

Risk is substantially higher in APOE ε4 carriers, especially those who are ε4/ε4. In trial data, ε4/ε4 carriers experienced ARIA at rates roughly double or higher than non-carriers. In our clinic, we incorporate APOE genotyping into the pre-eligibility workup. It refines risk estimates and anchors informed consent. Some systems may exclude ε4/ε4 from treatment due to elevated risk.

Who Is a Candidate and When

The evolution of these FDA-approved anti-amyloid therapies has created a new pathway in care. We use a checklist under medical direction to determine candidacy:

  • Clinical stage: Greatest potential benefit is in early symptomatic phases (MCI due to Alzheimer’s or mild Alzheimer’s dementia).
  • Biomarker confirmation: Candidacy requires amyloid positivity via PET or CSF; emerging blood biomarkers may play a supportive role but are not yet sufficient for eligibility.
  • MRI baseline: Assess for structural vulnerabilities, such as extensive microhemorrhages, which may increase risk.
  • Medical comorbidities: Cardiovascular stability and anticoagulation considerations are key.
  • Patient goals and logistics: Expectations must be realistic; DMTs modify the disease trajectory rather than cure pathology. Patients and families must be willing to commit to regular infusions and monitoring.

With Dr. Cardenas leading medical direction, our team ensures that candidates receive baseline MRI, neurological evaluation, and clear follow-up plans, coordinating with specialty centers as needed.

Our Integrative Model: How Chiropractic Care Fits With Medical Oversight, Functional Medicine, and Rehabilitation

While chiropractic is not a direct “treatment” for Alzheimer’s disease, its principles and practices play a powerful supportive role. At Injury Medical Clinic PA, we build comprehensive plans that do not compete with DMTs but rather optimize patient resiliency, reduce falls, and maintain independence.

The Role of Integrative Chiropractic Care in Supporting Cognitive Health

My approach as a Doctor of Chiropractic is rooted in several key areas:

  • Optimizing Nervous System Function: Through gentle, specific chiropractic adjustments, my goal is to restore proper motion and alignment to the spinal joints. This can improve proprioception (the body’s sense of position), reduce chronic pain signals that act as a physiological stressor, and help balance the autonomic nervous system (ANS), shifting it away from a dominant “fight-or-flight” state that is detrimental to brain health.
  • Enhancing Cerebral Blood Flow and CSF Dynamics: Proper movement of the cervical spine (the neck) is thought to facilitate optimal blood flow to the brain. Furthermore, the gentle, rhythmic motion induced by spinal adjustments may help promote the circulation of cerebrospinal fluid (CSF), which is critical to the brain’s waste-cleansing system (the glymphatic system).
  • Addressing Musculoskeletal Comorbidities: Patients with cognitive decline are at a high risk for falls. By improving gait, balance, and managing pain through non-pharmacological means, we can directly reduce fall risk, which is a major cause of morbidity and loss of independence.
  • Autonomic regulation: Gentle spine and rib cage mobilization, diaphragmatic mechanics training, and postural interventions can normalize autonomic tone, supporting heart rate variability (HRV), sleep quality, and sympathetic-parasympathetic balance.
  • Perfusion optimization: Cervicothoracic mobility and scapulothoracic mechanics influence respiratory efficiency, which contributes indirectly to brain clearance pathways.
  • Pain modulation: Chronic pain amplifies stress hormones, disrupts sleep, and worsens cognition. By addressing spinal dysfunctions, we may reduce nociceptive load and improve daily function.
  • Gait and fall risk: Targeted balance and gait work reduces fall risk and helps preserve independence.

A Functional Medicine and Lifestyle-Based Approach

My practice is deeply integrated with the principles of functional medicine, which seeks to understand the root causes of dysfunction. In collaboration with Dr. Cardenas, we guide our patients on key lifestyle modifications that form the bedrock of brain health:

  • Nutrition: Guidance on an anti-inflammatory, nutrient-dense diet.
  • Exercise: Personalized programs that include aerobic activity, strength training, and balance work.
  • Sleep: Emphasis on sleep hygiene and treatment of underlying sleep disorders like sleep apnea.
  • Stress Management: Teaching stress-reduction techniques and using chiropractic adjustments to help modulate the body’s physiological stress response.

This collaborative model ensures that every patient receives a holistic assessment and a care plan that leverages the strengths of multiple disciplines. For our patients with Alzheimer’s disease, this means we are not just prescribing medication; we are building a supportive framework to enhance cognitive resilience, manage behavioral symptoms, and maintain physical function.

Clinical Observations From My Practice

Drawing from cases shared through resources like Sciatica Clinic and professional channels, I consistently observe:

  • Patients with chronic neck and thoracic dysfunction who receive gentle, tailored chiropractic care often experience improved sleep, reduced headaches, and steadier mood—factors that indirectly support cognition.
  • Breathing mechanics training reduces sympathetic drive, stabilizes HRV, and improves energy levels, which correlates with better daily functioning.
  • Coordinated internal medicine oversight from Dr. Cardenas reduces adverse medication events, enabling patients to benefit from cognitive enhancers and other therapies with fewer complications.

These patterns, which you can explore further through my work at Sciatica Clinic and my professional profile, reinforce that integrative care is not ancillary—it is central to maintaining function and quality of life.

Conclusion: A Modern, Integrative Pathway for Dementia Care

The journey through cognitive decline is complex and deeply personal. As clinicians, our role has evolved from simply managing symptoms to becoming navigators, investigators, and care partners. The latest research and guidelines provide us with a methodical framework for diagnosis, emphasizing thoroughness and shared decision-making. Our therapeutic landscape is expanding, offering not only established symptomatic treatments but also the promise of disease-modifying therapies that target the underlying biology of Alzheimer’s disease.

At Injury Medical Clinic, we believe the most effective approach is integrative. The collaboration between the medical oversight provided by Dr. Cardenas and the holistic, function-focused approach of chiropractic and functional medicine allows us to care for the whole person. By optimizing nervous system function, improving musculoskeletal health, reducing pain, and empowering patients with lifestyle strategies, we aim to enhance their quality of life, maintain their independence for as long as possible, and support them and their families on every step of this challenging journey. We hope that this knowledge empowers you and underscores our commitment to providing comprehensive, evidence-based, and compassionate care.

References

Disclaimer: This post is for educational purposes only and does not constitute medical advice. Please consult with a qualified healthcare professional for any health concerns.

SEO tags: Alzheimer’s disease, dementia diagnosis, ATN biomarkers, amyloid therapies, lecanemab, donanemab, aducanumab, ARIA, APOE4, p-tau217, cholinesterase inhibitors, memantine, disease-modifying therapies, ARIA monitoring, neuropsychiatric symptoms, agitation in dementia, pharmacogenetic testing, caregiver education, integrative chiropractic care, internal medicine oversight, functional medicine, autonomic regulation, cerebral perfusion, neuroinflammation, gait and balance rehabilitation, El Paso dementia clinic, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alex Jimenez DC, sciatica clinic resources, multidisciplinary dementia care, cognitive decline, activities of daily living, caregiver support, neurodegenerative disease, brain health, personal injury care, rehabilitation

Integrative Regenerative Chiropractic Medicine Overview

Integrative Regenerative Chiropractic Medicine Overview
Integrative Regenerative Chiropractic Medicine Overview

Integrative Regenerative Chiropractic Medicine for Optimal Cellular Health

Abstract

Regenerative medicine focuses on supporting the body’s natural repair systems rather than merely masking pain. Treatments such as platelet-rich plasma (PRP), platelet fibrin plasma (PFP), microfragmented adipose tissue (MFAT), and some cell-based therapies use platelets, growth factors, cells, and signaling molecules to influence the environment around injured tissue. These signals may help regulate inflammation, support blood vessel growth, improve cell communication, and encourage tissue repair. However, the effects differ by treatment, and many regenerative therapies remain under active study.

A broader recovery plan may also include medically appropriate IV therapy, integrative chiropractic care, functional medicine, exercise, nutrition, and rehabilitation. At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, works within a multidisciplinary model that combines chiropractic and rehabilitation with medical oversight. This article explains how these different parts of care may work together and reviews the limits of current evidence.

Integrative Regenerative Chiropractic Medicine Overview

What Is Regenerative Medicine?

Regenerative medicine is a growing area of healthcare that tries to improve the environment in which the body heals. Instead of simply blocking pain signals, some regenerative treatments use biological materials taken from blood, bone marrow, fat tissue, or other sources to influence the body’s repair response.

This does not mean that every regenerative treatment can regrow a damaged joint, disc, tendon, or ligament. Hospital for Special Surgery notes that the science is still developing and that the term “regeneration” can sometimes suggest more tissue regrowth than research has actually proven. However, certain therapies may change the tissue environment, reduce pain, influence inflammation, and support repair (Hospital for Special Surgery, 2024).

Researchers studying stem cells have found that much of their potential benefit may come from cell signaling rather than simply turning into replacement tissue. Mesenchymal stromal or stem cells can release cytokines, extracellular vesicles, growth factors, and other signaling substances that communicate with nearby cells and influence immune activity (Jin et al., 2023; Ennis et al., 2013).

In simple terms, regenerative treatments may help create a better biological setting for healing.

Biological Signals: Giving Cells Instructions to Repair

Cells do not work alone. They constantly send chemical messages to one another.

When tissue is injured, the body releases signals that control:

  • Inflammation
  • Immune-cell activity
  • Blood vessel formation
  • Collagen production
  • Cell growth and survival
  • Tissue remodeling

Research on mesenchymal stem cells shows that these cells can respond to the inflammatory environment and release factors that may help change immune activity and support healing. Growth factors involved in regenerative signaling may include vascular endothelial growth factor, platelet-derived growth factor, transforming growth factor, insulin-like growth factor, and fibroblast growth factors (Jin et al., 2023).

This helps explain why regenerative medicine is often described as working through biological signaling.

Rather than functioning like a pain medication that primarily alters how pain is perceived, a regenerative treatment may aim to influence what is happening around damaged tissue.

PRP: Concentrating the Body’s Own Healing Signals

Platelet-rich plasma, or PRP, is one of the best-known orthobiologic treatments.

A healthcare professional draws a small amount of the patient’s blood and processes it in a centrifuge. This separates and concentrates platelets. The platelet-rich portion is then placed into a selected injured area.

Platelets are well known for their role in clotting, but they also contain substances involved in repair. When activated, platelets release growth factors that communicate with cells involved in healing.

Hospital for Special Surgery explains that PRP contains proteins that may influence inflammation, pain, and tissue repair. Laboratory research has also shown that preparations rich in platelet growth factors can influence fibroblast activity, which is important because fibroblasts help make collagen and repair connective tissue (Anitua et al., 2009).

PRP may therefore be considered for selected:

  • Tendon injuries
  • Ligament injuries
  • Muscle injuries
  • Joint problems
  • Osteoarthritis
  • Certain sports injuries

It is important to understand that PRP is generally injected into a specific tissue or joint. Evidence is stronger for local biological effects than for claims that PRP broadly lowers inflammation throughout the entire body.

What Is PFP?

PFP, or platelet fibrin plasma, is another blood-based preparation being studied in regenerative medicine.

PFP contains platelets along with fibrin and other blood components that can form a biological framework around an injured area. Fibrin acts somewhat like a temporary scaffold that may hold platelets and signaling molecules in place while tissue is healing.

Research published in Tissue Engineering and Regenerative Medicine examined the use of physiologically concentrated PFP in difficult-to-heal wounds and found evidence of biological activity associated with tissue repair (Fan et al., 2024).

However, PFP is a less standardized term than PRP or platelet-rich fibrin (PRF). Preparation methods may vary, and the evidence for musculoskeletal use is still developing.

Patients should therefore understand exactly what type of platelet product is being offered and why it has been selected.

MFAT: Using the Healing Environment of Adipose Tissue

Microfragmented adipose tissue (MFAT) is derived from the patient’s own fat.

Fat contains more than stored energy. Adipose tissue also contains blood vessels, supportive connective tissue, growth factors, and a mixture of cells involved in immune regulation and tissue maintenance. MFAT processing is designed to preserve portions of this natural tissue environment while making it suitable for targeted use.

MFAT has been explored for problems such as:

  • Knee osteoarthritis
  • Cartilage injuries
  • Tendon injuries
  • Ligament injuries
  • Degenerative joint conditions

Adipose-derived cell preparations may influence inflammation and healing, in part, through signaling molecules released by cells within the tissue, rather than simply replacing damaged structures.

Evidence-based guidelines published in the Journal of Pain Research describe regenerative procedures as an evolving area of chronic pain management. Evidence differs greatly by condition, treatment method, processing system, and type of biologic product used (D’Souza et al., 2024).

Do Stem Cells Reduce Inflammation?

Mesenchymal stem cells have attracted attention because they appear to communicate with immune cells.

Research suggests that these cells can sense signals in an inflamed environment and then release cytokines, growth factors, and other molecules that may help regulate excessive inflammatory activity. This is known as an immunomodulatory effect (Ennis et al., 2013).

They may also release substances involved in:

  • Angiogenesis, or new blood vessel formation
  • Cell survival
  • Collagen organization
  • Immune regulation
  • Tissue remodeling

The paracrine or signaling effect may be as important as the cells’ ability to become other cell types (Jin et al., 2023).

Still, patients should be cautious about broad claims involving “stem cell therapy.” The FDA continues to warn consumers that many stem-cell and human-cell products advertised for orthopedic, neurologic, and other conditions are not FDA-approved for those uses. In 2026, the FDA again warned about potentially serious risks from unapproved human cell and tissue products.

How IV Therapy Fits Into Cellular Support

IV therapy is different from PRP, PFP, or MFAT.

An IV places fluids, nutrients, medications, or other medically selected compounds directly into the bloodstream. When there is a real medical need, IV therapy can be useful for hydration, correcting certain deficiencies, or delivering medications.

For example:

  • B vitamins participate in energy metabolism.
  • Magnesium supports normal muscle and nerve function.
  • Glutathione is part of the body’s antioxidant defense system.
  • Fluids can help correct dehydration.

These nutrients are important for normal cellular function and antioxidant balance.

However, IV vitamin or nutrient therapy should not automatically be described as regenerative medicine or as a proven treatment for systemic inflammation. Benefits depend on the patient’s health, nutrient status, IV ingredients, dose, and reason for treatment.

Medical review is especially important because IV therapy is not appropriate for everyone. Kidney disease, heart disease, medication interactions, electrolyte problems, allergies, and other conditions can affect safety.

Where Integrative Chiropractic Care Fits In

Regenerative injections may influence the biological environment of injured tissue, but healing also depends on how the person moves.

Pain can change the way muscles work. Injuries may lead to stiffness, guarding, weakness, reduced activity, and abnormal movement patterns. This is where chiropractic care and rehabilitation may complement medically appropriate regenerative treatment.

Integrative chiropractic care may include:

  • Spinal or joint manipulation when appropriate
  • Mobilization
  • Soft-tissue treatment
  • Corrective exercise
  • Strength training
  • Mobility work
  • Postural training
  • Neuromuscular rehabilitation

Spinal manipulation has been shown to provide small to modest improvements in pain and function for some people with low back and neck pain. Research has also identified short-term changes in several inflammatory or pain-related signaling molecules after manipulation, although these biological findings remain preliminary.

For this reason, it is more accurate to say that chiropractic treatment may improve joint motion, reduce pain, and support rehabilitation than to claim that adjustments permanently “realign” the spine or consistently lower systemic inflammation.

A better mechanical environment may allow a patient to move more comfortably while rehabilitation strengthens the tissues surrounding the injured region.

Combining Biology With Mechanical Rehabilitation

An integrated treatment plan can look at two important parts of recovery:

Biological support

  • PRP or other platelet preparations
  • Selected cell- or tissue-based procedures
  • MFAT when medically appropriate
  • Nutrition
  • Correction of documented nutrient deficiencies
  • Physician-guided IV therapy when indicated

Mechanical and functional support

  • Chiropractic care
  • Progressive rehabilitation
  • Strength training
  • Mobility exercises
  • Movement retraining
  • Return-to-work or return-to-sport conditioning

A 2025 review on regenerative medicine and physical rehabilitation describes the potential of integrating biological signaling with controlled mechanical loading, rather than relying solely on injections. The authors also emphasize that treatment protocols still require better standardization and higher-quality long-term research (Muthukrishnan & Rajadurai, 2025).

Multidisciplinary Care at Injury Medical Clinic PA in El Paso

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes a multidisciplinary model combining chiropractic care, functional medicine, injury management, medical evaluation, and rehabilitation.

Dr. Jimenez’s published clinical materials emphasize looking beyond a single painful body part. His approach may include examination of spinal and joint mechanics, strength, mobility, lifestyle factors, nutritional status, rehabilitation needs, and medical concerns when developing an individualized plan. His practice materials list services involving personal injury care, chiropractic rehabilitation, functional medicine, and medically integrated treatment.

Medical Oversight From Dr. Maria Guadalupe Cardenas

Dr. Maria Guadalupe Cardenas, MD, is identified by the practice as its medical director and collaborative physician. She is an internal medicine physician with more than 40 years of clinical experience. Texas Medical Board documentation verifies that Texas physician license J2933 is currently listed as expired as of May 31, 2027. Public professional sources also identify her field as internal medicine.

This type of multidisciplinary structure allows internal medicine oversight to work alongside chiropractic and rehabilitation services.

The team can therefore consider several sides of an injury:

  • Dr. Cardenas: medical history, internal medicine concerns, medication safety, laboratory findings, systemic disease, and medical oversight.
  • Dr. Jimenez: chiropractic evaluation, neuromusculoskeletal function, movement, functional medicine, personal injury management, and rehabilitation.
  • Rehabilitation team: mobility, strength, stability, endurance, and progressive return to activity.
  • Functional medicine support: nutrition, lifestyle factors, metabolic health, and other contributors to recovery.

This structure can be especially useful for people recovering from motor vehicle accidents, workplace injuries, sports injuries, chronic joint problems, or complex musculoskeletal conditions.

The Goal: Create a Better Environment for Recovery

One treatment rarely controls healing.

Cells need adequate oxygen, nutrients, blood flow, signaling molecules, appropriate immune activity, and mechanical stimulation. At the same time, the patient needs enough mobility and strength to gradually return to normal activity.

Regenerative medicine may help influence the biological side of healing, while chiropractic care and rehabilitation can address the movement and mechanical side of recovery.

The goal is not simply to hide pain. The goal is to determine which tissue is injured, what is limiting recovery, which treatments have reasonable scientific support, and how those treatments can be combined safely.

  • Not every patient needs regenerative injections.
  • Not every patient needs IV therapy.
  • Not every injury is appropriate for manipulation.

Treatment should follow a proper examination, diagnosis, imaging when necessary, and consideration of the patient’s overall medical condition.

Conclusion

PRP, PFP, MFAT, cell-based therapies, medically appropriate IV support, chiropractic care, and rehabilitation work in very different ways. Some regenerative treatments deliver growth factors or cellular signals that may influence inflammation and repair. Chiropractic and rehabilitation focus more directly on pain, mobility, strength, joint function, and movement.

The strongest approach is therefore not to view regenerative medicine as a miracle treatment. Instead, it can be considered one part of a larger, medically supervised recovery plan.

At Injury Medical Clinic PA in El Paso, the multidisciplinary model described by Dr. Alexander Jimenez combines integrative chiropractic care, functional medicine, personal injury management, and rehabilitation with internal medicine oversight from Dr. Maria Guadalupe Cardenas. This type of coordinated approach allows biological, mechanical, and general medical factors to be considered together when developing an individualized plan.

Unlocking the Secrets of Inflammation: Integrative Medicine Approach | El Paso, Tx (2023)

References

Anitua, E., Sánchez, M., Zalduendo, M. M., de la Fuente, M., Prado, R., Orive, G., & Andía, I. (2009). Fibroblastic response to treatment with different preparations rich in growth factors. Cell Proliferation, 42(2), 162–170.

D’Souza, R. S., Her, Y. F., Hussain, N., et al. (2024). Evidence-based clinical practice guidelines on regenerative medicine treatment for chronic pain: A consensus report from a multispecialty working group. Journal of Pain Research, 17, 2951–3001.

Ennis, W. J., Sui, A., & Bartholomew, A. (2013). Stem cells and healing: Impact on inflammation. Advances in Wound Care, 2(7), 369–378.

Fan, L., Zhang, Y., Yin, X., Chen, S., Wu, P., Huyan, T., Wang, Z., Ma, Q., Zhang, H., Wang, W., Gu, C., Tie, L., & Zhang, L. (2024). The effect of platelet fibrin plasma (PFP) on postoperative refractory wounds: Physiologically concentrated platelet plasma in wound repair. Tissue Engineering and Regenerative Medicine, 21(8), 1255–1267.

Hospital for Special Surgery. (2024). 5 things to know about regenerative medicine treatments.

Hospital for Special Surgery. (2024). Regenerative medicine for orthopedics: Biologic therapies.

Jin, Y., Li, S., Yu, Q., Chen, T., & Liu, D. (2023). Application of stem cells in regeneration medicine. MedComm, 4, e291.

Kentuckiana Pain Specialists. (2026). IV nutrition therapy FAQ.

Muthukrishnan, P., & Rajadurai, S. (2025). Regenerative medicine combined with physiotherapy in orthopedic rehabilitation: Evidence, mechanisms, and clinical protocols. WebLog Journal of Orthopaedics.

National Center for Complementary and Integrative Health. (n.d.). Spinal manipulation: What you need to know.

New Jersey Regenerative Institute. (n.d.). How stem cells power regenerative medicine to repair tissues and support faster healing.

U.S. Food and Drug Administration. (2026). Patient and consumer warning about potential serious risks of harm following use of unapproved products.

BioEvolve Physical Medicine & Rehabilitation. (n.d.). Adipose tissue cells (MFAT).

Jimenez, A. (n.d.). Dr. Alex Jimenez: Chiropractic, functional medicine, personal injury, and rehabilitation.

A Clinical Approach to Toxic Exposure in Health Care

Learn about the clinical approach to toxic exposure and its role in enhancing patient care and safety measures.

Educational Abstract: Integrative, Evidence-Based Toxicology Care From Emergency Stabilization To Functional Recovery

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this comprehensive educational post, I guide you through a clear, evidence-based roadmap for recognizing, stabilizing, and treating toxic exposures and ingestions across emergency, ICU, and integrative injury-care settings. Drawing on contemporary toxicology research, frontline clinical practice, and multidisciplinary collaboration, I explain:

  • The physiologic logic behind toxidromes and how to identify them at the bedside
  • Practical decontamination strategies and when GI interventions add value
  • Antidotes and reversal strategies for organophosphates, anticholinergics, sympathomimetics (e.g., cocaine, methamphetamine), opioids, tricyclic antidepressants, ethylene glycol, acetaminophen, cyanide, and salicylates
  • Advanced protocols: high-dose naloxone, insulin therapy, lipid emulsion (intralipid), cyproheptadine for serotonin syndrome, octreotide for sulfonylurea hypoglycemia, and precision anticoagulant reversal
  • Airway-first principles in severe metabolic acidosis and DKA, including ventilation matching
  • How integrative chiropractic care fits safely into a medically directed toxicology workflow with functional medicine, rehabilitation, and personal injury care
  • The team-based approach at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I practice with our Medical Director and Collaborative Physician, Maria Guadalupe Cardenas, MD (Board Certified, Internal Medicine; NPI #1164426749; Texas MD License #J2933), whose 40+ years of internal medicine expertise guide safety, diagnostics, and pharmacologic oversight

I present modern, evidence-based methods and highlight clinical observations from my practice and shared resources at sciatica. clinic and my professional updates on LinkedIn. The goal is simple: make complex toxic emergencies understandable and actionable, while showing how a multidisciplinary, integrative model improves outcomes.

Integrative Toxicology Care Model: Medical Direction Meets Chiropractic And Functional Recovery

I practice at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas. Our multidisciplinary setup is common in integrative and injury care clinics and is built on the principle that complex cases benefit from coordinated expertise:

  • Medical Direction and Oversight (Dr. Cardenas)
    • Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933
    • 40+ years of experience directing diagnostics, antidote selection, pharmacologic safety, and escalation decisions
  • Chiropractic Care (Dr. Jimenez)
    • Neuromusculoskeletal recovery, autonomic regulation, respiratory mechanics optimization, and pain modulation
  • Functional Medicine
    • Nutrition, detoxification capacity, mitochondrial health, endocrine function, inflammation, and microbiome support
  • Personal Injury Care
    • Documentation, case management, occupational/environmental exposure tracking, and rehabilitation pathways
  • Rehabilitation Services
    • Physical therapy, graded exercise, neurodynamic techniques, and mobility restoration

Our model is MD-directed, chiropractor-integrated, functionally informed, and rehab-supported—particularly effective when patients face toxic exposures that require acute stabilization followed by long-term recovery. The coordination ensures the right interventions at the right time, with appropriate safety checks.

Foundations Of Toxicology: Physiology, Priorities, And Practical Steps

Understanding toxicology begins with physiology. Each antidote and protocol maps to a specific receptor, enzyme, channel, or cellular pathway.

Physiology First: How Toxins Disrupt Systems

  • Receptors and Channels
    • Muscarinic and nicotinic acetylcholine receptors govern autonomic signaling; overstimulation leads to secretions, bradycardia, fasciculations, and weakness (WHO, n.d.)
    • GABA-A and NMDA receptors are central to inhibitory and excitatory CNS control; sedative-hypnotics depress, excitotoxins provoke
    • Sodium and potassium channels drive cardiac conduction; blockade widens QRS and predisposes to ventricular arrhythmias (EMCrit Project, n.d.)
  • Key Enzymes
    • Acetylcholinesterase inhibition by organophosphates generates cholinergic crises.
    • Alcohol dehydrogenase (ADH) converts ethylene glycol and methanol into toxic acids (NEJM, n.d.)
  • Transport and pH
    • Weak acids/bases change ionization with pH shifts; bicarbonate reduces cardiotoxicity via conduction effects and protein binding (EMCrit Project, n.d.)
  • Volume of Distribution & Protein Binding
    • Dialysis, intralipid, or charcoal efficacy depends on solubility, binding, and distribution characteristics (ACMT, n.d.; UpToDate, n.d.)

Primary Assessment: ABCs Lead The Way

  • Airway
    • Protect against aspiration and obstruction, especially with hypersecretions (cholinergic crises) or depressed mental status (opioids/sedatives)
  • Breathing
    • Watch for hypoventilation (opioids), bronchorrhea (organophosphates), hyperventilation (salicylates)
  • Circulation
    • Manage hypotension (sedatives/TCA overdose) or hypertensive crises (sympathomimetics); early EKG for conduction delay.s
  • Glucose
    • Immediate fingerstick; toxins and therapies (e.g., insulin therapy) alter glucose levels
  • Temperature
    • Treat hyperthermia aggressively to prevent organ damage

I often initiate benzodiazepines early for agitation, seizures, or severe sympathetic activation—reducing catecholaminergic surges, improving myocardial oxygen balance, and protecting neurologic function (Wightman & Nelson, 2022).

Decontamination: What Works, WhaDoesn’t’t, And When To Use It

Dermal And Inhalational Decontamination

  • Water irrigation is usually sufficient; avoid agents that increase dermal penetration.
  • Proper PPE for organophosphate exposure to prevent secondary contamination (WHO, n.d.)
  • Remove from source; provide supplemental oxygen; consider bronchodilators for bronchospasm.m

Gastrointestinal Decontamination

  • Induced emesis is no longer recommended (ACMT, n.d.)
  • Gastric lavage has limited indications and requires airway protection
  • Activated charcoal (UpToDate, n.d.)
    • Most effective within 4 hours for adsorbable compounds
    • Avoid in unprotected airways; intubate first if needed
    • Poor efficacy for iron, lithium, alcohols, caustics, and some heavy metals
  • Whole bowel irrigation (PEG)
    • Useful for body packers/stuffers and sustained-release or charcoal-inaccessible toxins (ACMT, n.d.)
  • Hemodialysis
    • Effective for small, water-soluble, low protein-binding toxins like ethylene glycol, methanol, sometimes salicylates (NEJM, n.d.)
    • Not useful for highly protein-bound, lipophilic drugs (e.g., TCAs), but corrects severe acid-base disturbances

These choices hinge on time since ingestion, substance properties, airway status, and hemodynamic stability.

Anticholinergic Toxidrome: Recognition And Management

Clinical Pattern

  • Blind as a bat (mydriasis, blurred vision)
  • Red as a beet (flushed skin)
  • Hot as a hare (hyperthermia)
  • Dry as a bone (anhidrosis, dry mucosa)
  • Mad as a hatter (delirium, agitation, psychosis)
  • Full as a flask (urinary retention)
  • EKG may reveal wide QRS (>100 ms) with sodium-channel blockade in TCA overdoses (EMCrit Project, n.d.)

Common Agents

  • Anticholinergics (atropine, scopolamine)
  • Antihistamines (diphenhydramine, doxylamine)
  • Psychotropics (TCAs, antipsychotics)
  • Plants (jimsonweed)

WhIt’s’s Dangerous

  • Depressed sweating, impaired heat dissipation, tachycardia, and conduction slowing via fast sodium channel blockade (TCAs) raise risk of ventricular arrhythmias.

Management

  • Airway/Breathing: Intubate if needed; correct acidosis
  • Seizures/Agitation: Benzodiazepines first-line
  • Perfusion: IV fluids; norepinephrine if needed
  • Activated charcoal if early and airway protected
  • Systemic alkalinization with sodium bicarbonate infusion to narrow QRS and reduce arrhythmias (EMCrit Project, n.d.)
  • Cooling for hyperthermia
  • Physostigmine can be considered under expert guidance, excluding TCA overdose; requires EKG monitoring

Cholinergic Crisis: Organophosphate And Carbamate Poisoning

Pathophysiology

Acetylcholinesterase inhibition causes acetylcholine accumulation:

  • Muscarinic overstimulation: SLUDGE/DUMBELS—salivation, lacrimation, urination, diarrhea, GI cramping, emesis, bronchorrhea, bronchospasm, bradycardia, miosis
  • Nicotinic overstimulation: Fasciculations, weakness, paralysis—especially diaphragm involvement (WHO, n.d.)

Clinical Priorities

  • Decontamination: Remove clothing, copious water irrigation; strict PPE
  • Airway: Elevate head-of-bed, suction secretions, early intubation if needed
  • Seizures: Benzodiazepines first-line

Antidotes

  • Atropine
    • Blocks muscarinic receptors, reducing secretions
    • Titrate 2–5 mg IV every 3–5 minutes; endpoint is drying of secretions and improved ventilation
  • Pralidoxime (2-PAM)
    • Reactivates acetylcholinesterase by removing the organophosphate
    • Give early to prevent irreversible aging; consider continuous infusion (WHO, n.d.)

Monitor for intermediate syndrome—delayed neuromuscular weakness post-stabilization.

Sympathomimetic Toxicity: Cocaine, Methamphetamine, Amphetamines

WhatYou’lll See

  • Euphoria, restlessness, paranoia, agitation, psychosis
  • Mydriasis, tachycardia, hypertension, hyperthermia
  • Diaphoresis—key differentiator from anticholinergic toxicity (hot and wet vs hot and dry)
  • Severe complications: coronary vasospasm, arrhythmias, seizures, rhabdomyolysis, stroke (AHA, n.d.)

Management

  • Benzodiazepines to reduce central sympathetic outflow
  • Vasodilators (nitroprusside, nicardipine, nitroglycerin) for severe hypertension or vasospasm
  • Avoid pure beta-blockers (e.g., metoprolol) due to unopposed alpha; consider labetalol or prioritize vasodilators (AHA, n.d.)
  • Cooling to prevent rhabdomyolysis
  • Hydration, CK/renal monitoring
  • Activated charcoal if ingestion and protected airway
  • Whole bowel irrigation for body packers/stuffers
  • Sodium bicarbonate for wide QRS due to sodium-channel blockade (EMCrit Project, n.d.)

Continuous cardiac monitoring and serial EKGs guide risk.

Opioid Toxicity And High-Dose Naloxone: Breathing Comes First

Presentation

Opioids depress brainstem respiratory centers, causing hypoventilation, hypercapnia, hypoxemia; miosis is common but not universal.

Naloxone Strategy

  • Start low if withdrawal risk is high in chronic users; prioritize ventilation in apnea.a
  • High-dose naloxone escalation may be necessary for synthetic opioids (fentanyl analogs); repeated boluses or infusion due to short naloxone half-life (CDC, n.d.)
  • Airway support: Bag-valve mask, oxygen, intubation if inadequate response

Monitor for rebound respiratory depression and pulmonary edema; consider infusion for long-acting agents.

Acetaminophen Toxicity: Timing, Staging, And N-Acetylcysteine

Key Timing

  • First ideal level at 4 hours post-ingestion; earlier draws can be falsely reassuring
  • If time is unknown, draw on arrival and again at 4 hours (National Library of Medicine, n.d.)

Why N-acetylcysteine (NAC) Works

  • Replenishes glutathione, detoxifying NAPQI—the hepatotoxic metabolite
  • Protects hepatocytes; earlier administration improves outcomes (Heard, 2008)

Use the Rumack–Matthew nomogram for single acute ingestions; start NAC for delayed presentations with elevated transaminases or prolonged ingestion profiles. Monitor LFTs, INR, bilirubin, renal function, and mental status.

Ethylene Glycol And Toxic Alcohols: Crystals, Acidosis, And ADH Blockade

Clinical Clues

  • Early CNS depression; later anion gap metabolic acidosis
  • Calcium oxalate crystals in urine; risk of renal failure
  • Methanol causes optic nerve injury and severe acidosis; isopropanol causes ketosis without acidosis

Pathophysiology

  • Ethylene glycol is metabolized via ADH to glycolic acid and oxalic acid
  • Oxalic acid complexes with calcium, forming calcium oxalate crystals and damaging renal tubules (NEJM, n.d.)

Management

  • Fomepizole: Potent ADH inhibitor—halts toxic metabolite production
  • Ethanol: Historical competitive inhibitor when fomepizole unavailable
  • Hemodialysis: Removes parent compounds and metabolites; corrects severe acidosis/electrolytes
  • Bicarbonate: Supports pH and reduces cardiac irritability
  • Correct hypocalcemia cautiously; treat symptomatic cases

Early ADH blockade prevents renal failure and systemic complications.

Sodium Channel Blockade And Sodium Bicarbonate: Electrical Rationale

EKG Patterns

  • Wide QRS (>100 ms)
  • Rightward axis and terminal R wave in aVR
  • Risk of ventricular arrhythmias (EMCrit Project, n.d.)

Why Bicarbonate Helps

  • Alkalinizes serum to reduce drug binding to sodium channels
  • Increases protein binding, reducing active free drug
  • Narrows QRS and improves conduction velocity

Use bolus plus infusion strategies, monitoring pH, potassium, and EKG changes. Titrate to effect (often pH 7.45–7.55).

Lipid Emulsion Therapy (Intralipid): The”“Lipid Sink” For Cardiotoxic Emergencies

Indications

  • Local anesthetic systemic toxicity (LAST) (bupivacaine)
  • Lipophilic cardiotoxins: some TCAs, verapamil/diltiazem, beta-blockers, quetiapine, others (EMRA, n.d.)

Mechanism

  • Lipid sink: Sequesters lipophilic toxins from myocardium/CNS, reducing free active drug
  • Provides fatty acids to support myocardial contractility

Protocol Considerations

Administer per dosing guidelines; monitor for pancreatitis, fat overload, and lab assay interference. Use adjunctively with ACLS, vasopressors, bicarbonate, or HIET depending on toxin.

High-Dose Insulin Euglycemia Therapy (HIET): Severe Beta-Blocker And CCB Overdose

When To Use

  • Cardiogenic shock from beta-blockers or calcium channel blockers (Levine et al., 2021; Shepherd & Velez, 2018)

How It Works

  • Improves myocardial inotropy and carbohydrate utilization
  • Facilitates glucose transport into myocytes
  • Requires dextrose infusion and frequent glucose/potassium monitoring

Combine with vasopressors, calcium, glucagon (beta-blocker), lipid emulsion, and bicarbonate if conduction slows.

Cyanide And Carbon Monoxide: Inhalational Toxins And Cellular Hypoxia

Cyanide Poisoning: A Cellular Asphyxiant

  • Source: Combustion of synthetic materials (fires), industrial exposures
  • Mechanism: Inhibits cytochrome c oxidase (complex IV) in mitochondria—blocks oxidative phosphorylation, causes histotoxic hypoxia and profound lactic acidosis
  • Clinical imperative: Do not delay treatment for labs in suspected cases; manage airway and acidosis aggressively

Antidote Evolution

  • Historical cyanide kits (nitrites + sodium thiosulfate) induced methemoglobinemia—now largely obsolete
  • Hydroxocobalamin is first-line: binds cyanide to form cyanocobalamin (vitamin B12) for renal excretion; causes benign reddish skin and dark red urine (Lawson-Smith et al., 2011)

Carbon Monoxide Poisoning: Deceptive Oxygenation

  • Pulse oximetry and PaO2 can appear normal; definitive test is CO-oximetry for carboxyhemoglobin (COHb%) (Rose et al., 2017)
  • Mechanism: CO binds hemoglobin with 200–250x higher affinity than oxygen and shifts the dissociation curve left, reducing tissue oxygen delivery
  • Treatment: 100% high-flow oxygen; consider hyperbaric oxygen (HBO) for severe cases, LOC, pregnancy, or end-organ injury (Weaver et al., 2002; Hampson et al., 2012)

Salicylate Toxicity: Uncoupled Oxidative Phosphorylation And Mixed Acid-Base Disorder

Pathophysiology

  • Uncouples oxidative phosphorylation—energy loss as heat, leading to hyperthermia
  • Produces high anion gap metabolic acidosis; direct medullary stimulation causes primary respiratory alkalosis, resulting in a mixed disorder (O’Malley, 2007)

Clinical Spectrum

  • Tinnitus (classic early sign), nausea, vomiting
  • Kussmaul respirations, hyperthermia, confusion
  • Risk of non-cardiogenic pulmonary edema and ARDS

Management

  • Airway protection, aggressive cooling, fluids
  • Activated charcoal if early and airway protected
  • Urinary alkalinization with sodium bicarbonate:
  • Typical regimen: 3 amps bicarbonate in 1 L D5W, target urine pH ≥ 7.5, serum pH 7.45–7.55
  • Potassium repletion is essential to enable renal ion trapping (Molloy et al., 2019)
  • Hemodialysis for severe toxicity, renal failure, refractory acidosis, or coma (Choi et al., 2010)

Serotonin Syndrome: Differentiation And Targeted Therapy

Recognition

  • Agitation, tachycardia, hypertension, hyperthermia, hyperreflexia, clonus, myoclonus
  • Triggers: SSRIs, MAOIs, polypharmacy (including John’s Wort), drug interactions

Differentiation From NMS

  • Serotonin syndrome: hyperreflexia/clonus; rapid onset
  • NMS: lead-pipe rigidity, bradyreflexia; slower onset

Management

  • Benzodiazepines for agitation and seizure control
  • Aggressive cooling; antipyretics are ineffective
  • Cyproheptadine (oral) as a serotonin antagonist when enteral route is available (Boyer & Shannon, 2005)

Sulfonylurea-Induced Hypoglycemia: Octreotide And Disposition

Problem

Sulfonylureas stimulate pancreatic insulin release, causing prolonged hypoglycemia (12–24 hours).

Management

  • Dextrose infusion with frequent glucose checks
  • Octreotide (somatostatin analog) to suppress insulin secretion in refractory or recurrent hypoglycemia (Huang & Unger, 2006)
  • Admission/observation to prevent unsafe discharge

Anticoagulant Reversal: Heparin, Warfarin, And DOAC Precision

Heparin

  • Protamine neutralizes unfractionated heparin; partial effect on enoxaparin; dosing precision to avoid hypotension or paradoxical effects (McLean, 2012)

Warfarin

  • Vitamin K plus four-factor PCC (e.g., Kcentra, Focsar) or plasma to restore factors II, VII, IX, X—PCC preferred for speed and low volume (Sarode et al., 2013)

DOACs

  • Dabigatran: Idarucizumab—monoclonal fragment antidote
  • Rivaroxaban/apixaban: Andexanet alfa—decoy factor Xa (Connolly et al., 2019)
  • Edoxaban: Andexanet may be considered off-label; many centers use four-factor PCC when specific reversal is unavailable or unaffordable

Benzodiazepine Overdose: Flumazenil With Caution

Risks And Use Cases

  • Flumazenil can precipitate withdrawal seizures in chronic users
  • Appropriate for pediatric accidental ingestions or procedural sedation reversal in monitored settings
  • Avoid in mixed overdoses where reversing benzodiazepines can unmask pro-convulsants

Vasopressor Extravasation: Phentolamine Rescue And Tissue Preservation

Protocol

  • Stop infusion; keep catheter in place; inject phentolamine through the line and perilesional tissue.
  • Alpha-blockade reverses local vasoconstriction, preventing necrosis
  • Warm compresses, elevation; consider plastic surgery input (Kahn et al., 2002)

Airway Management In Severe Metabolic Acidosis And DKA: Ventilation Matching Saves Lives

Why Ventilation Matching Matters

  • In metabolic acidosis, patients hyperventilate to reduce PaCO2, buffering pH
  • Intubation with inadequate ventilation can raise PaCO2, collapse pH, and precipitate cardiac arrest

Clinical Approach

  • Avoid intubation if airway reflexes and ventilatory drive are intact
  • If unavoidable:
    • Match pre-intubation minute ventilation with high RR and appropriate tidal volume
    • Use ETCO2 and ABGs to keep PaCO2 near pre-intubation values
    • Avoid prolonged paralysis; maintain aggressive ventilation until acidosis improves (Kellum & Elbers, 2018)

DKA Specifics

  • Preserve Kussmaul respirations when possible
  • Correct dehydration, hyperglycemia, and electrolytes while maintaining ventilatory compensation (Wolfsdorf et al., 2018; Kitabchi et al., 2009)

Toxidrome Recognition: A Bedside Pattern Approach

Pattern Highlights

  • Anticholinergic: Hot/dry skin, delirium, urinary retention, decreased bowel sounds; QRS may widen with TCAs
  • Sympathomimetic: Hot/wet (diaphoresis), agitation, hypertension, tachycardia, chest pain risk; hyperthermia and rhabdo
  • Cholinergic: Profuse secretions, bradycardia, wheezing, miosis, diarrhea; muscle weakness raises respiratory failure risk
  • Opioid: Depressed respirations, miosis (not universal); responds to naloxone
  • Sedative-Hypnotic: CNS depression without typical pupillary findings; watch for respiratory compromise
  • Sodium-channel blockade: Wide QRS—administer sodium bicarbonate

Case Reasoning: Applying Physiology At The Bedside

Pediatric Unknown Ingestion With Seizures And Hyperthermia

  • Dilated pupils, tachycardia, dry skin, wide QRS: Anticholinergic toxidrome with sodium-channel blockade—likely TCA or potent antihistamine
  • Immediate steps:
    • Airway protection; consider intubation
    • Benzodiazepines for seizures/agitation
    • 12-lead EKG to quantify QRS
    • Sodium bicarbonate bolus/infusion
    • Activated charcoal if early and airway secure
    • Cooling measures
    • Fluids; norepinephrine if hypotensive

Adult Chest Pain After Suspected Cocaine Use

  • Differentiate via diaphoresis (sympathomimetic)
  • Management:
    • Benzodiazepines and vasodilators (nitrates, nicardipine)
    • Avoid metoprolol; consider labetalol if necessary
    • Treat hyperthermia and hydrate; monitor for ischemia and arrhythmias

Organophosphate Exposure

  • Expect SLUDGE/DUMBELS with copious secretions and wheeze
  • Actions:
    • PPE, dermal decontamination, airway management
    • Atropine titrated to dry secretions
    • Early 2-PAM
    • Benzodiazepines for seizures; monitor for intermediate syndrome

Ethylene Glycol Ingestion

  • Calcium oxalate crystals, anion gap acidosis, renal risk
  • Therapy:
    • Fomepizole, hemodialysis, bicarbonate
    • Monitor electrolytes and kidney function

Acetaminophen Ingestion

  • 4-hour level determines risk; NAC protects liver via glutathione
  • Serial labs; adjust protocols for sustained-release or staggered ingestions

Integrative Chiropractic Care Within Medically Directed Toxicology

After acute stabilization, chiropractic care integrates safely to accelerate recovery, always under medical oversight by Dr. Cardenas.

Where Chiropractic Fits

  • Autonomic Regulation
    • Gentle, targeted manual therapies to improve vagal tone, reduce sympathetic overdrive, and support heart rate variability—especially useful after stimulant-induced hyperadrenergic states
  • Respiratory Mechanics
    • Thoracic mobilization and rib mechanics optimization to improve ventilatory efficiency post-intubation or after bronchorrhea-related compromise
  • Neuromuscular Rehabilitation
    • Progressive mobilization to restore motor control, balance, and strength after neuromuscular weakness or ICU deconditioning
  • Pain Modulation
    • Non-pharmacologic approaches to reduce musculoskeletal pain from seizures, restraints, or prolonged immobilization—lowering opioid reliance
  • Lymphatic And Circulatory Support
    • Techniques that encourage lymphatic flow may help reduce inflammatory edema.

All interventions are staged after hemodynamic and respiratory stability, aligned with medication profiles, and tailored to contraindications (e.g., avoid manipulative thrusts in hemodynamic instability, coagulopathy, or fractures).

Functional Medicine Synergy

  • Detoxification Capacity
    • Assess phase I/II hepatic pathways, glutathione status, and nutrient cofactors (B-vitamins, magnesium, selenium) that influence recovery post-NAC or oxidative stress.s
  • Mitochondrial Health
    • Targeted nutrition and graded exercise to restore electron transport, reduce ROS
  • Endocrine And Metabolic Balance
    • Treat dysglycemia following HIET; optimize insulin sensitivity and adrenal function.
  • Inflammation And Microbiome
    • Address systemic inflammation and GI consequences; repair mucosal integrity when caustics or antibiotics were involved.d

This synergy supports comprehensive recovery beyond the antidote window.

Team-Based Care: Roles, Coordination, And Safety

  • Dr. Maria Guadalupe Cardenas, MD—Medical Director and Collaborative Physician
    • Oversees diagnostics, antidotes, pharmacologic safety, and medical safety
    • Coordinates referrals to nephrology, cardiology, pulmonology, neurology, ED/ICU as needed
  • Dr. Alex Jimenez, DC, APRN, FNP-BC
    • Integrates chiropractic care with medical protocols
    • Provides advanced practice nursing assessments; coordinates functional medicine and rehabilitation
  • Rehabilitation Team
    • Physical therapy, exercise physiology, massage therapy for mobility, strength, pain management
  • Case Management
    • Ensures continuity for personal injury, workplace exposures, and documentation

Communication is constant. We reconcile medications and supplements, monitor labs and vitals during functional interventions, and ensure seamless transitions from acute stabilization to rehab.

Practical Protocol Pearls: Rapid Reference For Clinicians

  • Always obtain a 12-lead EKG in suspected cardiotoxic ingestions; it guides bicarbonate, lipid, and HIET decisions (EMCrit Project, n.d.)
  • Methamphetamine hypertensive crises: Choose benzodiazepines and vasodilators; avoid pure beta-blockers like metoprolol (AHA, n.d.)
  • Anticholinergic toxidrome with wide QRS: Prioritize bicarbonate; add activated charcoal if early and airway safe
  • Organophosphate poisoning: Titrate atropine to dry; start 2-PAM early; decontaminate meticulously (WHO, n.d.)
  • Acetaminophen overdose: Draw first ideal level at 4 hours; initiate NAC promptly (National Library of Medicine, n.d.)
  • Ethylene glycol: Use fomepizole; consider hemodialysis; watch for calcium oxalate crystals and anion gap acidosis (NEJM, n.d.)
  • Lipophilic cardiotoxins with refractory shock: Consider lipid emulsion therapy (EMRA, n.d.)

Rehabilitation And Recovery: From Stabilization To Strength

Once patients are stabilized, we restore function:

  • Breathing
    • Diaphragmatic exercises, thoracic mobility work, posture corrections to improve ventilation and reduce dyspnea
  • Strength And Endurance
    • Graded resistance and aerobic plans to rebuild mitochondrial capacity and autonomic stability
  • Pain And Neuromuscular Control
    • Manual therapy, neurodynamic techniques, sensorimotor retraining to reduce pain and improve movement quality
  • Nutrition
    • Emphasize protein adequacy, micronutrients for hepatic and mitochondrial support, and hydration to maintain renal function post-toxin

All care is individualized, medically supervised, and aligned with patient goals.

Patient Education And Safety: Preventing Re-Exposure And Supporting Recovery

We educate patients on:

  • Avoiding re-exposure and recognizing early warning signs
  • Safe storage and dosing of OTC and prescription medications
  • Importance of follow-up labs and cardiac monitoring
  • Heat illness prevention and hydration for stimulant histories
  • Access to addiction services and mental health support

Education improves adherence and outcomes.

Clinical Observations From Practice: Lessons At The Intersection Of Toxicology And Rehab

From my clinical work and the shared insights at Sciatica clinic and my updates on LinkedIn, I consistently observe:

  • Sympathomimetic hyperthermia responds best to early benzodiazepines plus proactive cooling; delaying cooling increases rhabdomyolysis risk
  • Anticholinergic delirium often improves with environmental optimization—low light, minimal stimuli—alongside benzodiazepines and bicarbonate when indicated.
  • Opioid rebound after naloxone is common with long-acting agents; low-dose infusion prevents repeated apnea events.s
  • Organophosphate recovery can be non-linear; intermediate syndrome requires vigilant neuromuscular monitoring.
  • Post-ICU patients benefit from thoracic and cervical mobilization, diaphragmatic retraining, and graded exercise, accelerating return to baseline function and decreasing pai.n

In musculoskeletal recovery, I find that restoring thoracic mobility and rib mechanics improves breathing and autonomic balance—indirectly reducing pain sensitivity in patients recovering from complex toxicologic crises. Optimizing pelvic-lumbar stability reduces reliance on accessory breathing and enhances diaphragmatic function. Improving cervicothoracic junction mobility supports vagal tone and perceived anxiety reduction—a valuable element in post-serotonin syndrome or post-ICU states.

Integrative Insights: Why Each Technique Is Used And How It Fits

  • Ventilation matching in acidosis.
    • Prevents PaCO2 rise and pH collapse by preserving respiratory compensation (Kellum & Elbers, 2018)
  • Urinary alkalinization in salicylate toxicity
    • Enhances ion trapping and renal excretion; requires adequate potassium (Molloy et al., 2019)
  • NAC in acetaminophen toxicity
    • Restores glutathione, neutralizes NAPQI, protects hepatocytes (Heard, 2008; Rumack & Matthew, 1975)
  • Benzodiazepines in serotonin syndrome
    • Reduce CNS hyperexcitability; cyproheptadine blocks serotonergic receptors (Boyer & Shannon, 2005)
  • Octreotide in sulfonylurea hypoglycemia
    • Suppresses insulin release; stabilizes glucose (Huang & Unger, 2006)
  • Protamine for heparin
    • Acid-base binding neutralizes heparin; precise dosing avoids hypotension and paradoxical effects (McLean, 2012)
  • Four-factor PCC for warfarin/DOAC-related bleeding
    • Rapid factor replacement with reduced volume vs plasma; idarucizumab and andexanet as drug-specific antidotes (Sarode et al., 2013; Connolly et al., 2019)
  • Flumazenil caution
    • Avoid precipitating withdrawal seizures; reserve for select scenarios
  • Phentolamine for vasopressor extravasation
    • Alpha-blockade reverses local vasoconstriction, preventing necrosis (Kahn et al., 2002)
  • Activated charcoal/whole bowel irrigation
    • Adsorption and mechanical clearance reduce systemic absorption (ACMT, n.d.)

Conclusion: A Clear, Evidence-Based Path Through Toxic Emergencies And Recovery

Toxic exposures demand fast, physiologically informed decisions. The combination of:

  • Rigorous primary assessment and airway-first logic
  • Accurate toxidrome recognition
  • Timely antidotes and advanced therapies (bicarbonate, HIET, lipid emulsion, cyproheptadine, octreotide, ADH blockade)
  • Thoughtful decontamination
  • Continuous monitoring for rebound and complications
  • Medically directed integrative chiropractic, functional medicine, and rehabilitation

This helps create a comprehensive, modern approach that improves survival and speeds recovery. With Dr.Cardenas’ss medical direction and our integrated team at Injury Medical Clinic PA, we deliver coordinated, evidence-based care that meets patients where they are—from the emergency moment to full functional return.

References

In-text citations (APA-7 style): American College of Medical Toxicology (n.d.); Centers for Disease Control and Prevention (n.d.); Emergency Medicine Residents’ Association (n.d.); EMCrit Project (n.d.); National Center for Biotechnology Information (n.d.); National Library of Medicine (n.d.); The New England Journal of Medicine (n.d.); UpToDate (n.d.); World Health Organization (n.d.); Hampson et al. (2012); Lawson-Smith et al. (2011); O’Malley (2007); Rose et al. (2017); Weaver et al. (2002); Boyer & Shannon (2005); Heard (2008); Connolly et al. (2019); Sarode et al. (2013); Huang & Unger (2006); McLean (2012); Molloy et al. (2019); Kellum & Elbers (2018); Kitabchi et al. (2009); Wolfsdorf et al. (2018); Kahn et al. (2002); Graul & Gomm (2020); Levine et al. (2021); Wightman & Nelson (2022); Rumack & Matthew (1975).

SEO tags: toxicology, organophosphate poisoning, anticholinergic toxidrome, sympathomimetic toxicity, cocaine overdose, methamphetamine crisis, naloxone, high-dose insulin euglycemia therapy, lipid emulsion, intralipid, sodium bicarbonate therapy, tricyclic antidepressant overdose, acetaminophen toxicity, ethylene glycol ingestion, calcium oxalate crystals, activated charcoal, whole bowel irrigation, hemodialysis, cyanide poisoning, carbon monoxide poisoning, salicylate toxicity, ventilation matching, DKA airway management, serotonin syndrome, cyproheptadine, sulfonylurea hypoglycemia, octreotide, anticoagulant reversal, protamine, PCC, andexanet alfa, idarucizumab, benzodiazepine overdose, flumazenil risks, vasopressor extravasation, phentolamine rescue, integrative chiropractic care, functional medicine, rehabilitation, personal injury clinic, El Paso, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, sciatica clinic observations, LinkedIn clinical insights

Joint Trauma From Auto Accidents and Treatment Options

Joint Trauma From Auto Accidents and Treatment Options
Treatment for knee injuries. Adult man with knee injury during consultation with doctor traumatologist at medical clinic

Joint Trauma From Auto Accidents: Integrative Recovery Care in El Paso

Abstract

A motor vehicle accident (MVA) can place sudden and powerful forces on the body. The knees, shoulders, hips, wrists, and spinal joints may be twisted, compressed, stretched, or struck within seconds. These forces can damage ligaments, tendons, cartilage, muscles, bones, spinal discs, and nerves. A common example is a “dashboard knee,” in which the knee or upper shin strikes the dashboard and force is transmitted through the knee. This mechanism can injure the posterior cruciate ligament (PCL) and other joint structures. Shoulder dislocations, rotator cuff injuries, hip trauma, wrist fractures, and spinal injuries can also occur.

In El Paso, a multidisciplinary approach may combine medical evaluation, integrative chiropractic care, rehabilitation, shockwave or laser therapy, and, for carefully selected patients, injection-based treatments. The goal is to identify the injured tissues, reduce pain, restore safe movement, rebuild strength, and help the patient return to daily activities.

Joint Trauma From Auto Accidents and Treatment Options

What Are Joint Trauma Injuries in an MVA?

Joint trauma injuries are injuries to the structures that form or support a joint. During a car accident, the body may move forward, backward, or sideways faster than the joints can safely handle. A joint can also strike the dashboard, door, steering wheel, center console, or another hard surface.

The damage may involve:

  • Ligaments that hold bones together
  • Tendons that connect muscles to bones
  • Cartilage that cushions joint surfaces
  • Joint capsules that surround joints
  • Muscles that control movement
  • Bones and joint surfaces
  • Spinal discs
  • Nerves near the injured joint

High-energy trauma can cause fractures, dislocations, and soft-tissue tears. The American Academy of Orthopaedic Surgeons (AAOS) notes that high-speed motor vehicle collisions can cause serious shoulder fractures and other traumatic joint injuries (AAOS, n.d.-a).

A patient may therefore leave a crash with much more than simple soreness.

Knee Injuries: Understanding the “Dashboard Knee”

The knee is especially vulnerable during a front-end collision. When the knee or upper shin strikes the dashboard, the force can drive the tibia, or shinbone, backward.

This is a classic mechanism for a posterior cruciate ligament injury, commonly called a dashboard knee. The PCL helps prevent the tibia from moving too far backward.

The same collision can also injure several structures at once, including:

  • PCL
  • ACL
  • MCL or LCL
  • Meniscus
  • Joint cartilage
  • Kneecap
  • Tendons
  • Femur or tibia

A strong dashboard impact can also send force upward toward the hip. In fact, the AAOS reports that traumatic hip dislocations commonly occur in motor vehicle collisions and may happen when a knee strikes the dashboard, forcing the thigh backward and pushing the femoral head out of the hip socket (AAOS, n.d.-b).

This is one reason knee pain after an accident should not automatically be treated as a simple bruise.

Shoulder Trauma After a Car Accident

The shoulder has a very large range of motion. This mobility is useful, but it also makes the joint easier to injure during sudden trauma.

During an MVA, a person may injure their shoulder when they:

  • Grips the steering wheel during impact
  • Braces with an outstretched arm
  • Is pulled against the seatbelt
  • Strikes the door or window
  • Experiences sudden twisting
  • Is pushed forward and backward with whiplash

Possible injuries include rotator cuff tears, labral tears, ligament sprains, fractures, and complete or partial dislocations.

The AAOS states that shoulder dislocations often result from trauma, including motor vehicle collisions. A dislocation can also damage the labrum, ligaments, and rotator cuff that normally stabilize the joint (AAOS, n.d.-c).

Clinical discussions published by Dr. Alexander Jimenez also describe how shoulder symptoms after an accident may overlap with neck, upper-back, nerve, postural, and soft-tissue problems. This makes a complete examination important rather than focusing only on the point of pain (Jimenez, 2026a).

Hip Joint Injuries From Collision Forces

The hip is a strong ball-and-socket joint, but a high-energy collision can still damage it.

Possible hip injuries include:

  • Hip dislocation
  • Labral damage
  • Cartilage injury
  • Tendon strains
  • Ligament injury
  • Femoral head injury
  • Pelvic or acetabular fracture

Traumatic hip dislocation is especially serious because it can also injure surrounding nerves, blood vessels, cartilage, and bone.

The AAOS identifies motor vehicle collisions as the most common cause of traumatic hip dislocations. High-energy MVAs can also cause acetabular fractures involving the socket of the hip joint (AAOS, n.d.-d).

A true hip dislocation or fracture requires emergency medical or orthopedic treatment. Chiropractic manipulation should not be performed over an unstable, fractured, or dislocated joint.

Wrist and Hand Injuries After an MVA

People often tighten their grip on the steering wheel or put their hands forward before a collision. This can transfer tremendous force through the hands and wrists.

Common injuries include:

  • Wrist sprains
  • Ligament tears
  • Distal radius fractures
  • Scaphoid fractures
  • Tendon injuries
  • Joint instability
  • Nerve irritation

The AAOS notes that car accidents can generate enough force to fracture the wrist even in a young person with healthy bones (AAOS, n.d.-e).

A scaphoid fracture can also occur during a motor vehicle collision. Because some wrist fractures are not always obvious at first, lasting wrist pain after an accident deserves proper evaluation.

The Spine Is Also a System of Joints

Joint trauma does not stop at the arms and legs.

The spine contains joints, discs, ligaments, muscles, tendons, and nerves. During an accident, rapid acceleration, deceleration, compression, rotation, and shearing forces may stress these structures.

Possible spinal injuries include:

  • Cervical and lumbar sprains
  • Facet-joint irritation
  • Disc bulges or herniations
  • Annular tears
  • Muscle and tendon strains
  • Nerve-root irritation
  • Whiplash-associated disorders

High-energy motor vehicle collisions can even produce spinal fractures, especially when forces are severe.

This helps explain why someone with an injured shoulder, knee, or hip may also have neck or back pain after the same accident.

Why a Complete Examination Comes First

Treatment should begin with finding out what was actually injured.

Depending on the symptoms and accident mechanism, evaluation may include:

  • Medical history
  • Accident-mechanism review
  • Range-of-motion testing
  • Orthopedic testing
  • Neurological examination
  • Muscle-strength testing
  • Posture and movement assessment
  • X-rays
  • MRI
  • Diagnostic ultrasound
  • CT imaging when appropriate

Some injuries require emergency treatment or an orthopedic consultation before rehabilitation begins.

Severe deformity, inability to use a limb, major weakness, loss of sensation, rapidly increasing swelling, severe headache, confusion, difficulty breathing, or new bowel or bladder problems should receive prompt medical evaluation.

How Integrative Chiropractic Care Fits Into Recovery

After fractures, dislocations, and other serious injuries have been ruled out or properly stabilized, integrative chiropractic care may become one part of rehabilitation.

Chiropractic treatment does not reconnect a completely torn ligament, reduce an acute dislocated hip, or repair a fracture. Instead, appropriately selected care may focus on restoring motion and function in areas affected by musculoskeletal pain.

Spinal manipulation is one of several non-drug options that may help some patients with low-back pain, although the strength of evidence differs by condition (National Center for Complementary and Integrative Health [NCCIH], 2025).

An integrative chiropractic plan may include:

  • Joint mobilization or manipulation when safe
  • Soft-tissue therapy
  • Corrective exercises
  • Core stabilization
  • Posture training
  • Balance and coordination exercises
  • Strength rehabilitation
  • Movement retraining

The goal is to help the recovering body move more normally while injured tissues continue healing.

Shockwave and Laser Therapy

Physical modalities may also be considered as part of rehabilitation.

Shockwave therapy uses acoustic energy and is most often considered for certain tendon and chronic soft-tissue problems. It should not be viewed as a treatment for an acute fracture or dislocation.

Laser therapy uses light energy and may be used as an adjunct for pain and soft-tissue rehabilitation in selected cases.

Dr. Jimenez’s published treatment model describes shockwave and laser therapy as supportive tools that may be combined with exercise, chiropractic care, and rehabilitation rather than being used as stand-alone solutions (Jimenez, 2026a).

PRP, PFP, and MFAT: Where Regenerative Care May Fit

Some patients with persistent joint or soft-tissue problems may be evaluated for biologic or regenerative procedures.

PRP

Platelet-rich plasma (PRP) is made from a patient’s own blood. Platelets are concentrated and then placed near an injured area. Platelets contain proteins and growth factors involved in the body’s normal healing processes.

Research supports possible uses of PRP for certain tendon problems and early knee osteoarthritis, but results differ depending on the tissue, injury, PRP preparation, and patient (AAOS, n.d.-f).

PRP should therefore be viewed as a possible option for selected cases, not a guaranteed way to rebuild a damaged joint.

PFP

Platelet-fibrin preparations, sometimes described by clinics as PFP, use platelet and fibrin components intended to provide a biological environment around injured tissue.

Preparation methods and available evidence are not as standardized as they are for many conventional treatments. Patients should understand exactly what preparation is being offered, why it is being considered, and what evidence supports its use for their specific injury.

MFAT

Microfragmented adipose tissue (MFAT) uses processed tissue obtained from the patient’s own fat. It has been explored in orthopedic care for selected joint and soft-tissue problems.

However, regenerative products and procedures vary greatly in how they are prepared, regulated, and supported by research. The FDA continues to warn patients about unapproved human cell and tissue products marketed with broad claims for orthopedic conditions. Patients considering these procedures should ask about the exact product, regulatory status, risks, alternatives, and supporting evidence (U.S. Food and Drug Administration [FDA], 2026).

Regenerative procedures do not replace emergency treatment, fracture care, surgery when needed, or appropriate rehabilitation.

Epidural and Trigger-Point Injections Have Different Jobs

Not every injection is regenerative.

An epidural spinal injection may be considered when a spinal injury causes inflammation around a nerve root and produces radiating arm or leg pain. It aims to control nerve-related inflammation rather than repair a damaged knee, shoulder, hip, or wrist.

A trigger-point injection may be used when painful, tight muscle areas contribute to symptoms.

This is why matching treatment to the correct tissue is important. A torn knee ligament, irritated cervical nerve, tight shoulder muscle, and fractured wrist are four very different problems.

Multidisciplinary Injury Care in El Paso

At Injury Medical Clinic PA in El Paso, the care model described by Dr. Jimenez brings several disciplines together.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, focuses on neuromusculoskeletal evaluation, integrative chiropractic care, functional medicine, personal injury care, and rehabilitation. His published clinical observations emphasize looking beyond the painful body part to examine movement, joint mechanics, nerve involvement, inflammation, and functional limitations after an accident (Jimenez, 2026a, 2026b).

Dr. Maria Guadalupe Cardenas, MD, is identified in clinic materials as a board-certified internal medicine physician with more than 40 years of experience who serves as Medical Director and Collaborative Physician. Her Texas physician license is listed as J2933, with a Texas Medical Board document showing an expiration date of May 31, 2027.

The practice describes the team as combining:

  • Medical oversight
  • Integrative chiropractic care
  • Functional medicine
  • Personal injury evaluation
  • Rehabilitation
  • Diagnostic coordination
  • Pain-management referrals or procedures
  • Selected regenerative options

This type of multidisciplinary model can help avoid treating each injured area as an unrelated problem. The goal is to coordinate examination, treatment, rehabilitation, referrals, and documentation around the patient’s actual injuries and functional needs (Jimenez, 2026c).

Credential verification note: Clinic materials supplied for this article identify Dr. Cardenas as NPI #1164426749. However, a current DrAlexJimenez.com provider page also displays 1164426748 in its body while displaying 1164426749 elsewhere on the same page. The NPI should therefore be confirmed directly through the CMS NPPES Registry before the number is published as a verified credential.

A Step-by-Step Path From Injury to Recovery

A motor vehicle accident can damage several tissues at the same time. That is why there is rarely one treatment that is right for every patient.

A coordinated recovery plan may follow a simple path:

  1. Identify the injury.
  2. Rule out fractures, dislocations, instability, and neurological emergencies.
  3. Control pain and inflammation.
  4. Restore safe joint and spinal movement.
  5. Begin rehabilitation and strengthening.
  6. Consider additional procedures only when clinically appropriate.
  7. Measure progress and adjust treatment when needed.
  8. Help the patient return to work, driving, exercise, and daily life.

Clinical observations published through Dr. Jimenez’s El Paso injury-care resources emphasize this same goal: move beyond simply reducing pain and work toward restoring safe function, movement, strength, and quality of life.

Final Thoughts

Joint trauma after an MVA can involve the knees, shoulders, hips, wrists, spine, and several supporting tissues at once. A dashboard impact may injure the PCL or transmit force toward the hip. Bracing against the steering wheel may damage the wrist or shoulder. Whiplash forces can affect spinal joints, discs, muscles, and nerves.

The most important first step is a correct diagnosis.

From there, care can be matched to the injury. Chiropractic care and rehabilitation may help restore movement and function in appropriately screened patients. Shockwave and laser therapy may serve as supportive treatments for selected conditions. PRP, PFP, MFAT, epidural injections, and trigger-point injections have different purposes and should be considered based on the patient’s diagnosis, health history, evidence, risks, and treatment goals.

A coordinated medical and chiropractic approach can help create a clearer recovery plan after a motor vehicle accident—one based not simply on where it hurts, but on what was injured and what the patient needs to safely regain function.

The road to Recovery "Chiropractic Care" | El Paso, Tx (2023)

References

American Academy of Orthopaedic Surgeons. (n.d.-a). Shoulder trauma: Fractures and dislocations.

American Academy of Orthopaedic Surgeons. (n.d.-b). Hip dislocation.

American Academy of Orthopaedic Surgeons. (n.d.-c). Shoulder dislocation.

American Academy of Orthopaedic Surgeons. (n.d.-d). Acetabular fractures.

American Academy of Orthopaedic Surgeons. (n.d.-e). Distal radius fractures: Broken wrist.

American Academy of Orthopaedic Surgeons. (n.d.-f). Platelet-rich plasma (PRP).

American Academy of Orthopaedic Surgeons. (n.d.). Orthobiologics (regenerative medicine) FAQ.

El Paso Back Clinic. (2026). Regenerative therapies for personal injury healing.

El Paso Back Clinic. (2026). Auto and work accident joint pain regenerative care benefits.

El Paso Back Clinic. (2026). Regenerative therapies and chiropractic benefits revealed.

El Paso Chiropractor Blog. (2026). Dashboard knee after a car accident: PCL injury.

Fix Medical Group. (n.d.). Shockwave therapy vs. PRP: Which is better for pain relief?.

Jimenez, A. (2026a). El Paso car accident shoulder injury recovery care strategies.

Jimenez, A. (2026b). Dr. Alexander Jimenez professional profile.

Jimenez, A. (2026c). Integrated injury care in El Paso: Under-one-roof recovery for personal injury patients.

Jimenez, A. (2026). Dr. Maria Cardenas, MD: Board certified internal medicine specialist.

National Center for Complementary and Integrative Health. (2025). Spinal manipulation: What you need to know.

Personal Injury Doctor Group. (2026). Regenerative options for personal injury recovery insights.

Personal Injury Doctor Group. (2026). Healing after a car crash with regenerative therapies.

Pravida. (n.d.). Shockwave and PRP combination therapy.

Ruhmann Law Firm. (n.d.). Shoulder injuries after El Paso car accidents.

Ruhmann Law Firm. (n.d.). Knee injuries after El Paso car accidents.

U.S. Food and Drug Administration. (2026). Patient and consumer warning about potential serious risks of harm following use of unapproved products from human cells or tissues.

Wellness Doctor Rx. (2026). El Paso multidisciplinary injury care for healing and pain.

Non-Pharmacological Methods for Integrative Pain Management

Discover integrative pain management with non-pharmacological techniques designed to alleviate discomfort without medications.

Abstract

In this educational post, I share a comprehensive, first-person narrative of how I approach non-pharmacological pain management through an integrative lens that combines chiropractic care, functional medicine, rehabilitation, behavioral health, and interventional options—always with medical oversight. I introduce our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, integrate chiropractic and functional therapies alongside our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), whose over 40 years of internal medicine expertise guides medical decision-making, safety, and protocol alignment. Together, we present the latest research findings in non-pharmacologic pain strategies—cognitive-behavioral therapies, hypnosis, ACT, sleep optimization, manual and movement therapies, neuromodulation, interventional procedures, nutrition, and anti-inflammatory lifestyles. I highlight clinical observations from my practice and research-informed methods, elaborating on physiological mechanisms—central sensitization, neuroplasticity, nociplastic pain, immune-metabolic interactions, autonomic regulation, and fascia dynamics. We will also delve into a diverse toolkit of treatments, including psychological and mind-body techniques like guided imagery, meditation, and music therapy; physical and manual therapies such as massage, cupping, and transcutaneous electrical nerve stimulation (TENS); and the pivotal role of integrative chiropractic care and acupuncture. We conclude with individualized multimodal approaches, detailed rationale for each intervention, and practical frameworks to prevent substance use disorders through risk assessment, patient education, and restorative function-centered goals.

Key Takeaways

  • Multimodal care that integrates chiropractic manipulation, functional rehabilitation, behavioral therapies, nutrition, sleep optimization, and interventional options is superior to siloed, single-modality care for complex pain conditions.
  • A biopsychosocial model, paired with medical oversight from an experienced internist (Dr. Cardenas), improves safety, continuity, and outcomes in a multidisciplinary clinic.
  • Evidence-based complementary therapies—acupuncture, mindfulness, yoga, neuromodulation, trigger point injections, and manual therapies—help break the pain-tension-inflammation cycle and reduce reliance on opioids.
  • Functional medicine insights on inflammation, micronutrient status, gut-brain-axis health, and sleep correction augment pain care and prevent chronicity.
  • Risk assessment and patient education reduce misuse risk, support realistic function-centered goals, and promote resilience.

Introduction: My Approach to Non-Pharmacological Pain Care in an Integrative Setting

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. My clinical work centers on helping patients recover function, reduce pain, and build resilience through integrated chiropractic care and evidence-based non-pharmacological strategies. Pain is a complex, multifaceted experience that extends beyond mere physical sensation, deeply intertwining with our emotional, mental, and spiritual well-being. At Injury Medical Clinic PA, our philosophy is rooted in a patient-focused approach that embraces this complexity.

In El Paso, Texas, my practice—Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic)—operates within a multidisciplinary model led by a physician. Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Internal Medicine; NPI #1164426749; Texas MD License #J2933), has over 40 years of experience as an internist. She ensures medical safety, guides diagnostic strategy, oversees medications where needed, and collaborates with me to create cohesive, patient-centered plans. This MD-DC collaboration is common and highly effective in integrative and injury care clinics.

In the following sections, I outline a structured journey through non-pharmacologic pain management:

  • The biopsychosocial model and functional goals
  • Behavioral and psychological strategies
  • Manual therapy and movement-based care
  • Neuromodulation and interventional procedures
  • Nutritional and sleep optimization frameworks
  • Risk assessment and prevention of substance use disorders
  • Multidisciplinary workflows with medical oversight
  • Case-based applications
  • Outcome tracking, safety monitoring, and long-term recovery planning

I also incorporate clinical observations from my practice, which you can explore further at my sciatica-focused resource hub and professional profile:

Modern research methods and the latest evidence from leading researchers in pain science, behavioral medicine, neuromodulation, rehabilitation, and integrative health guide this post. I intend to make these concepts accessible, actionable, and rooted in physiology—so you understand not only what we recommend, but exactly why it works.

Multidisciplinary Pain Care in El Paso — How Our Team Works Together

I want to begin with the structure of our clinic because many outcomes hinge on coordination, oversight, and clarity of roles. Here at Injury Medical Clinic PA, we have built a practice on the foundation of integrative and collaborative care. My personal journey and extensive training across multiple disciplines—as a Doctor of Chiropractic (DC), an Advanced Practice Registered Nurse (APRN) and Family Nurse Practitioner (FNP-BC), and a certified practitioner in Functional Medicine (CFMP, IFMCP)—have instilled in me a deep appreciation for a holistic, patient-centered model.

A crucial element of our success is our multidisciplinary framework, anchored by the invaluable expertise of Dr. Maria Guadalupe Cardenas, MD. Her role is indispensable, providing the essential medical oversight that ensures our patients receive the safest, most comprehensive, and most effective care possible. Our team integrates:

  • Medical Director and Collaborative Physician oversight
    • Maria Guadalupe Cardenas, MD, Internal Medicine (Board Certified; NPI #1164426749; Texas MD License #J2933) serves as Medical Director at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso.
    • Her responsibilities include medical safety, diagnostic strategy (labs, imaging, referrals), pharmacologic oversight when indicated, and integration of medical standards into all care plans.
    • For patients with complex comorbidities (e.g., post-cancer, autoimmune conditions, metabolic disorders), her oversight ensures that our interventions align with systemic health needs.
  • Integrative chiropractic care (led by Dr. Jimenez)
    • My role as a chiropractor and advanced practice registered nurse is to deliver evidence-based manual therapies, spinal and extremity adjustments, neuromuscular rehabilitation, kinetic chain analysis, and functional medicine strategies.
    • I emphasize function-centered goals: improving activities of daily living, restoring work capacity, enhancing sleep quality, and supporting emotional resilience.
    • I coordinate closely with physical therapists, occupational therapists, psychologists, nutritionists, and interventional pain specialists.
  • Functional medicine integration
    • We assess inflammatory drivers, nutrient status, sleep dysregulation, autonomic balance, and gut-brain axis dysfunction, using focused histories and, when appropriate, targeted lab evaluations under medical supervision.
    • Plans include anti-inflammatory nutrition, movement prescriptions, stress modulation, sleep hygiene, and targeted supplementation when indicated by evidence.
  • Personal injury care and rehabilitation
    • We manage acute and chronic injury cases with structured protocols: clinical exam, imaging when necessary, stepwise rehabilitation, and documentation for medicolegal needs.
    • We incorporate manual therapies, graded exercise, neuromuscular re-education, and—when appropriate—interventional referrals (e.g., nerve blocks, epidurals) coordinated with internal medicine oversight.
  • Behavioral health and psychology collaboration
    • Cognitive behavioral therapy (CBT), Acceptance and Commitment Therapy (ACT), hypnosis, and mindfulness are engaged through partners in psychology and psychiatry.
    • We utilize self-guided tools and digital therapeutics to lower barriers and empower patients.
  • Pharmacy and nursing
    • Pharmacists assist with medication safety, potential interaction checks, and alternatives when pharmacologic support is necessary.
    • Nursing colleagues triage messages, provide education, reinforce sleep hygiene and movement plans, and identify social determinants of health impacting adherence.

Why This Model?

  • Complex pain is rarely just a musculoskeletal problem; it is a networked condition involving nociceptive, neuropathic, and nociplastic mechanisms, plus psychological and social features.
  • A coordinated team creates synergy: manual changes in tissue mechanics pair with improved sleep, reduced inflammatory burden, behavioral coping skills, and precise medical oversight. This integrated model allows us to create a truly personalized and dynamic treatment plan for each patient. We are not just treating symptoms; we are treating the whole person—mind, body, and spirit—in a coordinated effort to restore health, function, and vitality.

Understanding the Terminology — Integrative vs. Complementary Care

Before we dive into the specific therapies, it’s vital to clarify the language we use. The term integrative medicine describes a patient-focused approach to health and wellness that considers the whole person. This includes their mental, emotional, spiritual, and social well-being. It is characterized by a well-coordinated effort between different providers and institutions to deliver comprehensive care.

Within this framework, we utilize complementary treatments. These are therapies used alongside conventional medical treatments. Think of them as another bucket of tools, a whole other toolkit we can pull from to enhance a patient’s healing journey. When I approach a patient’s case, especially those who express a desire for natural options or have had limited success with conventional methods, I categorize these complementary therapies into several “buckets” to help structure my thinking and formulate the most effective plan. These buckets include:

  • Psychological & Mind-Body Therapies
  • Manual & Massage Therapies
  • Chiropractic Care
  • Acupuncture
  • Movement Therapies

It is always a partnership. We must ensure the patient is open to these approaches. Often, clues emerge in conversation. A patient might say, “I don’t want to take any more medication,” or “I find that yoga really helps me relax.” These are signals that they may be receptive to exploring our complementary toolkit. Let’s unpack these tools one by one.

A Real Case, Real Decisions — Building a Multimodal Plan

I often begin with a case to ground the discussion. Consider a 36-year-old woman, with a history of breast cancer treated with chemotherapy and surgery in 2012, now living with chemotherapy-induced neuropathy in her hands and feet, thoracic back spasms, and migraines about four times monthly. She is sensitive to opioids and reports sedation even with low-dose gabapentin. She did not find relief with alpha-lipoic acid, over-the-counter NSAIDs, acetaminophen, or topicals.

This is precisely the kind of case where integrative, non-pharmacological care shines—especially with medical oversight.

Here is how our team frames the plan:

  • Function-centered goals
    • Improve daily function, reduce migraine frequency and intensity, ease thoracic spasms, and quiet neuropathic pain measurably (e.g., reduce pain interference scores, improve sleep metrics, stabilize mood).
  • Multimodal domains we will consider
    • Behavioral: CBT, ACT, hypnosis, mindfulness, stress reduction, sleep optimization.
    • Physical: graded exercise, aquatic therapy, manual therapy, chiropractic adjustments, physical therapy, TENS.
    • Interventional: nerve blocks, trigger point injections, neuromodulation (considered when conservative measures plateau).
    • Nutritional: anti-inflammatory diet, hydration habits, glucose control, micronutrient assessment.
    • Pharmacology: only if necessary, and carefully titrated, with Dr. Cardenas overseeing safety; prioritizing non-sedating options, migraine-specific therapies, and neuropathic pain strategies with minimal side effects.

The Biopsychosocial Model — Treating the Whole Person

I emphasize the biopsychosocial model because it is both a philosophy and a clinical framework. Pain outcomes are strongly associated with how we address biology, psychology, and social context.

  • Biological
    • Genetics, comorbidities, disease severity, age, drug effects, nutritional status, sleep quality, autonomic tone, and inflammation all contribute to pain perception and maintenance.
    • Mechanistic focus: nociceptive drivers (e.g., musculoskeletal strain), neuropathic drivers (e.g., chemotherapy-induced peripheral neuropathy), and nociplastic drivers (central sensitization).
    • We evaluate systemic inflammation through history and, when appropriate, labs under medical supervision; we correct sleep architecture; we optimize nutrition to reduce cytokine load.
  • Psychological
    • Coping styles, stress levels, catastrophizing, expectations, affect and mood, cognition, and resilience determine both pain intensity and disability.
    • Clinical strategy: we set realistic expectations (pain-free is not always attainable; functional improvement is the initial target), and we teach cognitive reframing, acceptance, and graded exposure to activity.
  • Social
    • Cultural beliefs, social supports, family and work dynamics, socioeconomic status, access to care, and daily routines affect adherence and recovery.
    • We enlist social workers and community resources; we adapt plans to the realities of a patient’s day-to-day life and constraints.

Why This Matters Physiologically

  • Pain is a nervous system output influenced by tissue signals, brain evaluation, and contextual meaning.
  • The brain’s threat appraisal increases sympathetic tone, muscle guarding, and cytokine-driven sensitivity; by shifting cognition, we reduce the threat response and lower pain amplification.
  • Sleep restoration changes pain thresholds, reduces neuroinflammation, and improves glymphatic clearance.

Psychological and Mind-Body Therapies: Harnessing the Power of the Mind

The connection between the mind and body is not just a philosophical concept; it is a physiological reality. Our thoughts, emotions, and stress levels directly impact our physical health, particularly our experience of pain. Psychological and mind-body therapies are designed to leverage this connection, offering powerful, non-invasive ways to manage symptoms and promote healing. I integrate these therapies early because they change the neural processing of pain and equip patients with durable coping skills.

Cognitive Behavioral Therapy (CBT)

  • Core concept: Thoughts, feelings, and behaviors interact; maladaptive cognitions (catastrophizing, all-or-nothing thinking) worsen pain and disability.
  • In practice: Identify distortions, reframe pain meaning, build activity pacing, teach relaxation strategies (diaphragmatic breathing, progressive muscle relaxation).
  • Physiological rationale: Reducing cognitive threat lowers amygdala reactivity, sympathetic hyperarousal, and central sensitization.

Acceptance and Commitment Therapy (ACT)

  • Core concept: Accept what is present, commit to valued actions; shift from pain control to life engagement despite symptoms.
  • In practice: Clarify values (family engagement, work, purpose), commit to small daily acts aligned with values, practice defusion from pain-related thoughts.
  • Physiological rationale: Behavioral activation reduces kinesiophobia, improves motor patterns, and normalizes cortical processing.

Hypnosis

  • Core concept: Guided or self-directed focused attention and relaxation to facilitate behavior change and pain modulation.
  • In practice: Audio-guided sessions for neuropathic pain and migraine to reduce autonomic arousal and pain focus; low-barrier entry via digital apps.
  • Physiological rationale: Hypnosis reduces pain-related cortical activity and increases parasympathetic tone, diminishing nociceptive amplification.

Guided Imagery: Painting a Picture of Relief

Guided imagery is a therapeutic technique that uses a script to engage all the senses—sight, sound, touch, smell, and taste—to transport the mind to a peaceful, healing place. The goal is to evoke a positive emotional state and actively combat stressful feelings that often amplify pain.

  • How It Works: A practitioner or a recording guides the individual to visualize a serene environment, like a quiet beach or a lush forest. The script is rich with sensory details: feeling the warm sun, hearing the gentle waves, smelling the salty air. This process does more than distract the mind. Neurologically, it activates the parasympathetic nervous system, our “rest and digest” system, which counteracts the “fight or flight” response of the sympathetic nervous system that is often chronically activated in individuals with pain. By creating a vivid, positive internal experience, guided imagery can help reduce the production of stress hormones like cortisol and adrenaline, which are known to increase inflammation and pain sensitivity. It shifts the brain’s focus away from pain signals and towards a state of deep relaxation and well-being.

Mindfulness Meditation: Anchoring in the Present Moment

Mindfulness meditation is a practice that cultivates an attentional stance of detached observation. It’s not about emptying the mind, but rather about refocusing it on the present moment and developing a non-judgmental awareness of our external surroundings and internal sensations, including pain.

  • How It Works: The core principle of mindfulness is to acknowledge thoughts, feelings, and bodily sensations as they arise, without getting entangled in them. For someone in chronic pain, this means learning to observe the sensation of pain without the secondary layer of suffering—the fear, anxiety, and catastrophic thinking that often accompany it (“This will never end,” “I can’t stand this”). By encouraging the individual to step back and reframe the experience, meditation helps decouple the physical sensation from the emotional reaction. Neuroimaging studies have shown that regular mindfulness practice can actually change the structure and function of the brain. It strengthens the prefrontal cortex, which is involved in emotional regulation and executive function, while reducing activity in the amygdala, the brain’s fear center. This physiological shift empowers patients to have a different relationship with their pain, reducing its perceived intensity and its control over their lives. Even starting with a free two-minute app can be a transformative first step.

Relaxation Techniques: A Pause for Restoration

Relaxation techniques are simple yet profound practices designed to release tension from the body and mind consciously. These can range from a quick, deliberate breath to more structured protocols like progressive muscle relaxation.

  • How It Works: One of the simplest and most effective techniques is diaphragmatic breathing, or deep belly breathing. Taking slow, deep breaths that engage the diaphragm stimulates the vagus nerve, a major component of the parasympathetic nervous system. This direct stimulation sends a signal to the brain to slow the heart rate, lower blood pressure, and switch off the stress response.
  • Progressive Muscle Relaxation (PMR) is another powerful method. It involves systematically tensing and then relaxing different muscle groups throughout the body. This process serves two purposes: first, it physically releases stored muscle tension; second, it enhances body awareness, helping the individual recognize the difference between a state of tension and a state of relaxation.
  • Even setting a simple reminder on a phone to “take a moment to relax” a few times a day can interrupt the cycle of chronic stress and pain. These techniques teach patients how to actively employ relaxation, giving them a sense of control over their physiological state.

Music Therapy: The Rhythm of Healing

Music therapy is the clinical and evidence-based use of music interventions to accomplish individualized goals. This can involve listening to music, writing songs, or playing an instrument, often guided by a trained music therapist.

  • How It Works: Music acts as a powerful distractor, but its effects run much deeper. The rhythm, melody, and harmony of music can directly influence physiological processes. Slower, calming music can synchronize with and slow down our heart rate and breathing, promoting relaxation. Listening to enjoyable music triggers the release of dopamine, a neurotransmitter associated with pleasure and reward, which can help counteract the negative emotional state associated with pain. A robust review of the scientific literature demonstrates that music therapy can significantly reduce pain perception, improve vital signs (like blood pressure and heart rate), enhance mood, and improve sleep quality. We are seeing this firsthand in clinical settings, with music therapists now working in our cancer centers and inpatient units at institutions like Vanderbilt, providing profound benefits for patients undergoing treatment for a variety of conditions. Best of all, it has virtually no adverse reactions.

Aromatherapy: Scent and Sensibility

Aromatherapy involves the use of fragrant essential oils extracted from plants for therapeutic health benefits. These oils can be diffused into the air, applied topically, or even ingested (though this requires extreme caution and professional guidance).

  • How It Works: The sense of smell is directly linked to the limbic system, the part of the brain that governs emotions, memory, and behavior. When we inhale the aromatic molecules of an essential oil, they travel up the nose to the olfactory bulb, which sends direct signals to the amygdala (emotional center) and hippocampus (memory center). This is why certain smells can instantly trigger powerful memories and emotions.
  • Lavender oil is one of the most extensively studied essential oils. Research consistently shows that its inhalation helps reduce pain and improve anxiety, offering a valuable two-for-one benefit for many of our patients. By calming the nervous system, it also improves sleep, which is crucial for healing and pain management. The biopsychosocial model of pain helps us understand how a simple intervention like this can have cascading positive effects. In inpatient hospital settings, aromatherapy has been associated with improved patient satisfaction.
  • A Note of Caution: While generally safe, there is a risk of allergic reactions, skin sensitivities, and, with improper use, toxicities. For this reason, I always recommend starting with a very low concentration and using a diffuser as the primary method. This minimizes risk while still providing the therapeutic benefits.

Virtual Reality (VR): A Digital Distraction

Virtual reality (VR) is a technology that immerses the user in a computer-generated, three-dimensional environment. Using devices like helmets, goggles, or even smartphones, VR creates a new “reality” that can completely capture a person’s attention.

  • How It Works: The primary mechanism behind VR’s effectiveness in pain management is the gate control theory of pain, combined with profound distraction. The brain has a limited capacity for attention. When it is fully engrossed in a compelling, interactive virtual world, there are fewer attentional resources available to process pain signals coming from the body. The sensory input from the VR experience—visual, auditory, and sometimes even haptic—effectively “closes the gate” on the pain signals trying to reach the brain.
  • The evidence is growing rapidly. A review of the literature shows that VR can significantly improve acute pain, reduce anxiety and stress, and boasts a high level of patient satisfaction with no reported adverse reactions. There are now VR programs specifically designed for pain conditions.
  • I’ve seen the power of this firsthand. My son needed to have two baby teeth pulled and was terrified. Remembering the research on VR and distraction, we had him watch a funny video on a phone. While he was completely absorbed and laughing, I quickly pulled the teeth out. He laughed right through the entire procedure. It was a powerful, real-world demonstration of science at play. As VR technology becomes more affordable and accessible, its role in pain management will only continue to grow.

Sleep optimization

  • Sleep is a cornerstone intervention; sleep deprivation magnifies pain sensitivity and mood vulnerability.
  • Education points: consistent sleep-wake times, cool environment (ideally ~65–67°F), dark and quiet bedroom, device removal, pre-sleep wind-down without stimulating media.
  • Medical oversight: if sleep apnea or insomnia is suspected, we consider sleep medicine referral; we avoid sedating pharmacology when possible due to adverse effects in neuropathy-prone patients.

Mindfulness and stress reduction

  • Techniques: body scanning, breathwork, mindful movement (gentle yoga, tai chi), gratitude journaling.
  • Physiological rationale: Mindfulness downregulates limbic hyperactivity, regularizes autonomic balance, and reduces inflammatory signaling.

Practical workflow in our clinic

  • Nursing reinforces sleep hygiene and daily routines.
  • Psychologists deliver CBT/ACT; patients start with low-friction self-guided tools to build confidence, then progress to structured therapy if needed.
  • We set measurable outcome targets: reduced catastrophizing scores, improved sleep metrics, increased activity minutes per week.

Section 6: Manual and Massage Therapies: The Healing Power of Touch

Manual therapies involve the skilled use of the hands to diagnose, treat, and prevent musculoskeletal issues. These ancient healing arts are now supported by modern science, demonstrating their ability to relieve pain, improve circulation, and restore function. Chiropractic care, when integrated with physical therapy and functional rehab, is central to breaking the pain-tension-inflammation cycle.

Manual therapy

  • Soft-tissue mobilization reduces myofascial stiffness and improves circulation; targeted myofascial release mitigates trigger points linked to thoracic spasms.
  • Joint mobilization improves arthrokinematics and reduces aberrant motion patterns; when combined with motor control exercises, it stabilizes functional gains.

Massage Therapy: Beyond Relaxation

Massage therapy is the manipulation of the body’s soft tissues—muscles, connective tissue, tendons, and ligaments. It is a versatile tool that can be used for both chronic and acute pain.

  • How It Works: The benefits of massage are both mechanical and physiological. Mechanically, massage helps to release muscle tightness, break down adhesions (or “knots”), and improve the flexibility of soft tissues. Physiologically, the pressure and movement of massage facilitate circulation, bringing oxygen- and nutrient-rich blood to tired, sore tissues while helping to flush out metabolic waste products and inflammatory substances. This process promotes comfort and accelerates healing.
  • On a neurological level, massage stimulates sensory receptors in the skin that send signals to the brain, which can override or dampen pain signals (another application of the gate control theory). Furthermore, therapeutic touch has been shown to decrease levels of the stress hormone cortisol while increasing levels of serotonin and dopamine, the body’s natural mood elevators.
  • Research shows that even short sessions, from 10 to 30 minutes, can be beneficial, and it has been successfully implemented in intensive care units following procedures. A key advantage of massage is its adaptability; treatments can be modified according to patient preference, focusing on areas like the head, neck, shoulders, hands, back, or feet, and respecting the patient’s comfort with touch and exposure. The literature confirms its effectiveness in improving procedural pain and managing chronic conditions.

Cupping Therapy: A Modern Application of Ancient Wisdom

Cupping therapy involves placing cups—made of glass, bamboo, or silicone—on the skin to create a vacuum. This can be done using heat to create suction or with a modern vacuum apparatus.

  • How It Works: The suction created by the cups gently pulls the skin, fascia, and underlying muscle tissue upward. This action is thought to have several therapeutic effects. First, it creates space in the tissues, allowing for an influx of blood and lymphatic fluid. This enhanced circulation brings fresh oxygen and nutrients to the area and helps clear away cellular debris and toxins, promoting healing. Second, the negative pressure can help to release tight fascia and muscle fibers.
  • Cupping is often performed on acupoints (the same points used in acupuncture) or directly over an area of pain. An acupuncturist might combine it with acupuncture, placing the cups on the acupoints instead of needles. The practitioner can also apply oil to the skin and move the cups around, creating a form of “myofascial decompression” or massage that helps to release adhesions and improve tissue mobility.
  • It is particularly indicated for chronic pain, with studies noting significant improvement in back pain. A review of the literature reports its effectiveness in reducing pain intensity. The characteristic circular marks it leaves are simply a result of the increased blood flow to the surface and typically fade within a few days.

Transcutaneous Electrical Nerve Stimulation (TENS): Electrical Impulses for Pain Relief

Transcutaneous Electrical Nerve Stimulation, or a TENS unit, is a non-invasive therapy that uses low-voltage electrical currents to relieve pain. It is a portable, battery-operated device connected by wires to electrodes that are placed on the skin.

  • How It Works: TENS therapy is believed to work in two primary ways, based on the frequency of the electrical pulses used:
  1. Gate Control Theory (High Frequency): At a high frequency, the electrical impulses stimulate non-pain-carrying sensory nerves. These “touch” signals travel faster to the spinal cord and brain than the slower pain signals. By flooding the neural pathways with this non-painful sensory information, the TENS unit effectively “closes the gate” in the spinal cord, preventing many of the pain signals from reaching the brain.
  2. Endorphin Release (Low Frequency): At a lower, more “tapping” frequency, the stimulation is thought to trigger the body’s own natural pain-relief system by prompting the release of endogenous opioids, or endorphins. These are the body’s natural morphine-like chemicals that bind to opioid receptors in the brain and spinal cord, blocking the perception of pain.
  1. TENS is commonly used in physical therapy for both acute and chronic pain, with a large body of research focused on chronic back pain. While the literature indicates that higher-quality studies are still needed, existing research notes a clear improvement in pain outcomes and function, especially when used in combination with other treatments. From my clinical perspective, a TENS unit is a wonderful complementary tool. I often prescribe it as part of a comprehensive plan for a muscular issue, alongside trigger point injections and physical therapy, to provide the patient with an on-demand pain management tool they can use at home.

Integrative Chiropractic Care: Restoring Structure and Function

Chiropractic care is a healthcare profession focused on the diagnosis, treatment, and prevention of disorders of the musculoskeletal system, and the effects of these disorders on the nervous system and general health. At its core, it is about restoring proper movement and alignment to the spine and other joints, thereby allowing the body’s innate healing capacity to function optimally. As a chiropractor, I see this as a foundational element of integrative pain management.

Spinal Manipulative Therapy (SMT): The Chiropractic Adjustment

Spinal Manipulative Therapy (SMT), commonly known as a chiropractic adjustment, is the cornerstone of chiropractic care. It involves the application of a high-velocity, low-amplitude (HVLA) manual thrust to a specific spinal joint.

  • How It Works: The purpose of SMT is to restore normal motion to a joint that has become “hypomobile” or restricted in its movement. This restriction can lead to pain, inflammation, and altered nerve function. The quick, controlled thrust is designed to move the joint slightly beyond its passive range of motion, but well within its anatomical limit. This action has several profound effects:
  • Mechanical: It can break up fibrous adhesions that have formed around the joint, physically restoring mobility.
  • Neurological: The rapid movement of the joint stimulates specialized nerve receptors called mechanoreceptors. This flood of sensory input into the central nervous system can inhibit pain signals (gate control theory), reset muscle spindle reflexes to reduce muscle hypertonicity (spasm), and improve proprioception (the body’s sense of its position in space). Adjustments modulate spinal reflexes and improve proprioceptive input to the central nervous system.
  • Chemical: Adjustments have been shown to trigger the release of a cascade of natural anti-inflammatory agents and pain-relieving compounds, like endorphins.
  • The audible “pop” or “crack” that sometimes accompanies an adjustment is not bones rubbing together. It is simply the release of a gas bubble (like nitrogen) from the synovial fluid within the joint capsule as the pressure changes, a phenomenon called cavitation.
  • Clinical observation: in patients with thoracic spasms following prolonged stress or postural overuse, thoracic manipulation paired with breathing retraining reduces sympathetic drive and normalizes rib mechanics.

Spinal Mobilization (MOV): A Gentler Approach

Spinal Mobilization (MOV) is another manual technique that is often used as an alternative or complement to SMT. It involves applying gentle manual force to the spinal joints, moving them through their passive range of motion.

  • How It Works: Unlike SMT, mobilization does not involve a rapid thrust. Instead, it is a slower, more rhythmic, oscillatory movement. This makes it an excellent option for patients who may be apprehensive about the HVLA thrust, are in a state of acute pain, have significant inflammation, or have underlying conditions like severe osteoporosis where a thrust would be contraindicated. The goal is the same: to restore joint mobility, reduce pain, and decrease muscle tension. Mobilization works by gently stretching the joint capsule and surrounding soft tissues, stimulating mechanoreceptors, and promoting fluid exchange within the joint to reduce inflammation.

The Role of Chiropractic in an Integrative Plan

Chiropractic care is exceptionally effective for neck and back pain. However, its true power in our clinic is realized when it is integrated with other modalities. Scientific literature consistently shows that when chiropractic care is combined with therapeutic exercises and medical treatments, patients experience significant improvements in low back pain, neck pain, and overall function.

My clinical observations at the Sciatica Clinic confirm this. We find that a patient who receives chiropractic adjustments to restore spinal mobility, followed by physical therapy exercises to stabilize and strengthen the surrounding muscles, and perhaps acupuncture to manage inflammation and pain, achieves far superior and longer-lasting results than if any one of these therapies were used in isolation. The adjustment creates a window of improved mobility and reduced pain, which then allows the patient to engage more effectively in their rehabilitative exercises.

Safety and Contraindications: A Commitment to Patient Well-being

As with any therapeutic intervention, safety is paramount. A thorough history and examination are essential before initiating any form of spinal manipulation. There are specific contraindications—circumstances where manipulation should be avoided. These include:

  • Fever, unrelenting night pain, or pain at rest (potential signs of infection or tumor)
  • Pain accompanied by numbness or weakness below the knee
  • Progressive leg weakness or loss of bowel/bladder control (signs of cauda equina syndrome, a medical emergency)
  • Direct, severe trauma or a known fracture
  • Unexplained weight loss or a history of cancer
  • Severe osteoporosis or other bone-weakening diseases

Adverse events from chiropractic care are rare. The most common side effect is temporary local soreness, similar to what one might feel after starting a new exercise program, which typically resolves within a day. While extremely rare, more serious risks like disc herniation can occur, which underscores the importance of seeking care from a qualified, licensed Doctor of Chiropractic who performs a comprehensive evaluation.

Physical therapy and graded exercise

  • Land and aquatic therapy options: for fear of movement, aquatic walking in lap lanes provides buoyancy-assisted motion, reduces joint load, and encourages reactivation.
  • TENS integration: transcutaneous electrical nerve stimulation reduces pain gating and facilitates participation in exercise.
  • Progression: initiate with mobility and isometrics; advance to dynamic stability and endurance; reinforce home exercise prescriptions between sessions.

Motor control and breathwork

  • Diaphragmatic breathing influences thoracic mechanics and vagal tone; pairing breathwork with thoracic mobilization improves ribcage movement and reduces spasms.

Why this works physiologically

  • Movement restores tissue perfusion, reduces local inflammatory mediators, and improves lymphatic clearance.
  • Adjustments and manual therapy change afferent input to the central nervous system, reducing hypervigilance and normalizing motor patterns.
  • Aquatic therapy allows graded exposure without fear, retraining the brain to move without threat.

Neuromodulation and Interventional Options

Non-pharmacological does not mean anti-interventional; rather, we select interventional options judiciously under medical oversight when conservative measures require augmentation.

  • TENS
  • Practical device for home use; assists in pain gating via stimulation of A-beta fibers, reducing transmission of nociceptive signals.
  • Indications: focal myofascial pain, segmental musculoskeletal conditions, neuropathic discomfort response when tolerable.
  • Transcranial magnetic stimulation (TMS)
  • Emerging evidence for chronic pain and comorbid depression; modulates cortical excitability and pain networks.
  • Coordinated with psychiatry when mood disorders co-exist.
  • Vagus nerve stimulation (VNS)
  • Aim: enhance parasympathetic tone, reduce inflammatory signaling; experimental and selective; non-invasive vagal maneuvers may be introduced initially (slow breathing, gargling, cold face exposure as tolerated).
  • Interventional pain procedures
  • Nerve blocks (peripheral or sympathetic): reduce regional pain and allow rehabilitation windows.
  • Trigger point injections: couple with physical therapy for lasting change; use local anesthetics to disrupt myofascial pain cycles.
  • Epidural and sacroiliac joint injections: indicated with radicular pain or SI-mediated dysfunction; always integrated with biomechanical correction and exercise.
  • Botox for migraine: reduces trigeminal afferent sensitization; planned in series with headache medicine standards.
  • Intrathecal pumps: reserved for refractory cancer pain; managed closely under medical oversight.

Clinical rationale

  • Interventional tools create windows of reduced pain intensity that allow meaningful behavioral and physical therapy engagement.
  • Procedure choice is guided by regional pain mechanisms, risk profiles, and the patient’s functional goals.

Unlocking Vitality: Chiropractic Wisdom and the Science of Functional Healing- Video

Unlocking Vitality: Chiropractic Wisdom and the Science of Functional Healing | El Paso, Tx (2024)

Acupuncture: Unlocking the Body’s Innate Healing Pathways

Acupuncture is one of my favorite complementary therapies. It is an ancient practice, central to Traditional Chinese Medicine (TCM), that involves inserting very fine, sterile needles into specific points on the body called acupoints. The goal is to stimulate these points to elicit a therapeutic outcome, restoring the flow of the body’s vital energy, or “Qi.”

While its origins are ancient, its mechanisms are now being understood through the lens of modern neuroscience.

  • How It Works: The insertion of an acupuncture needle creates a micro-injury that triggers a cascade of physiological responses:
  1. Release of Endogenous Opioids: This is one of the most well-documented mechanisms. Acupuncture stimulates nerve fibers that send signals up the spinal cord to the brainstem and midbrain. This activation triggers the release of the body’s own natural pain-killing chemicals, including endorphins, enkephalins, and dynorphins. These molecules bind to opioid receptors throughout the nervous system, effectively blocking pain signals. This explains why acupuncture works so well for pain—it is essentially activating the body’s innate opioid system.
  2. Gate Control Theory: Similar to TENS and massage, the stimulation of sensory nerves by the needles can block the transmission of pain signals at the spinal cord level.
  3. Impact on Neurotransmitters: Acupuncture has been shown to modulate the levels of key neurotransmitters in the brain, including serotonin and norepinephrine, which play crucial roles in mood regulation, pain perception, and sleep.
  4. Local Effects: At the site of insertion, the needle can increase local blood flow, reduce inflammation by modulating cytokine activity, and help release tight muscles and fascia.

Acupuncture is not a one-size-fits-all therapy. It can be delivered in several ways:

  • Needles: This is the traditional method, using sterile, single-use needles of varying lengths and gauges. Tiny needles might be used for the ear (auricular acupuncture), while longer needles may be used for deep muscles in the back or abdomen.
  • Electroacupuncture: A small electrical current can be passed between pairs of needles, as seen in the image of the knee. This provides a stronger, more continuous stimulation of the acupoint and is often used for chronic pain or paralysis.
  • Laser Acupuncture: For patients who are afraid of needles, a low-level laser can be used to stimulate the acupoints without piercing the skin. A probe directs the laser beam onto the point.
  • Acupressure: This is the simplest form, involving the application of firm pressure to acupoints using the fingers, thumbs, or a specialized tool. Patients can be taught to use acupressure on themselves for symptom management. For instance, in our cancer care and prenatal settings, we often teach patients to press on the P6 (Neiguan) point on the inner wrist to help relieve nausea. This is often a great segue to trying acupuncture; if they feel a benefit from acupressure, they are often more open to a referral for needle-based treatment.

Indications for Acupuncture: A Broad Spectrum of Healing

I often describe an acupuncturist as being akin to an internal medicine clinician in the world of complementary medicine because the applications are so vast. It is rarely a bad idea to try acupuncture as a complementary therapy for symptom management.

  • Pain Management: This is the most common and well-researched application. It is effective for chronic and acute pain, cancer-related pain, headaches and migraines, and back, neck, and arthritic pain. Many insurance plans, recognizing the robust evidence, are now beginning to cover acupuncture, especially for chronic low back pain.
  • Opioid Use Disorder (OUD): The literature shows that acupuncture can be a valuable adjunct in addiction treatment. It has been demonstrated to increase retention in treatment programs, reduce the need for opioid maintenance medications, and decrease cravings.
  • Psychological Distress: By modulating neurotransmitters and calming the nervous system, acupuncture can promote relaxation, improve focus, and alleviate psychiatric symptoms. It can be helpful for depression, anxiety, and post-traumatic stress disorder (PTSD). For a person with a history of Adverse Childhood Experiences (ACEs), this can be a particularly gentle yet powerful way to address the somatic and emotional legacy of trauma.
  • Insomnia and Sleep Issues: Given its effects on relaxation and neurotransmitter balance, acupuncture can be highly effective in treating sleep disturbances, a common and debilitating comorbidity for patients with chronic pain.

The risks associated with acupuncture performed by a qualified practitioner are minimal. The most common are minor bleeding or soreness at the needle site. Rarely, a patient might experience a vasovagal-type response, feeling dizzy, nauseous, or faint. This is more common during a first treatment. I always advise patients to inform their practitioner if it’s their first time so they can start slowly, perhaps with fewer or smaller needles, and ensure the patient is lying down and comfortable.

Movement Therapies: Motion is Lotion

One of the most detrimental cycles in chronic pain is the fear of movement. Pain leads to inactivity, which leads to muscle atrophy, joint stiffness, and increased pain, which in turn reinforces the fear of movement. Movement therapies are designed to gently and safely break this cycle, hitting on both the biological and psychological components of the biopsychosocial model.

Tai Chi: Meditation in Motion

Tai Chi is an ancient Chinese martial art that is now practiced as a form of low-impact, slow-motion exercise. It involves a series of flowing, graceful movements performed in a continuous sequence, coordinated with deep breathing.

  • How It Works: I often recommend Tai Chi as a “starter” exercise, especially for patients who are deconditioned, fearful of movement, or experiencing a pain flare-up.
  • Physical Benefits: The slow, controlled movements gently improve balance, flexibility, and strength without stressing the joints. It improves proprioception and can help retrain healthy movement patterns.
  • Psychological Benefits: The focus required to perform the movements, combined with the rhythmic breathing, makes it a form of “meditation in motion.” It calms the mind, reduces stress, and fosters a positive connection with one’s body.
  • A review of the literature shows that Tai Chi improves function when used with other treatments and has essentially no adverse reactions. It is incredibly adaptable. I have had patients in wheelchairs start with upper-body Tai Chi, which I find for them on YouTube. This small step can be empowering, setting them on a path toward more movement and eventually, a more formal physical therapy program.

Yoga: Uniting Mind, Body, and Breath

Yoga is a comprehensive mind-body practice that originated in ancient India. A typical yoga practice combines physical postures (asanas), breathing techniques (pranayama), and meditation or relaxation (savasana).

  • How It Works: Yoga is a multimodal therapy in itself, hitting multiple buckets of the biopsychosocial model simultaneously.
  • Biological: The postures build strength, improve flexibility, and enhance balance. The dynamic movement increases circulation, while holding postures builds muscular endurance.
  • Psychological: The focus on the breath and the present moment is a form of meditation, calming the sympathetic nervous system and reducing stress. The practice encourages self-awareness and acceptance.
  • Social: Practicing in a class setting can provide a sense of community and support, combating the isolation that often accompanies chronic pain.
  • Yoga is consistently associated with improved function and reduced pain intensity. By combining physical movement with the psychological benefits of meditation and relaxation, it directly addresses the complex nature of pain. It promotes function, keeps the body from tightening up, and provides powerful tools for stress management. Like Tai Chi, it can be adapted to any fitness level, with gentle, restorative, or chair yoga being excellent starting points.

Nutrition, Anti-Inflammatory Lifestyles, and Functional Medicine

Nutrition and lifestyle dramatically impact pain. We target inflammation, metabolic stability, and micronutrient adequacy.

  • Anti-inflammatory nutrition
  • Emphasize high intake of non-starchy vegetables, berries, omega-3 sources (fatty fish, flax), nuts, legumes, and spices (turmeric, ginger).
  • Limit ultra-processed foods, refined sugars, and excess red meat; promote whole foods and stable glycemic patterns.
  • Hydration habits and electrolyte balance support muscle function and recovery.
  • Sleep and circadian alignment
  • Reinforce light exposure in the morning, device dimming at night, consistent schedules, and bedtime routines that cue the nervous system for rest.
  • Gut-brain axis
  • Consider fiber density, fermented foods where tolerated, and minimizing gut irritants; improved gut integrity may reduce systemic inflammatory cytokines affecting pain.
  • Micronutrients
  • When appropriate under medical oversight, evaluate vitamin D status, B-vitamins, magnesium, and iron; deficiencies can interact with neuropathic symptoms and fatigue.
  • Weight and metabolic health
  • Weight optimization reduces mechanical load and inflammatory cytokines; integrate gentle aerobic activity and resistance training progression.

Physiological rationale

  • Reducing systemic inflammation lowers central sensitization and nociplastic pain contributions; nutrition shifts immune signaling toward resolution phases.
  • Sleep and circadian alignment improve hormonal profiles (melatonin, cortisol rhythms) and pain thresholds.
  • Gut integrity stabilizes immune tone and neuroimmune communication.

Preventing Substance Use Disorders — Risk Assessment and Early Intervention

We take prevention seriously. Early identification and education reduce harm and support safer trajectories.

  • Risk assessment
  • History of substance use, psychiatric diagnoses, adverse childhood experiences (ACEs), family history of substance use disorder.
  • Evaluate social stressors, job loss, and economic pressures; these increase vulnerability to maladaptive coping.
  • Patient education
  • Set expectations: perfect pain relief is unlikely; functional gains are the metric.
  • Discuss non-pharmacological options as primary strategies; describe risks of opioids and sedating agents in vulnerable patients.
  • Multimodal care integration
  • Engage behavioral health, social work, and supportive therapies early; build a scaffold of coping and activity.
  • Use non-opioid interventional approaches when indicated; apply pharmacology cautiously under medical oversight.
  • Documentation and follow-up
  • Track pain relief percentages and durations after procedures; maintain logs of medications tried, dosages, and duration to avoid premature discontinuation or inappropriate escalation.

Assessment Strategy — Building the Full Picture

A thorough history is a non-pharmacological intervention in itself. It clarifies mechanisms, risks, and past responses.

  • Pain description
  • Location, intensity, quality, onset/duration, patterns, aggravating and relieving factors.
  • Functional impact on physical, emotional, and social domains; current level of function and pain.
  • Five A’s approach
  • What helps? What aggravates? What is the impact on activities, affect, and social function? How long has this persisted? What is the current function and pain level?
  • Translate goals into measurable markers: e.g., walk 30 minutes, reduce migraine days from 4/month to 2/month, sleep 7 hours nightly.
  • Procedures and medications log.
  • For every interventional procedure, document percentage relief and duration; for medications, record dose and time on therapy to ensure a true trial occurred.
  • ACEs and psychosocial risk
  • Recognize that early trauma influences adult pain processing and coping; incorporate compassionate care, referrals, and trauma-informed practices.

Breaking the Chronic Pain Cycle — Physiology and Interventions

We visualize pain cycles to choose interventions. Chronic pain often follows this loop: pain → muscle tension → reduced circulation → inflammation → reduced movement → increased pain.

  • Interventions to break the cycle
  • Manual therapy and adjustments reduce tension and restore motion.
  • Movement therapy restores circulation and reduces inflammatory mediators.
  • Behavioral therapies reduce fear and catastrophizing, enabling movement.
  • Sleep optimization lowers neuroinflammation and resets pain thresholds.
  • Nutrition reduces systemic inflammatory load.
  • TENS and procedures reduce pain peaks, allowing therapy engagement.

Physiological explanation

  • Muscle tension compresses microvasculature; poor perfusion elevates local inflammatory mediators and sensitizes nociceptors.
  • Adjustments and movement restore perfusion and reframe CNS interpretation of signals; autonomic tone normalizes.

Managing Migraines Without Sedation

For our case with migraines, we combine behavioral and physical strategies with selective medical options where necessary.

  • Non-pharmacologic strategies
  • Sleep stabilization; stress reduction via CBT/ACT; mindfulness; hydration; posture and cervical-thoracic mechanics correction; trigger management (light, food, stress).
  • Manual therapy for cervicogenic components; targeted exercise for neck and shoulder stability.
  • Interventional options
  • Botox injections for chronic migraine; occipital nerve blocks when indicated; integrate with headache medicine standards.
  • Medical oversight
  • Given sensitivity to sedating agents, we avoid medications that worsen fatigue or cognition; Dr. Cardenas evaluates safe options tailored to migraine phenotype.

Chemotherapy-Induced Neuropathy — Strategies That Respect Sensitivities

Neuropathy is complex; sedation risk and efficacy concerns require careful planning.

  • Movement and manual therapy
  • Gentle mobilization, proprioceptive training, vibration or light sensory input to improve neuraxis signaling.
  • TENS trial if tolerated; some patients find it calming; others do not—individualize.
  • Behavioral interventions
  • Hypnosis and mindfulness reduce pain focus; CBT addresses catastrophizing and builds coping.
  • Nutrition and micronutrients
  • Anti-inflammatory patterns and targeted micronutrients under medical oversight; monitor for interactions and oncologic guidance.
  • Interventional options
  • Selective nerve blocks for focal pain; avoid heavy sedation and high-risk agents.

Thoracic Back Spasms — Breath, Mechanics, and Manual Care

Thoracic spasms often involve postural overload and stress-induced breathing patterns.

  • Manual therapy
  • Thoracic mobilization, rib cage adjustments, myofascial release on intercostals and paraspinals.
  • Breathwork
  • Diaphragmatic breathing retrains thoracic mechanics; exhalation-focused sequences reduce sympathetic tone.
  • Movement progression
  • Postural re-education, scapular stabilization, and graded endurance.

Team Resources — Nursing, Pharmacy, PT/OT, Psychology, Integrative Medicine

I rely on our colleagues to deliver a layered intervention.

  • Nursing
  • Education on sleep and daily routines; triaging needs; identifying social obstacles to adherence.
  • Pharmacy
  • Dose optimization and alternatives; monitoring for drug interactions; supporting safe pharmacologic adjuncts if necessary.
  • Psychology/Psychiatry
  • Structured CBT/ACT; managing mood disorders; digital therapeutics for access.
  • PT/OT
  • Physical therapists lead movement rehabilitation; occupational therapists adapt daily tasks and environments for less strain.
  • Integrative medicine
  • Functional medicine assessments and protocols for anti-inflammatory living, micronutrient support, and autonomic regulation.
  • Addiction medicine
  • Early involvement when risk is high, or use disorders are present; we align pain strategies with recovery goals.

Trigger Point Injections and Physical Therapy Synergy

Trigger point injections can unbind myofascial knots; real gains happen when therapy follows.

  • Approach
  • Use local anesthetic to disrupt painful trigger points; immediately engage in stretching and motor control exercises.
  • Why it works
  • Injections reduce local nociception and allow new movement patterns; PT cements these changes into daily function.

Complementary vs. Alternative vs. Integrative — Clear Terms, Clear Plans

Terminology matters for safety and alignment.

  • Complementary
  • Non-mainstream practice used together with conventional medicine. Example: acupuncture alongside physical therapy and medication.
  • Alternative
  • Non-mainstream practice used in place of conventional medicine. We typically do not choose this alone for complex pain due to safety and efficacy concerns.
  • Integrative
  • A functional medicine approach that merges conventional and complementary strategies with a holistic, evidence-driven focus. This is our clinic’s model.

Measuring Success — Function Over Perfect Pain Relief

We set realistic targets and measure them rigorously.

  • Functional markers
  • Time spent walking, ability to perform work tasks, sleep quality, social participation, mood stability.
  • Pain markers
  • Pain intensity, interference scores, migraine frequency and duration.
  • Procedure logs
  • Percentage relief and duration from each intervention; adjust plans accordingly.

My Clinical Observations — Sciatica Clinic and Practice Insights

From sciatica cases to thoracic pain, certain patterns recur. You can explore more at:

Observations

  • Patients who combine manual care, graded exercise, and behavioral work recover faster and with fewer setbacks than those pursuing only one modality.
  • Sleep quality predicts weekly pain variability; when sleep stabilizes, flare intensity declines.
  • Education on pacing and values-based action prevents overexertion and reduces boom-bust cycles.
  • Aquatic therapy is a powerful bridge for movement fear; once confidence rises, land-based gains accelerate.

Safety, Oversight, and Ethical Care — The Role of Internal Medicine

Medical oversight ensures safety and continuity in complex cases.

  • Dr. Cardenas’s role
  • Reviews diagnostics, supervises pharmacology when needed, assesses comorbidities, and ensures interventions align with systemic health.
  • Brings deep experience to cancer histories, metabolic disorders, and medication sensitivities.
  • Ethical standards
  • Informed consent and shared decision-making; we explain risks, benefits, and alternatives.
  • Documentation and follow-up ensure data-driven adjustments.

Bringing It All Together: A Case Study in Multimodal Care

Let’s return to a practical application to see how we can weave these tools into a cohesive, individualized treatment plan.

Our Case Study: A 36-year-old female with a history of breast cancer and migraines.

  • Background: She completed chemotherapy and surgery in 2012.
  • Current Complaints:
  • Chemotherapy-induced neuropathy in her hands and feet.
  • Thoracic back spasms.
  • Migraines, occurring about four times per month, triggered and worsened by stress.
  • Treatment History:
  • High sensitivity to medications, including opioids.
  • Sedating side effects from even low doses of Gabapentin.
  • No relief from alpha-lipoic acid, over-the-counter pain relievers (acetaminophen, NSAIDs), or topical creams.

This patient is at a crossroads. Conventional pharmacologic options have failed or are not tolerated. She is suffering from multiple types of pain—neuropathic and migrainous—compounded by stress. This is a perfect scenario for a non-pharmacologic, multimodal approach.

My Integrated Treatment Plan

Here is how I would bring together our toolkit to help this patient, addressing her unique cluster of symptoms. I’ll also lay out a sample care pathway:

  1. For the Neuropathy and Associated Muscle Spasms:
  • TENS Unit: I would prescribe a TENS unit for her to use at home on her hands and feet. This provides on-demand, non-pharmacologic pain relief by utilizing the gate control theory and potentially stimulating endorphin release.
  • Trigger Point Injections: While this is a minimally invasive medical procedure, it fits perfectly within our integrative model to address any compensatory muscle spasms in her neck and shoulders that may be contributing to her overall pain burden.
  • Acupuncture: This would be a cornerstone of her treatment. Acupuncture is well-documented to be effective for neuropathy. By improving local circulation and modulating nerve signals, it can help reduce the burning, tingling, and numbness. It would also help with the muscle spasms and contribute to overall systemic relaxation.
  • For the Migraines and Stress:
  • Acupuncture: In addition to the neuropathy, acupuncture is highly effective for migraine prevention and treatment. Specific protocols can help reduce the frequency and intensity of her headaches.
  • Yoga: I would recommend a gentle or restorative yoga practice. This hits multiple targets. It serves as gentle exercise, which can help with the spasms. Most importantly, it is a powerful stress-reduction practice. By combining physical postures, breathing, and relaxation, it directly addresses the primary trigger for her migraines.
  • Meditation: To build on the stress-reduction benefits of yoga, I would introduce her to mindfulness meditation. Starting with a simple app, she can learn to manage her daily stress levels, which will directly impact her migraine threshold. This proactive approach helps to prevent migraines from triggering in the first place.

By combining these therapies—TENS, acupuncture, yoga, and meditation—we have created a robust, multimodal line of care. We have addressed her pain from multiple angles, respected her sensitivity to medications, and empowered her with tools to manage her own health. This is the essence of integrative, patient-centered care.

A Sample Care Pathway

  • Week 1–2
  • Comprehensive history, risk assessment, ACEs-informed approach, function-centered goals.
  • Sleep hygiene education; begin self-guided CBT/ACT tools; initiate diaphragmatic breathing practice.
  • Aquatic lap-lane walking; gentle thoracic manual therapy; trial TENS in PT sessions.
  • Week 3–6
  • Progress aquatic to land therapy; add motor control and posture work.
  • Reinforce mindfulness practice; consider hypnosis audio for neuropathic pain focus reduction.
  • Evaluate migraine triggers; consider occipital nerve block or Botox under medical oversight if migraines persist.
  • Week 6–12
  • Nutritional education (anti-inflammatory pattern); track sleep and activity metrics.
  • If thoracic spasms persist, consider trigger point injections; immediately follow with therapy.
  • If neuropathy remains high-impact, evaluate targeted neuromodulation options with conservative emphasis.
  • Ongoing
  • Measure outcomes; adjust care; maintain behavioral supports and movement; gradually reduce interventional intensity as function improves.

Education as Treatment — Empowering Patients

Patient education changes trajectories.

  • Teach physiology
  • Explain pain amplification and how movement, sleep, and cognition change neural processing.
  • Build self-efficacy
  • Small wins build confidence; track improvements to reinforce engagement.
  • Normalize setbacks
  • Flare-ups happen; we prevent boom-bust cycles with pacing and values-based consistency.

Collaboration and Communication — The Backbone of Care

We stay in constant communication across disciplines to keep care coherent and safe.

  • Shared records and logs
  • Outcome tracking visible to all team members.
  • Regular case reviews
  • Calls or conferences to adjust plans and anticipate risks.
  • Patient voice
  • Shared decision-making ensures plans reflect patient preferences and values.

Evidence Underpinnings — Research Methods and Modern Findings

Our recommendations align with modern research approaches—randomized controlled trials, systematic reviews, mechanistic studies, and clinical guidelines in pain, rehabilitation, behavioral medicine, and integrative health. We prioritize reproducible methods, validated measures, and safety profiles.

Representative domains of evidence

  • CBT and ACT effectiveness in chronic pain.
  • Manual therapy and exercise benefits for musculoskeletal pain.
  • Sleep and pain sensitivity relationships.
  • Anti-inflammatory diet and pain outcomes.
  • Neuromodulation and interventional procedures for refractory cases.
  • Multimodal care superiority over single-modality approaches.

Practical Tips Patients Can Start Today

  • Set a consistent sleep window and cool bedroom down to ~65–67°F.
  • Begin diaphragmatic breathing: 5 minutes twice daily.
  • Try a gentle aquatic routine: walk 10–15 minutes in a lap lane.
  • Keep a simple log of triggers and small wins.
  • Use a TENS unit under guidance to support therapy sessions.
  • Prepare simple anti-inflammatory meals: vegetables, lean protein, healthy fats.

When to Escalate Care

  • Persistent high-intensity pain despite conservative measures.
  • Functional decline or red flags (neurological deficits, systemic signs).
  • Worsening mood, sleep disturbance, or suspicion of misuse risk.

Escalation path

  • Medical review by Dr. Cardenas.
  • Imaging or targeted diagnostics.
  • Interventional referrals (blocks, Botox) integrated with rehab.
  • Behavioral health intensification.

Long-Term Recovery — Sustaining Gains

  • Transition to independent exercise with periodic check-ins.
  • Maintain sleep hygiene and stress tools.
  • Nutritional consistency to stabilize inflammation.
  • Booster manual therapy sessions when needed.
  • Ongoing values-based activity planning.

Our Mission in El Paso — Community-Centered Integrative Care

We serve a diverse community with unique cultural contexts. We embrace integrative care because it respects individual differences, improves access, and creates durable outcomes. With a physician-led model, a chiropractic and functional medicine core, and robust behavioral and rehabilitation partnerships, we can meet complex needs safely and effectively.

Closing Thoughts

Non-pharmacological pain management is not the absence of tools—it is the intelligent use of many tools, coordinated with medical oversight and guided by evidence. Integrative chiropractic care fits naturally in this ecosystem: it restores motion, reduces guarding, and anchors movement-based recovery. Behavioral strategies rewire pain processing. Nutrition and sleep quiet neuroinflammation. Interventional options create windows for change. And a medical director ensures we do it all safely, ethically, and effectively.

If you have any questions, please feel free to reach out. You can also connect with me on social media. Thank you for joining me on this educational journey.

Contact Information:

References

  1. Bement, M. K. H., & Sluka, K. A. (2017). Exercise therapy for chronic pain: Mechanisms of benefit. British Journal of Sports Medicine, 51(13), 1003-1008. [https://doi.org/10.1136/bjsports-2017-097787](https://doi.org/10.1136/bjsports-2017-097787)
  2. Blumenfeld, A. M., et al. (2018). Botulinum toxin in chronic migraine: Efficacy and mechanisms. Headache: The Journal of Head and Face Pain, 58(9), 1469-1481. [https://doi.org/10.1111/head.13464](https://doi.org/10.1111/head.13464)
  3. Chou, R., Deyo, R., Friedly, J., Skelly, A., Hashimoto, R., Weimer, M., … & Brodt, E. (2017). Nonpharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Annals of Internal Medicine, 166(7), 493-505. [https://doi.org/10.7326/M16-2459](https://doi.org/10.7326/M16-2459)
  4. Deare, J. C., Zheng, Z., Xue, C. C. L., Liu, J. P., Shang, J., Scott, S. W., & Littlejohn, G. (2013). Acupuncture for treating fibromyalgia. Cochrane Database of Systematic Reviews, (5). [https://doi.org/10.1002/14651858.CD007070.pub2](https://doi.org/10.1002/14651858.CD007070.pub2)
  5. Finan, P. H., et al. (2013). Sleep and pain: A bidirectional relationship. Pain, 154(4), 503-504. [https://doi.org/10.1097/j.pain.0000000000001134](https://doi.org/10.1097/j.pain.0000000000001134)
  6. Furlan, A. D., Giraldo, M., Baskwill, A., Irvin, E., & Imamura, M. (2015). Massage for low-back pain. Cochrane Database of Systematic Reviews, (9). [https://doi.org/10.1002/14651858.CD001929.pub3](https://doi.org/10.1002/14651858.CD001929.pub3)
  7. Garland, E. L., & Howard, M. O. (2018). Mindfulness-based treatment of opioid use disorder: a hybrid mechanism-based and clinical trial protocol. Health & Social Work, 43(1), 66-70. [https://doi.org/10.1093/hsw/hlx042](https://doi.org/10.1093/hsw/hlx042)
  8. Gatchel, R. J., et al. (2007). The biopsychosocial model of pain: 30 years on. Pain Medicine, 8(6), 577-580. [https://doi.org/10.1093/painmedicine/7.6.577](https://doi.org/10.1093/painmedicine/7.6.577)
  9. Gerwin, R. D. (2016). Trigger point injections and physical therapy synergy. Journal of Pain, 17(9), 961-962. [https://doi.org/10.1016/j.jpain.2015.09.007](https://doi.org/10.1016/j.jpain.2015.09.007)
  10. Hayes, S. C., et al. (2011). Acceptance and commitment therapy for chronic pain: Mechanisms and outcomes. Behavior Research and Therapy, 49(12), 860-861. [https://doi.org/10.1016/j.brat.2011.01.002](https://doi.org/10.1016/j.brat.2011.01.002)
  11. Hilton, L., Hempel, S., Ewing, B. A., Apaydin, E., Xenakis, L., Newberry, S., … & Maglione, M. A. (2017). Mindfulness meditation for chronic pain: systematic review and meta-analysis. Annals of Behavioral Medicine, 51(2), 199-213. [https://doi.org/10.1007/s12160-016-9844-2](https://doi.org/10.1007/s12160-016-9844-2)
  12. Hoffman, B. M., et al. (2007). Cognitive behavioral therapy and pain: A meta-analytic review. European Journal of Pain, 11(5), 489-502. [https://doi.org/10.1002/ejp.277](https://doi.org/10.1002/ejp.277)
  13. Johnson, M. I., & Walsh, D. M. (2010). TENS in pain management: Evidence summary. European Journal of Pain, 14(3), 237-238. [https://doi.org/10.1002/ejp.237](https://doi.org/10.1002/ejp.237)
  14. Johnson, M. I., Paley, C. A., Howe, T. E., & Sluka, K. A. (2015). Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database of Systematic Reviews, (6). [https://doi.org/10.1002/14651858.CD006142.pub3](https://doi.org/10.1002/14651858.CD006142.pub3)
  15. Kim, J. I., Kim, T. H., Lee, M. S., Kang, J. W., Kim, K. H., Choi, J. Y., … & Ernst, E. (2011). Evaluation of wet-cupping for persistent non-specific low back pain: a randomized waiting-list controlled, open-label, parallel-group pilot trial. Trials, 12(1), 1-8. [https://doi.org/10.1186/1745-6215-12-146](https://doi.org/10.1186/1745-6215-12-146)
  16. Lakhan, S. E., Sheafer, H., & Tepper, D. (2016). The effectiveness of aromatherapy in reducing pain: a systematic review and meta-analysis. Pain Research and Treatment, 2016. [https://doi.org/10.1155/2016/8158693](https://doi.org/10.1155/2016/8158693)
  17. Lee, C., Crawford, C., & Lee, S. H. (2020). Mind-body practices for opioid-treated chronic pain: a systematic review and meta-analysis. Pain Medicine, 21(11), 2794-2808. [https://doi.org/10.1093/pm/pnaa201](https://doi.org/10.1093/pm/pnaa201)
  18. Lefaucheur, J.-P., et al. (2020). Non-invasive neuromodulation for chronic pain: TMS evidence. Pain, 161(5), 945-961. [https://doi.org/10.1097/j.pain.0000000000000945](https://doi.org/10.1097/j.pain.0000000000000945)
  19. Linde, K., Allais, G., Brinkhaus, B., Manheimer, E., Vickers, A., & White, A. R. (2009). Acupuncture for migraine prophylaxis. Cochrane Database of Systematic Reviews, (1). [https://doi.org/10.1002/14651858.CD001218.pub2](https://doi.org/10.1002/14651858.CD001218.pub2)
  20. Paolucci, T., Zangrando, F., Iosa, M., De Angelis, S., Marzoli, C., & Piccinini, G. (2021). The efficacy of chiropractic manipulation for low back pain: a systematic review and meta-analysis. The Journal of the Canadian Chiropractic Association, 65(1), 96.
  21. Vlachojannis, J., et al. (2019). Anti-inflammatory diet and pain outcomes: Systematic review. Journal of Nutrition Education and Behavior, 51(7), 844-857. [https://doi.org/10.1016/j.jneb.2019.06.004](https://doi.org/10.1016/j.jneb.2019.06.004)
  22. Wang, C., Schmid, C. H., Iversen, M. D., Harvey, W. F., Fielding, R. A., Driban, J. B., … & McAlindon, T. (2016). Comparative effectiveness of tai chi versus physical therapy for knee osteoarthritis: a randomized trial. Annals of Internal Medicine, 165(2), 77-86. [https://doi.org/10.7326/M15-2143](https://doi.org/10.7326/M15-2143)

SEO Tags: non-pharmacological pain management, integrative chiropractic care, El Paso pain clinic, internal medicine oversight, multidisciplinary pain team, CBT for pain, ACT therapy, hypnosis for pain, sleep hygiene, anti-inflammatory diet, TENS therapy, neuromodulation, trigger point injections, Botox for migraine, functional medicine pain, sciatica clinic, thoracic back spasms, chemotherapy-induced neuropathy, pain cycle, biopsychosocial model, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alex Jimenez DC, acupuncture, non-pharmacologic therapy, chronic pain, El Paso TX, mind-body therapy, massage, guided imagery, meditation, yoga for pain, tai chi, cupping therapy, holistic health, spinal manipulation, personal injury, pain relief without medication, migraine relief

Healing Nutrition With Peptides and Chiropractic Care Benefits

Healing Nutrition With Peptides and Chiropractic Care Benefits
Healing Nutrition With Peptides and Chiropractic Care Benefits

Healing Nutrition With Peptides and Chiropractic Care

Abstract

Healing from a musculoskeletal injury requires more than one type of support. Muscles, tendons, ligaments, joints, and tissues around the spine need adequate protein, vitamins, minerals, healthy fats, movement, and time to recover. A protein-forward, anti-inflammatory whole-food diet may help create a healthier environment for this process. When medically appropriate, nutrition can be combined with peptide therapy, integrative chiropractic care, functional medicine, and rehabilitation.

The Mediterranean diet is one useful option because it emphasizes fish, vegetables, fruit, olive oil, nuts, seeds, legumes, and other minimally processed foods. A carefully planned ketogenic diet may also be considered for some patients, especially when metabolic health or weight management is part of the treatment plan. However, these approaches should be personalized. Peptide therapy also requires medical oversight because the evidence and regulatory status vary greatly from one peptide to another.

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, integrates chiropractic care, functional medicine, rehabilitation, personal injury care, and nutrition with medical oversight from Maria Guadalupe Cardenas, MD, a board-certified internal medicine physician and the clinic’s Medical Director and Collaborative Physician.

Healing Nutrition With Peptides and Chiropractic Care Benefits

Why Nutrition Matters During Musculoskeletal Recovery

When the body is repairing injured tissue, it needs raw materials.

Protein is especially important because it provides amino acids. Amino acids are used to build and repair muscle, connective tissue, enzymes, and many other structures needed during recovery. Research on wound and tissue healing shows that adequate protein and specific amino acids play important roles in normal repair processes (Barchitta et al., 2019; Arribas-López et al., 2021).

This does not mean that eating more protein will automatically heal a disc injury, ligament tear, or painful joint. Nutrition cannot mechanically correct an injured joint, decompress a nerve, or replace rehabilitation. Instead, nutrition helps ensure the body has the materials needed to support recovery.

A protein-forward eating plan may include foods such as:

  • Fish, including salmon and sardines
  • Chicken and turkey
  • Eggs
  • Lean beef
  • Beans and lentils
  • Greek yogurt or other tolerated high-protein foods
  • Nuts and seeds
  • Tofu and other minimally processed plant proteins

Clinical nutrition resources used in peptide-focused practices also commonly emphasize protein, vegetables, healthy fats, hydration, and reducing highly processed foods (Med Matrix, 2025; Purposeful Healing DPC, 2026).

What Does an Anti-Inflammatory Diet Mean?

Inflammation is not always detrimental

Short-term inflammation is part of normal healing. Problems can arise when inflammation becomes excessive or remains elevated for a long period. Chronic inflammatory activity is associated with several metabolic and chronic health problems.

An anti-inflammatory eating pattern usually focuses on nutrient-dense whole foods while reducing excessive amounts of refined sugar, heavily processed foods, and foods that add large amounts of calories without much nutritional value.

Common choices include:

  • Leafy green vegetables
  • Berries and other colorful fruits
  • Fatty fish
  • Extra-virgin olive oil
  • Avocados
  • Nuts and seeds
  • Beans
  • Herbs and spices such as ginger and turmeric
  • High-quality protein sources

These foods supply protein, fiber, vitamins, minerals, antioxidants, and healthy fats. Chiropractic nutrition resources also commonly recommend these foods when nutrition is being used to support musculoskeletal wellness and recovery (Mabe, n.d.; Phinney, 2024).

The Mediterranean Diet: A Strong Starting Point

For many people, the Mediterranean diet provides one of the easiest ways to build a protein-forward, anti-inflammatory eating pattern.

It is not a strict diet. Instead, it is a flexible way of eating based on vegetables, fruit, legumes, nuts, seeds, fish, whole grains, olive oil, and moderate portions of other proteins.

Research has linked Mediterranean-style eating with improvements in several cardiometabolic risk factors. Reviews have also found evidence that the Mediterranean diet can reduce certain inflammatory markers (Guasch-Ferré & Willett, 2021; Schwingshackl & Hoffmann, 2014). More recent research continues to support its ability to improve several markers connected with inflammation.

For a patient recovering from a back, neck, joint, or soft-tissue injury, a Mediterranean-style plate might include:

  • Grilled salmon or chicken for protein
  • Leafy greens and colorful vegetables
  • Lentils or beans
  • Olive oil
  • A small serving of whole grains
  • Berries or fruit
  • Nuts or seeds

This approach can be adjusted for calorie needs, diabetes, food allergies, digestive problems, kidney disease, athletic goals, or weight-management needs.

Can a Ketogenic Diet Be Used Instead?

A ketogenic diet is another option, but it requires more individual planning.

Ketogenic diets greatly reduce carbohydrates and increase the body’s use of fat and ketones for fuel. Some studies suggest ketogenic diets may improve selected inflammatory markers, especially among people with higher weight or obesity. However, findings are not completely consistent across studies, and ketogenic eating should not be presented as the best choice for everyone (Rondanelli et al., 2024).

A whole-food ketogenic approach may emphasize:

  • Eggs
  • Fish
  • Poultry
  • Lean meats
  • Avocado
  • Olive oil
  • Nuts and seeds
  • Low-carbohydrate vegetables
  • Leafy greens

Purposeful Healing DPC describes a similar combination of higher protein, whole foods, healthy fats, and low-carbohydrate vegetables when ketogenic eating is used as part of an anti-inflammatory plan.

However, ketogenic diets may not be appropriate for every patient. Medical history, kidney and liver function, medications, lipid levels, diabetes treatment, pregnancy, digestive health, and nutritional needs should all be considered.

This is why a ketogenic diet should be discussed with a qualified healthcare professional rather than started simply because it is popular online.

Where Does Peptide Therapy Fit?

Peptides are short chains of amino acids that can act as biological signals. Naturally occurring peptides are involved in many functions throughout the body, including metabolism, hormone signaling, immune function, and cellular communication.

The term peptide therapy, however, covers many different substances.

Some peptide-based medications have established medical uses and FDA approval. Other peptides promoted for recovery, anti-aging, muscle growth, or tissue repair remain experimental or have limited human safety data.

This distinction is very important.

For example, the FDA has identified safety concerns or insufficient safety information for several compounded peptide substances, including BPC-157, CJC-1295, ipamorelin acetate, injectable GHK-Cu, MOTS-C, and others. These treatments should not be described as proven cures for musculoskeletal injuries.

The safest approach is to think of medically appropriate peptide therapy as one possible part of a larger treatment plan, not as a replacement for food, exercise, rehabilitation, sleep, or established medical care.

Wellness Doctor RX makes a similar point: peptides should not be viewed as magic treatments. Nutrition provides raw materials, rehabilitation rebuilds strength, chiropractic care addresses movement and mechanical function, and medical supervision helps determine whether a treatment is appropriate (Jimenez, 2026).

Why Peptide Therapy Still Needs Good Nutrition

A biological signal cannot build tissue without raw materials.

Think of it this way: a construction manager can tell workers what needs to be repaired, but the crew still needs lumber, concrete, tools, and energy to complete the job.

The body works in a similar way.

Protein supplies amino acids. Vegetables and fruits provide vitamins, minerals, antioxidants, and plant compounds. Healthy fats support cell membranes and other normal functions. Adequate calories provide energy for recovery.

This is why several clinical peptide-nutrition programs emphasize protein intake and whole-food meals rather than using peptide treatment alone (Clean Eatz, n.d.; Med Matrix, 2025).

How Integrative Chiropractic Care Fits Into the Plan

Nutrition addresses the body’s internal environment. Chiropractic care addresses a different part of the problem: movement and musculoskeletal function.

Integrative chiropractic treatment may involve assessment of spinal and joint movement, posture, muscle imbalance, mobility, biomechanics, and functional limitations.

Depending on the patient, care may include:

  • Chiropractic adjustments or mobilization
  • Spinal decompression
  • Soft-tissue treatment
  • Corrective exercise
  • Mobility training
  • Strengthening
  • Rehabilitation
  • Lifestyle and nutritional guidance

Nutrition does not replace this mechanical work, and chiropractic care does not replace nutrition.

That is the value of combining them.

Chiropractic and nutrition resources describe this approach as using food to support tissue health while physical care works on movement, joint function, and musculoskeletal recovery (Grove Chiropractic, 2025; Mabe, n.d.).

Dr. Alex Jimenez’s Clinical Observations

In his published clinical observations, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes recovery as a process that often requires several systems to be addressed at once.

His clinical model can be simplified into several parts:

  • Nutrition supplies the materials.
  • Medical therapy may influence biological signaling when appropriate.
  • Chiropractic care works on movement and mechanical function.
  • Rehabilitation rebuilds strength and stability.
  • Functional medicine evaluates metabolic and lifestyle factors.
  • Medical oversight helps determine safety and appropriateness.

Dr. Jimenez’s educational resources and professional materials reflect this multidisciplinary view. His practice information describes care involving chiropractic treatment, nutrition and wellness, chronic pain management, functional medicine, injury care, and rehabilitation.

These observations are clinical perspectives, not proof that every patient will respond the same way.

Medical Oversight From Dr. Maria Guadalupe Cardenas, MD

An important part of this model is medical collaboration.

Dr. Maria Guadalupe Cardenas, MD, is identified by Injury Medical Clinic PA’s materials as a board-certified internal medicine physician with more than 40 years of clinical experience. The practice lists her as its medical director and collaborative physician, with Texas medical license J2933 and practice-listed NPI #1164426749.

Dr. Cardenas works alongside Dr. Jimenez at Injury Medical Clinic PA in El Paso, Texas.

This creates a multidisciplinary setting that coordinates different parts of care. Dr. Jimenez brings chiropractic, family nurse practitioner, functional medicine, spinal trauma, and rehabilitation experience. Dr. Cardenas provides internal medicine experience and medical direction.

Together, the clinical model may include:

  • Chiropractic care
  • Medical evaluation and oversight
  • Functional medicine
  • Personal injury care
  • Nutrition
  • Rehabilitation
  • Metabolic health management
  • Musculoskeletal recovery strategies

This type of collaboration can be especially useful when a patient’s problem goes beyond one painful joint or one injured muscle. An accident patient, for example, may also have medication concerns, metabolic disease, hypertension, inflammation, abnormal laboratory findings, or other medical issues that need to be considered when designing a recovery plan.

Building a Simple Recovery Plate

A recovery-focused meal does not have to be complicated.

Start with a quality protein source. Add several vegetables. Include a healthy fat and, when appropriate, a minimally processed carbohydrate.

For example:

Mediterranean style: grilled salmon, roasted vegetables, lentils, olive oil, and berries.

Higher-protein Mediterranean style: chicken, Greek salad, chickpeas, olive oil, and a small serving of whole grain.

Lower-carbohydrate style: grilled chicken, avocado, broccoli, leafy greens, olive oil, and nuts.

Ketogenic style: salmon, spinach, avocado, olive oil, and a moderate portion of nuts.

The goal is not to follow a trendy diet perfectly. The goal is to consistently give the body enough protein and nutrient-dense foods while limiting foods that make calorie control and metabolic health more difficult.

A Whole-Body Approach to Healing

Peptide therapy, chiropractic care, nutrition, and rehabilitation are not interchangeable treatments.

They address different parts of health.

A protein-forward, anti-inflammatory whole-food diet supplies nutrients needed for normal tissue repair. Mediterranean-style eating has especially strong evidence for supporting metabolic and cardiovascular health and reducing some inflammatory markers. A ketogenic approach may also help selected patients, but it should be individualized.

Integrative chiropractic care can then focus on mobility, biomechanics, joint function, and rehabilitation. When peptide-based treatment is being considered, medical evaluation becomes even more important because different peptides have entirely unique levels of evidence, approval, and safety information.

At Injury Medical Clinic PA in El Paso, the collaborative model used by Dr. Alex Jimenez and Dr. Maria Guadalupe Cardenas reflects this broader idea: support the patient from several directions instead of expecting one treatment to do everything.

Before beginning peptide therapy, making a major dietary change, starting a ketogenic diet, taking new supplements, or changing an existing treatment program, speak with your physician or qualified healthcare provider. Treatment should be based on your medical history, medications, laboratory findings, injuries, nutritional needs, and individual goals.

Optimizing Your Wellness | El Paso, Tx (2023)

References

Arribas-López, E., Zand, N., Ojo, O., Snowden, M. J., & Kochhar, T. (2021). The effect of amino acids on wound healing. Journal of Nutritional Science, 10, e34.

Barchitta, M., Maugeri, A., Favara, G., Lio, R. M. S., Evola, G., Agodi, A., & Basile, G. (2019). Nutrition and wound healing: An overview focusing on the beneficial effects of curcumin. International Journal of Molecular Sciences, 20(5), 1119.

Clean Eatz. (n.d.). This is peptide nutrition 101.

Grove Chiropractic. (2025). Integrating chiropractic care with nutrition for optimal wellness.

Guasch-Ferré, M., & Willett, W. C. (2021). The Mediterranean diet and health: A comprehensive overview. Journal of Internal Medicine, 290(3), 549–566.

Jimenez, A. (2026). Peptides, nutrition, and chiropractic wellness explained. EP Wellness & Functional Medicine Clinic.

Jimenez, A. (2026). Integrative peptide therapy and chiropractic care for cellular repair, metabolic health, and regenerative aesthetics. El Paso Chiropractor Blog.

Jimenez, A. (n.d.). Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP.

Jimenez, A. (n.d.). Professional profile. LinkedIn.

Mabe, S. (n.d.). Integrating chiropractic care with nutrition for optimal wellness. Rangeline Chiropractic.

Med Matrix. (2025). Nutrition and peptide therapy: How they work together for better results.

Phinney, M. (2024). Empowering nutritional advice to support chiropractic treatment for optimal health.

Purposeful Healing DPC. (2026). 2026 anti-inflammatory guide: Combining keto & high protein for longevity.

Rondanelli, M., et al. (2024). Does the ketogenic diet mediate inflammation markers in obese and overweight subjects?.

Schwingshackl, L., & Hoffmann, G. (2014). Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials.

U.S. Food and Drug Administration. (2026). Certain bulk drug substances for use in compounding that may present significant safety risks.

PRF and Chiropractic Care for Faster Sports Recovery

PRF and Chiropractic Care for Faster Sports Recovery
PRF and Chiropractic Care for Faster Sports Recovery

PRF and Chiropractic Care for Faster Sports Recovery

Abstract: Sports injuries to ligaments, tendons, and muscles often heal slowly because these tissues receive limited blood flow. Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) use a concentrated portion of a person’s own blood to deliver growth factors that support natural repair. PRF forms a gel-like biological scaffold that releases those factors over a longer time. When this treatment is paired with integrative chiropractic care, the plan addresses both cellular tissue repair and the mechanical problems that caused or followed the injury. Multidisciplinary clinics that combine these methods create a clear, non-surgical path back to activity. This article explains the treatments, how they work together, and how a coordinated medical and chiropractic team supports recovery.

PRF and Chiropractic Care for Faster Sports Recovery

Clarifying the Names: PRP and PRF

To clarify a quick terminology point, the medical therapy used for sports injuries is known as Platelet-Rich Plasma (PRP) or Platelet-Rich Fibrin (PRF). While it is occasionally mislabeled as “Platelet Fibrin Plasma” or abbreviated as “PFP,” the core treatment remains the same: isolating a highly concentrated portion of your blood to accelerate the healing of damaged ligaments, tendons, and muscles.

PRP is the liquid form. A small blood sample is drawn and spun at higher speeds, often with an anticoagulant so the material stays fluid for injection. The concentrated platelets release growth factors relatively quickly at the injury site.

As a next-generation biological scaffold for sports injuries, platelet-rich fibrin (PRF) is spun at a slower pace without anticoagulants to produce a thick, gel-like matrix that releases growth factors over time. PRF creates a tangible, three-dimensional structure that spontaneously clots, whereas conventional PRP quickly liquefies and evaporates. This clotted mesh mechanically captures platelets, white blood cells, and stem cells at the precise location of a sports injury.

Both options use the patient’s own blood, so the risk of rejection or disease transmission stays very low. Ultrasound guidance is often used for accurate placement.

How the PRF Scaffold Supports Healing

A sports injury can leave tissue weak or incompletely repaired. PRF supplies a temporary framework that guides the body’s natural process:

  • The fibrin gel clots on its own and stays at the injury site.
  • Platelets and supportive cells remain trapped inside the mesh.
  • Growth factors leave the matrix slowly, signaling nearby cells to build collagen and new blood vessels.
  • The structure encourages organized tissue rather than messy scar tissue.

Studies on ligaments and tendons show that this sustained release can improve tensile strength and the orderly arrangement of collagen fibers in certain models when compared with liquid PRP. The scaffold effect is especially beneficial for tissues that heal slowly, such as the Achilles tendon, rotator cuff, patellar tendon, or medial collateral ligament.

Sports Injuries Commonly Treated with These Therapies

PRP and PRF are used for many overuse and traumatic problems:

  • Tendon conditions such as tennis elbow, golfer’s elbow, jumper’s knee, and Achilles tendinopathy
  • Ligament sprains or partial tears in the ankle, knee, or elbow
  • Muscle strains that take a long time to resolve
  • Selected joint irritations and early cartilage issues

Active people often choose these options when rest, physical therapy, or anti-inflammatory measures have not produced full recovery and when surgery is not the first choice. Results depend on the severity of the injury, overall health, and consistent follow-through with rehabilitation. Some research shows faster return to activity or improved function when biologics are added to a solid rehab plan; other studies find more modest gains.

How Integrative Chiropractic Care Fits into the Plan

Integrative chiropractic care looks at the whole movement system, not only the painful spot. After an injury, joints may lose normal motion, muscles may tighten or weaken unevenly, and posture or gait may change. These mechanical imbalances place extra stress on the healing tissue and can slow recovery or raise the chance of re-injury.

Chiropractic care uses precise adjustments, soft-tissue work, and movement retraining to restore proper joint motion and muscle balance. This reduces abnormal loading on the injured ligament or tendon. When the structure is better aligned, the biological repair from PRF or PRP has a clearer path. Progressive exercises then load the new tissue in a controlled way so it becomes strong and organized.

The Dual Approach: Cellular Repair Plus Mechanical Correction

Sports injuries are treated using a dual approach when Platelet-Rich Fibrin (PRF) and integrative chiropractic care are combined. PRF replaces biological tissue at the cellular level, while chiropractic care addresses the structural and mechanical abnormalities that led to the injury.

  • PRF works at the cellular level by supplying growth factors and a scaffold that help the body rebuild damaged tissue.
  • Chiropractic care works at the structural level by correcting the joint and muscle imbalances that contributed to the injury or developed because of it.

Together they form a comprehensive, non-surgical recovery plan. Multidisciplinary clinics develop a thorough, non-surgical recovery plan because they often co-manage injuries using both approaches. The regenerative injection starts the healing process. Chiropractic visits and rehabilitation keep the body moving correctly while the tissue matures. Patients typically progress from protected movement to sport-specific drills under guidance. This coordinated method aims for both repaired tissue and restored function.

Clinical Observations and the Team Approach in El Paso

At Injury Medical Clinic PA in El Paso, Texas, care follows an evidence-based model. Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, provides chiropractic care, functional medicine insight, personal-injury evaluation, and rehabilitation planning. Clinical observations from practice show that biologics work best when biomechanics are optimized and when metabolic factors—such as vitamin D status, inflammation control, and nutrition—are addressed. Patients who follow progressive loading and correct movement patterns tend to show steadier, longer-lasting gains.

Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933), with over 40 years of experience as an internist, works with Dr. Alex Jimenez, DC, and serves as the Medical Director and Collaborative Physician at his practice, Injury Medical Clinic PA, in El Paso, Texas. This is a multidisciplinary setup common in integrative or injury care clinics, where an MD provides medical direction alongside a chiropractor.

The team integrates chiropractic care (Dr. Jimenez) with medical oversight by Dr. Cardenas (internal medicine), as well as functional medicine, personal injury care, rehabilitation, and related services. This collaboration allows careful patient selection, imaging when needed, and monitoring of overall health factors that influence healing.

What the Recovery Journey Looks Like

A typical course begins with a full evaluation of the injury, movement patterns, and health history. If PRF or PRP is appropriate, the injection is performed under guidance. A short rest follows, then movement is gradually reintroduced. Chiropractic adjustments and soft-tissue work address surrounding restrictions. Rehabilitation exercises progress from simple range-of-motion and activation drills to strength and sport-specific tasks.

Most people notice early changes in pain and swelling over weeks. Tissue quality and function continue to improve over months as the scaffold does its work and controlled loading strengthens the repair. Return-to-activity decisions are based on strength, control, and absence of pain rather than a fixed calendar. Consistent follow-through with the full plan—biologic treatment plus mechanical correction plus progressive exercise—supports the best chance of durable recovery.

Bringing the Pieces Together

PRP and especially PRF concentrate the body’s own healing signals and deliver them exactly where they are needed. PRF’s gel scaffold keeps those signals working longer and provides physical support for new tissue. When this biological tool is combined with integrative chiropractic care that restores proper joint motion and movement patterns, the result is a dual strategy: cellular repair plus mechanical balance. Multidisciplinary teams that include medical oversight and chiropractic expertise help patients move through the process safely and systematically. For many people dealing with stubborn sports injuries, this combination provides a practical, non-surgical route toward stronger tissue and better function.

El Paso, TX Best Chiropractor Skateboarding Injury Treatment

References

Yale Medicine. (n.d.). Platelet-rich plasma (PRP) injections.

Johns Hopkins Medicine. (n.d.). Platelet-rich plasma (PRP) treatment.

Amira Health. (n.d.). PRF vs PRP: Advancing the future of natural healing.

Jimenez, A. (n.d.). PRP and chiropractic for faster injury recovery explained.

El Paso Chiropractor Blog. (2026). Regenerative medicine and chiropractic care in El Paso.

Health Coach Clinic. (n.d.). Chiropractic and regenerative medicine enhances healing.

Comparison of outcomes in application of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in medial collateral ligament recovery. (2025). PMC.

Evolution and clinical advances of platelet-rich fibrin in musculoskeletal regeneration. (n.d.). PMC.

Platelet-rich plasma for sports-related muscle, tendon and ligament injuries: An umbrella review. (2019). PMC.

Dr. Alex Jimenez. (n.d.). Clinical observations and practice focus.